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Abstract 
The Polycomb group protein Bmi1 is a key transcriptional regulator of self renewal 
of embryonic and adult neural stem and progenitor cells (NSPC) and its over-
expression has been shown to occur in several types of brain tumour. In a 
Cre/LoxP-based conditional transgenic mouse model we show that fine-tuning of 
Bmi1 expression in embryonic NSPC is sufficient to increase their proliferation and 
self renewal potential in vitro. This is linked to downregulation of both the 
ink4a/ARF and the p21/Foxg1 axes. However, sustained over-expression of Bmi1 in 
differentiating progenitor cells leads to increased apoptosis of neuronal progenitor 
cells. Moreover, neurospheres derived from Bmi1 over-expressing NSPC contain 
more cells positive for glial markers such as NG2 and A2B5. Postnatally, however, 
increased self renewal capacity of NSPC is independent of Foxg1 and resistance to 
apoptosis is observed in neural progenitors derived from NSPC over-expressing 
Bmi1. No neoplastic transformation is seen in mice over-expressing Bmi1 in the 
SVZ stem cell compartment of transgenic mice (NestinCre;STOPFloxBmi1) aged up 
to 20 months. These studies provide strong evidence that fine tuning of Bmi1 ex-
pression is a viable tool to increase self renewal capacity of neural stem cells in vi-
tro and that it does not elicit neoplastic transformation of these cells. However, 
activation of Bmi1 over-expression in the postnatal SVZ concomitantly with inacti-
vation of p53, a common predisposing mutation to glial tumour development, 
leads to formation of low grade glioma in these mice. These data raise the possibil-
ity that genetic collaboration between Bmi1 and p53 may be a key event in the 
pathogenesis of low grade glial tumours. 
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Chapter 1— Introduction  
1.1 Neural stem cells in the developing and postnatal mammalian brain 
The peripheral and central nervous system (PNS and CNS respectively) arises from 
the neural plate, a sheet of cells, which originates from the ectoderm: one of the 
three structural primitive layers forming at gastrulation. Folding of the neural 
plate, through neurulation, transforms it into a tubular structure called the neural 
tube that has neural epithelial lining. The rostral part of neural epithelium forms 
the three brain vesicles (the forebrain (prosencephalon), midbrain and hindbrain). 
The forebrain vesicle gives rise to telencephalon and is related to the lateral ven-
tricles; both regions are of interest to this study as the lining of the latter hold a 
particular subset of neuroepithelial cells, which act neural stem cells (NSC) during 
the embryonic development of the brain and will give rise cells with similar proper-
ties in the postnatal/adult brain (Merkle and Alvarez-Buylla, 2006, Corbin et al., 
2008). During embryonic cortical development, a primary proliferative zone called 
the ventricular zone (VZ) forms from the neuroepithelium and it is composed of 
radial glia cells (RG- see discussion below). A second proliferative zone called the 
subventricular zone (SVZ), which contains prenatal and postnatal NSC (see discus-
sion below), emerges from the VZ during late embryonic development (Levison 
and Goldman, 1997).   
1.1.1 From neuroepithelium to radial glial cells with stem cell capacity  
Development of mammalian brain entails generation of billions of neurons and 
many more of glial cells from just a few neuroepithelial cells, which form the neu-
roepithelium. Neuroepithelium, a single layer of cells, appears pseudostratified as 
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nuclei of neuroepithelial cells migrate up and down the basal-apical axis during a 
special kind of cell cyle termed interkinetic nuclear migration (INM), a property 
shared by radial glial (RG) cells and to a limited extend by basal progenitors 
(Takahashi et al., 1993, Gotz and Huttner, 2005). Neuroepithelial cells undergo 
symmetric cell divisions to expand progenitor pools before the onset of neuro-
genesis (Knoblich, 2008). They do this by INM, a process that spans the entire api-
cal-basal axis in neuroepithelial cells: in G1 phase of the cell cycle, the nucleus mi-
grates to the basal side and stays there during S phase; during G2 phase, however, 
nucleus migrates back to apical side where mitosis occurs (Takahashi et al., 1993, 
Gotz and Huttner, 2005). At embryonic day (E) 9-10 in mice, the neuroepithelial 
cells divide symmetrically to generate more neuroepithelial cells with the same 
developmental properties but also asymmetrically to give rise to two cells with dif-
ferent developmental properties, one of them acts as a potential source of neu-
rons at this stage, though this is not supported by experimental data (Figure 1.1) 
(Kriegstein and Alvarez-Buylla, 2009). However, neuroepithelial cell transition to 
asymmetric divisions is associated with changes in their cellular identity. Indeed, 
with the onset and during the period of neurogenesis (from E14.5 to E16.5 in mice) 
neuroepithelial cells begins to acquire morphological and gene expression features 
generally associated with glial cells such as those found in the adult brain that have 
specialized functions and progenitor capacity (Merkle and Alvarez-Buylla, 2006, 
Conti and Cattaneo, 2010). These changes are associated with their transformation 
into Radial Glial (RG) cells. Also RG cells undergo asymmetrical and symmetrical 
mitotic divisions. The former kind of mitotic divisions leads to generation of inter-
mediate progenitors (neurogenic progenitor cells, nIPCs; or oligodendrocytic pro-
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genitor cells, oIPCs) that later terminally differentiate into neurons or oligodendro-
cytes (Figure1.1). On the other hand, symmetrical divisions increase the population 
of RG cells in the VZ (Figure1.1). Interestingly, INM is retained by RG cells though 
nuclear migration is confined to the portion of the cell in the VZ, where new neural 
progenitors and neurons are produced. 
 Moreover, the determinants of symmetric vs asymmetric divisions of RG cells 
have been implicated in regulation of their maintenance, cellular identity and 
products. For example, activation of Notch signalling promotes RG cell mainte-
nance and identity, whereas its inactivation by mutations in Notch effector genes 
Hes1, Hes3 and Hes5 leads to premature neuronal differentiation and even deple-
tion from most CNS regions (Hatakeyama et al., 2004).  Moreover, inactivation of 
Notch signalling through conditional disruption of Mindbomb1 (Mib1), a ubiquitin 
involved in endocytosis, leads to symmetric differentiation, whereby either two 
neurons or basal progenitors are produced and depletion of RG cells reached pre-
maturely (Yoon et al., 2008). Furthermore, RG cell spindle orientation has also 
been shown to be important for daughter cell fate determination: indeed, disrup-
tion of heterotrimeric G proteins or depletion of their binding partners/activators 
AGS-3, results in hyperdifferentiation of RG cells into neurons (Sanada and Tsai, 
2005). In a recent study by Itaru Imayoshi et al., (2010), inactivation of Notch sig-
nalling by conditional deletion of Rbpj, an intracellular signal mediator of all Notch 
receptors, results in complete loss of RG cells in telencephalon (Imayoshi et al., 
2010).  
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During these processes — neurogenesis and gliogenesis— that initiates a progres-
sive thickening of the cortex, RG cell bodies remain in the VZ whereas their proc-
esses remain in contact with both pial and ventricular surfaces (Gadisseux and 
Evrard, 1985). These RG cell morphological changes are accompanied by acquisi-
tion of the expression of astroglial markers such as the glial fibrillary acidic protein 
(GFAP), astrocyte-specific glutamate transporter (GLAST) and the brain lipid-
binding protein (BLBP); and intermediate filament proteins such as nestin, 
vimentin, the RC1 and RC2 epitopes (Choi and Lapham, 1978, Choi, 1988, Campbell 
and Gotz, 2002, Mori et al., 2005, Kriegstein and Alvarez-Buylla, 2009). In parallel, 
the tight junctional complexes between the neuroepithelial cells are replaced with 
adherence junctions (Aaku-Saraste et al., 1997, Stoykova et al., 1997). Moreover, 
the neuroepithelial cells start to make contact with endothelial cells of the devel-
oping vasculature, in a manner similar to those of astrocytes with progenitor ca-
pacity (Takahashi et al., 1990, Mission et al., 1991). These are the landmark 
changes that underline the transition of epithelial cells into RG cells, which are the 
precursors for both neuronal and glial cells, with specialized and progenitor capac-
ity, of the CNS (Anthony et al., 2004, Gotz and Huttner, 2005). Their capacity to 
generate all cell types of the brain was experimentally shown in a Cre/LoxP fate 
mapping experiment driven by promoter of BLBP, a protein expressed by RG cells 
throughout the developing brain (Hartfuss et al., 2001), where neurons, interneu-
rons and glial cells (with progenitor capacity) were labelled (Anthony et al., 2004) 
in keeping with a RG origin. 
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Fig. 1.1 Transformation of neuroepithelial cells into embryonic and postnatal neural 
stem cells through generation and expansion of further layers such as VZ, SVZ and 
MA: Symmetrically dividing neuroepithelial cells generate more neuroepithelial cells 
and expand the epithelium. In parallel, the elongating neuroepithelial cells convert into 
radial glial (RG) cell, the neural stem cells of the embryonic stage of development. RG 
divide symmetrically and asymmetrically, give rise to neurons and oligodendrocytes 
through generation of intermediate progenitors (nIPC and oIPC). At the end of embry-
onic development some RG cells convert into astrocytes. Further, some RG cells con-
vert into adult astrocytes  that migrate into SVZ, where they reside in adult brain as 
adult neural stem cells (termed B cells in rodents), which continue to generate neurons 
and oligodendrocytes. This illustration was adapted from Kriegstain A., Alvarez-Buylla 
A. (2009) as it depicts well what is known about stem cells of the developing and adult 
brain, and puts in context and provides a framework to understand the developmental 
stages chosen to study compare and contrast neural stem cells in this study.  
VZ, ventricular zone; SVZ, subventricular zone; MA, mantle; nIPC, neurogenic progeni-
tor cell; oIPC, oligodendrocytic progenitor cell. 
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In vitro, however, a population of RG cells can easily generate all three major types 
of brain cells (neurons, oligodendrocytes and astrocytes), when allowed to differ-
entiate, though only rarely can a single RG cell differentiate in all three cell types 
(Luskin et al., 1988, Qian et al., 2000). Moreover, the self-renewing RG cells of the 
VZ can give rise to IPCs that have no apical endfeet and ascending processes (Gotz 
and Huttner, 2005). Together these features; self-renewal capacity, generation of 
committed progenitors, and ability to differentiate into multiple cell types, suggest 
that RG cells act as the stem cells of the VZ.   
1.1.2 Neural stem cells in the postnatal mammalian brain  
In the last few years our view of the regenerative capacity of the adult mammalian 
brain has changed considerably. The traditional way of perceiving the adult brain 
as a static organ composed of postmitotic, fully differentiated cells has been chal-
lenged and several pivotal studies have shown how neurogenesis is retained dur-
ing adult life, therefore conferring a certain degree of plasticity to the adult CNS.  
Although, few reports in the 1960s (Messier et al., 1958, Smart, 1961, Altman and 
Das, 1965) described mitotic activity and neurogenesis in the postnatal rodent 
brain, it has only recently been convincingly shown by seminal work of Luskin 
(Luskin, 1993) in rats and Lois and Alvarez-Buylla (Lois and Alvarez-Buylla, 1993) in 
mice, that neurogenesis occurs in the adult rodent SVZ. 
Stem cells in several distinct anatomical brain regions persist throughout the life 
time of an organism. In the postnatal brain, multipotent stem cells are found not 
only in lateral walls of the lateral ventricles (SVZ) but also in the dentate gyrus of 
the hippocampus (subgranular zone, SGZ), between the hippocampus and the cor-
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pus callosum (subcallosal zone, SCZ), and lastly at the boundary between internal 
granular layer (IGL) and white matter in the cerebellum (Doetsch et al., 1999a, Seri 
et al., 2001, Alvarez-Buylla et al., 2002, Lee et al., 2005, Seri et al., 2006). Doetsch F 
(1999) and co-workers has shown that murine SVZ astrocytes act as NSC (they pro-
liferate and re-populate olfactory bulb neurons in vivo and differentiate into glia 
and neurons in vitro) during normal cell turnover in the adult brain and in response 
to injury  (Doetsch et al., 1999a). Similar observations were noted for a subset of 
GFAP positive astrocytes located in the SGZ, where they proliferate and give rise to 
immature neurons (DCX+, PSA-, and NCAM+) in vivo (Seri et al., 2001, Ming and 
Song, 2005). Moreover, a further subset of Sox2 positive SGZ cells, termed slowly 
proliferating NSC, has been shown to generate more rapidly dividing intermediate 
progenitor cells that generate migratory neuroblasts, which, in turn, differentiates 
into dentate gyrus granule neurons (Seri et al., 2004, Johnston and Lim, 2010). 
However, some controversies still exist concerning the “stem cell” nature and the 
precise location of NSC of the SCZ and cerebellum. The self-renewal capacity of SCZ 
cells seems rather limited according to the experimental data available to date 
(Seri et al., 2006): they form multipotent neurospheres in vitro and contribute to 
oligodendrocyte population in the corpus callosum in vivo. In the cerebellum, 
CD133+ cells from P7 mice have been shown to fullfill all criteria of NSC but only in 
vitro (Seri et al., 2001, Lee et al., 2005).  
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1.1.3 Neural stem cells in the SVZ 
In the SVZ of the adult mammalian nervous system, NSC are termed  B cells and 
they  give rise to neurons, oligodendrocytes and astrocytes through generation of 
more committed transiently amplifying intermediate progenitors (termed C cells in 
the SVZ) (Figure 1.2; adapted from  (Zhao et al., 2008)), (Alvarez-Buylla and Garcia-
Verdugo, 2002, Sutter et al., 2007). During the process of neurogenesis in adult 
SVZ, type C cells give rise to neuroblasts (type A cells) that migrate tangentially 
through the rostral migratory stream to olfactory bulb, where they terminally dif-
ferentiate into interneurons; granule and periglomerular neurons (Figure 1.2).  
 
A landmark study by Doetsch et al., 1997 has constructed a topological model for 
adult SVZ that enabled positive identification of not only type B cells but also C and 
Fig. 1.2: Location, structure and function of adult subventricular zone 
in mice: The SVZ is separated from the lateral ventricle by the 
ependymal (E) cell lining. Mouse SVZ cells, located in the lateral wall of 
the lateral ventricles, are depicted as B (stem cells), C (intermediate 
progenitors) and A (migratory neuroblasts) cells. Neuroblasts form the 
rostral migratory stream (RMS) and migrate to the olfactory bulb (OB) 
where they terminally differentiate into interneurons. Adapted from 
Zhao et al., 2008. 
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A cells (Doetsch et al., 1997). F. Doetsch and co-workers have found that A cells 
(positive for PSA-NCAM, TuJ1 and nestin but negative for GFAP and vimentin) were 
ensheathed by B cells that are positive for GFAP and vimentin, whereas the type C 
cells (positive for nestin and Dlx2 (Doetsch et al., 2002) but negative for other 
markers) formed focal clusters closely associated with A cells. 
Several reports have conclusively shown that the postnatal SVZ NSC have an astro-
cytic nature and are neurogenic. This was shown by Doetsch et al., 1999: mice 
were treated with cytosine-β-D-arabinofuranoside (Ara-C) for six days, a treatment 
that kills actively dividing type C and A cells but spares the quiescent type B cells. 
These cells were then activated and gave rise to C cells, which in turn differenti-
ated into neuroblasts that repopulate the olfactory bulb interneuron compartment 
(Doetsch et al., 1999a). The same authors have also shown that GFAP positive SVZ 
astrocytes can act as the stem cells under normal conditions. Here a transgenic 
mice (GFAP-tva), engineered to express the receptor (AP) for a replication-
competent avian leukosis (RACS) retrovirus in SVZ astroglial cells (and their prog-
eny) under the control of GFAP promoter (Holland and Varmus 1998), was used to 
label mitotically active GFAP-positive cells and follow their progeny (AP positive) in 
the brain. Indeed, the authors found that AP positive and GFAP expressing astro-
cytes give rise to AP positive type C cells and migrating neuroblasts in the RMS, 
and finally olfactory bulb interneurons (Doetsch et al., 1999a). These findings sug-
gest that the self-renewing and multipotent neural stem cells of the SVZ express 
GFAP and are part of a population of cells classically viewed as differentiated as-
trocytes.  
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A particularly crucial issue in stem cell research is the positive identification of 
stem cells in vivo. The most commonly used markers for identification and charac-
terisation of type B NSC of the SVZ are GFAP, Musashi, Nestin, PDGFR-α and CD133 
(Jackson and Alvarez-Buylla, 2008). These markers have contributed significantly to 
the characterisation of the anatomical location of these cells, however, they are by 
no means specific and there is no single marker available to identify adult SVZ 
stem cells.  
1.1.4 Neural stem and progenitor cells in vitro 
In culture, NSC can be maintained and expanded in non-adherent  serum free cul-
turing conditions  supplemented with epidermal growth factor (EGF) and basic fi-
broblast growth factor (bFGF-2 (Reynolds and Weiss, 1992). Under these condi-
tions, they form three-dimensional spatially distinct free-floating spheres termed 
neurospheres (NS), which can be subcloned several times upon dissociation. Con-
versely, they begin to differentiate upon addition of serum and withdrawal of mi-
togens (Reynolds and Weiss, 1992) and give rise  to all main cell types of the adult 
brain, oligodendrocytes (10-20%), neurons (20-30%), and astrocytes (60-70%) 
(Ferron et al., 2007). These assays are widely used to study the biological functions 
of NSC; the former method is used to asses their self-renewal capacity, whereas 
the latter their multipotency.  
Recent findings have challenged the classical view that only SVZ type B cells can 
form multipotent neurospheres under in vitro conditions. A study by Doetsch et 
al., 2002 showed that when the Dlx-2 positive transit-amplifying type C cells are 
treated with EGF, they can form multipotent neurospheres in vitro (Doetsch et al., 
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2002). Similarly, stimulation of oligodendrocyte precursor cells with growth factors 
transforms them into multipotent neurosphere forming cells (Kondo and Raff 
2000). It seems therefore more appropriate to define NS forming cells as NSPC.  
In addition, some studies have shown that NS cannot be considered clonal entities; 
in fact, they are motile and can merge with each other, leading to misinterpreta-
tion of the relationship between frequency of stem cells and NS in culture (Singec 
et al., 2006, Ferron et al., 2007). Recently, Louis and co-workers (Louis et al., 2008) 
have developed a new method that could address the problem of frequency of NSs 
and their relationship to number of NSPC in vitro. The method, named neural col-
ony-forming cell assay (NCFCA), makes use of the extended proliferative potential 
of stem cells (which is rather limited in progenitors) to enrich for NSPC. In the 
NCFCA, high density NSPC are cultured in a collagen-based serum-free medium 
which inhibits cell migration and aggregation but promotes the formation of clonal 
colonies of variable sizes. Colonies >2 mm in diameter could generate neurons, 
astrocytes and oligodendrocytes upon differentiation and were, therefore, most 
likely originating from a single NSPC (Louis et al., 2008). 
Adherent and niche-independent cultures of NSC have also been established: 
Here, neurospheres are plated on gelatin-coated dishes and cultured in the pres-
ence of EGF and FGF-2 until bipolar cells expressing Nestin and RC2 are identified. 
This homogeneous population of cells can be maintained in an undifferentiated 
state or induced to differentiate, and are potentially synonymous with the NSC 
component of neurospheres (Conti et al., 2005). This system has the advantage of 
allowing considerable expansion of a large quantity of these cells, which can be 
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rather relevant for purposes of regenerative medicine, where they have to be gen-
erated to test their contribution to brain repair.  
Furthermore, adherent cultures of NSCs provide a homogeneous population of 
stem cells which can facilitate expression analysis and produce less variable results 
across laboratories (Conti et al., 2005). However, it has been reported that pro-
longed culture of NSC in FGF-2 with the adherent method leads to loss of ability to 
differentiate into neurons, despite lack of evidence of genetic transformation 
(Qian et al., 2000, Corti et al., 2007). The NS assay and the NCFCA have the advan-
tage of providing a more physiological environment, with a mixture of cells at vari-
ous stages of differentiation, and this might be more appropriate for functional 
studies of NSC properties, such as self-renewal, proliferation, differentiation and 
survival. 
1.1.5 Functional properties of NSC in vitro 
During embryonic development and in adult life, the mammalian brain contains 
spatiotemporally defined, self-renewing and multipotent populations of neural 
stem/progenitor cells (NSPC), which generate neurons and glia cells of the devel-
oping brain and account for the limited regenerative potential of the adult brain 
respectively.  Although different in their cellular and molecular characteristics, 
embryonic and postnatal NSPC share the peculiar role of maintaining a balance 
between self-renewal, where symmetrical cell divisions give rise to cells with equal 
developmental potential, and differentiation, where asymmetrical divisions pro-
duce fate-committed progeny, which terminally differentiate into the different 
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cells of the brain  (Gage 2000; Temple 2001; Alvarez-Buylla and Lim 2004; Shen et 
al., 2004; Shen et al.,  2008). 
Much of our current understanding of biological, antigenic and functional proper-
ties of NSPC is derived from a combination of in vivo developmental and lineage 
tracing studies, and extensive use of a variety of in vitro assays. In particular the 
development of growth-factor-based (EGF and FGF2) protocols (Reynolds and 
Weiss 1992; Reynolds et al. 1992) for expansion and long term propagation of 
NSPC in vitro either as neurospheres or as adherent monolayer (Pollard et al., 
2006) have provided relatively simple, reproducible, fast and robust systems to 
study their biological and functional properties in vitro (Conti and Cattaneo 2010). 
Study of functional properties of NSPC in vitro is particularly significant especially 
because of a general lack of specific cell surface markers and/or distinct morpho-
logical properties to identify them in vivo (Louis et al., 2008).   
Moreover, studies have shown (Foroni et al., 2007; Goffredo et al., 2008; Sun et 
al., 2008) that exposure to growth factors and serial passages do not significantly 
alter antigenic and biological properties of NSPC as they still exhibit cardinal stem 
cell features such as self-renewal over a long period of time and multilineage dif-
ferentiation. However, other studies have casted doubts on the physiological rele-
vance of NSPC cultured in a synthetic in vitro milieu and alterations in their spatial 
identity, differentiation potential as well as genetic and epigenetic statuses have 
been described (Gage 2000; Hitoshi et al., 2002; Gabay et al., 2003; Smith et al., 
2003; Pollard et al., 2008). 
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In summary, although with all limitations of an in vitro system, these assays are 
useful; a) to provide a starting point for understanding physiologically relevant fea-
tures of NSPC in a simplified context, b) to allow to expand these cells to obtain a 
large amount of material to enable biochemical and genetic studies c) to allow 
analysis of phenotypic changes upon genetic manipulation by delivery of siRNA or 
over-expression vectors and/or upon application of pharmacological agents or re-
combinant proteins, d) to provide a stable and reproducible system to study bio-
logical functions of NSPC obtained from genetically modified animals.       
Self-renewal: The ability of NSPC to generate daughter cells with equal develop-
mental potential, through mitotic cell divisions, over a long period of time is de-
fined as self-renewal capacity, which can be measured by several assays. In cul-
ture, NSPC  can be maintained and expanded in non-adherent  serum free cultur-
ing conditions supplemented with epidermal growth factor (EGF) and basic fibro-
blast growth factor (bFGF-2) (Reynolds and Weiss, 1992). Under these conditions 
they give rise to three dimensional floating round cell clusters, named neuro-
spheres, the formation of which is currently used as indication of stem cell prop-
erty of the cultured cells (Deleyrolle and Reynolds 2009). When neurospheres are 
subcloned (that is dissociated and re-plated) only mitogen responsive NSPC will 
give rise to new neurospheres, while the majority of differentiated cells, which are 
also contained in the neurospheres, will die off (Reynolds and Rietze 2005). 
Apoptosis: Apoptosis is defined as an irreversible, programmed process of 
autonomous cell death that does not elicit inflammation (Fink and Cookson, 2005). 
Indeed, apoptosis plays an important role in development, disease and tissue ho-
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meostasis. A considerable number of studies have sought details of processes of 
cell death and apoptosis in neurospheres (Bez et al., 2003, Milosevic et al., 2004). 
Some of the mechanisms associated with initiation and execution of apoptosis in-
clude externalisation of phosphatidylserine proteins, activation of caspases that 
have proteolytic activity, expression of pro-apoptotic genes such as Bak, Bad and 
Blc-10 (Cory and Adams, 2002, Kang et al., 2002, Rai et al., 2005, Elmore, 2007). 
These and other genetic and biochemical changes eventually lead cells to apop-
tosis. It has been previously reported that neurospheres and neurosphere-forming 
cells undergo apoptosis in vitro and in vivo (Maric et al., 2007, Galvin et al., 2008). 
Details of the mechanisms and determination of the rate of apoptosis in NSPC and 
neurospheres can be studied with various assays based on different methodolo-
gies. Some of these are; a) TUNEL (Terminal dUTP Nick End-Labeling) method 
based on enzymatic labelling of DNA strand breaks, b) TEM (transmission electron 
microscopy) to visualise specific ultrastructural morphological characteristics, c) 
Immunohistochemistry or western blotting for detection of procaspases and active 
caspases, d) Fluorescent labelled Annexin V to detect phosphatidylserine residues 
on the outer membrane of cells (Kressel and Groscurth, 1994, Vermes et al., 1995, 
Gurtu et al., 1997, Bossy-Wetzel and Green, 2000, White and Cinti, 2004).  
Differentiation: Neurospheres are morphologically and functionally heterogene-
ous structures; in fact they not only contain self-renewing NSPC (ca. 1-10% of the 
total number of cells) but also committed glial and neuronal progenitors as well as 
more differentiated cells and dead cells. Upon plating onto laminin-coated surface 
and withdrawal of growth factors, neurospheres attach to the substrate and cells 
start migrating radially from the NS body toward the periphery while they differen-
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tiate into neurons (20-30%), astrocytes (60-70%) and oligodendrocytes (10-15%) 
(Doetsch et al., 1999a, Singec et al., 2006). It has been previously reported that as 
NSPC differentiate nestin expression is downregulated and expression of distinct 
neuronal and glial markers such as βIII-tubulin, GFAP and O4 is activated (McKay, 
1997).  
The greatest hurdle with in vitro studies of NSPC differentiation has been the iden-
tification of substrates and culture conditions that are permissive to maintenance 
of differentiation properties similar to those in vivo. Indeed, the neurogenic versus 
gliogenic potential of NSPC declines with the number of in vitro passages. Various 
differentiation methods based on combination of factors such as removal of mito-
gens (EGF and FGF) and exposure to foetal bovine serum and/or specific substrates 
and cytokines have been developed to counteract this effect (Tropepe et al., 1999, 
Garcion et al., 2004, Chojnacki and Weiss, 2008).  Yet, none of these methods have 
succeeded in achieving/preserving a percentage of neuronal differentiation 
greater than 20 percent of the population (Conti and Cattaneo, 2010). This dis-
crepancy may be due to the differences between structural organisation of neuro-
spheres compared with in vivo NSPC niches such as SVZ, which provides heteroge-
neity alongside spatial organization, specific cell-cell interactions, proximity to 
blood vessels and exposure to a plethora of cues that are absent from neuro-
spheres (Conti et al., 2005, Nelson et al., 2008). Despite these differences inherent 
to the culture conditions, differentiation of NS is a useful assay to study both mul-
tipotency and differentiation properties of NSPC cells in a simplified in vitro con-
text. 
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1.2  Molecular mechanisms controlling self renewal and differentiation of 
neural stem cells   
Several signalling pathways have been shown to be involved in regulation of self-
renewal and differentiation of embryonic, neonatal and adult NSPC, and not sur-
prisingly some of these very same pathways have also been found aberrantly ac-
tive in brain tumourigenesis. It is beyond the scope of this introduction to provide 
a comprehensive description of all signalling pathways involved in self-renewal and 
differentiation of NSC. Instead I will only focus on those pathways which are re-
lated to a) Bmi1 signaling pathway, or b) self-renewal and differentiation of fore-
brain NSC, particularly in mice, and c) transformation of normal NSC into BTSC.  
1.2.1 Sonic hedgehog 
In mammals, three secreted Hedgehog ligands (Sonic, Indian and Desert Hedge-
hog: Shh, Ihh, Dhh) have been identified. In the absence of these glycoproteins, 
the receptor Patched (Ptch) inhibits the activity of the transmembrane protein 
Smoothened (Smo). Upon binding of Shh with Ptch, inhibition of Smo is relieved, 
which in turn initiates a signalling cascade that results in dissociation of the tran-
scription factors Gli1-3 from a multiprotein complex, the main components of 
which are a serine/threonine protein kinase, Fused (Fu), Suppressor of Fused 
(SuFu) and Protein Kinase A (PKA), anchored to the cytoskeleton (Taipale and 
Beachy, 2001). Activated Gli proteins are translocated into the nucleus (see sche-
matic representation in Figure 1.3) and promote the transcription of genes, includ-
ing cell cycle regulators (cyclin D1, cyclin E, Myc, N-myc) and growth factors and 
their receptors (PDGF- /PDGFR, EGF/EGFR) (Pasca di Magliano and Hebrok, 2003, 
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Sanai et al., 2005, Sutter et al., 2007, Yadirgi and Marino, 2009). Shh has been 
shown to regulate self-renewal of NSCs in the SVZ and SGZ during late embryonic 
development (Ahn and Joyner, 2005) and postnatal life (Machold et al., 2003, 
Palma et al., 2005). Indeed, Gli1 is expressed by both GFAP-positive NSC (B cells) 
and GFAP-negative precursor cells (C cells) of the SVZ (Palma et al., 2005).   
 
Fig. 1.3 Schematic representations of the main signalling pathways in-
volved in the regulation of self-renewal and differentiation of NSPC 
(adapted from Yadirgi and Marino, 2009): effectors of these pathways, as 
expanded in the text below, include Bmi1, Shh, Wnt, BMPs, Notch, MAPKs, 
PI3K and PTEN.   
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These cells responded to endogenous Shh by increasing their proliferation, as as-
sessed by BrdU incorporation in vivo, and self-renewal, as assessed by secondary 
neurosphere formation. Moreover, migrating neuroblasts in the SVZ and rostral 
migratory stream (RMS) express Ptch, and Shh has been shown to exert a 
chemoattractive activity on SVZ-derived neuronal progenitors in vitro, an effect 
blocked by the Smoothened antagonist named Cur61414. 
Furthermore, experiments involving adenoviral transfer of Shh into the lateral ven-
tricle or conversely Shh-blockade with physiological antagonist or neutralizing an-
tibodies in the SVZ of adult mice, provided in vivo evidence that Shh can retain 
SVZ-derived neuroblasts (Angot et al., 2008). A recent paper of the group of Alva-
rez-Buylla has shown that Shh is also essential for expanding the pool of granule 
neuron precursors in the SGZ to establish the adult stem cell population, and that 
this function of Shh is dependent on the integrity of the primary cilia located on 
the surface of both embryonic and postnatal NSC (Huangfu and Anderson, 2005, 
Han et al., 2008). A study by Machold et al., 2003 has shown that conditional abla-
tion of Smo in nestin expressing NSPC, by using a NestinCre or an inducible Nestin-
CreERT2, results in postnatal depletion of SVZ B and C cells (Machold et al., 2003).  
Interestingly, Shh-Gli signalling is also required for sustained glioma growth and 
survival, and to regulate self-renewal in CD133+ glioma stem cells (Clement et al., 
2007). Furthermore, activation of the EGF pathway is a well-known signature ge-
netic abnormality in high-grade gliomas (Ekstrand et al., 1991) and its recently de-
scribed synergistic activity with Shh in mediating increased proliferation of SVZ 
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cells (Palma et al., 2005) may provide a mechanism for understanding the forma-
tion of these tumours.   
1.2.2 Notch 
Notch signalling is initiated upon ligand (Delta-like 1-Delta-like 5) receptor 
(Notch1-Notch5) interactions between neighbouring cells, followed by a series of 
proteolytic events that results in nuclear translocation of the cleaved intracellular 
domain of Notch (NICD; see schematic representation in Figure 1.3). Upon associa-
tion of NICD with nuclear protein mastermind (MAM) and transcriptional repressor 
protein complex CLS (components of which are RBP-J , Suppressor of hairless and 
Lag-1) (Bray, 2006, Louvi and Artavanis-Tsakonas, 2006), activation of downstream 
transcriptional targets including the HES (hairy and enhancer of split paralogues) 
family genes Hes1 and Hes5, Hers1 and Hers2 and the recently identified brain 
lipid-binding protein (BLBP) is achieved (Jarriault et al., 1995, Hsieh et al., 1996, 
Anthony et al., 2005, Louvi and Artavanis-Tsakonas, 2006). 
The Notch signalling pathway is required for maintaining the pool of multipotent 
NSCs in the developing and adult mouse brain, as well as in inducing differentia-
tion of these cells (Tanigaki et al., 2001, Hitoshi et al., 2002, Nagao et al., 2007). 
Indeed, mice deficient for Notch1 or RBP-J , a component of the pathway, showed 
a severe depletion of NSCs (Hitoshi et al., 2002). Instead, NSCs could be obtained 
from embryonic stem cells deficient for RBP-J  (Hitoshi et al., 2002). Moreover, 
neurospheres derived from E 14.5 mice lacking Presenilin1, a gene encoding a key 
regulator in Notch signalling, exhibit a skewed differentiation pattern dominated 
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by neurons (MA2P+) and astrocytes (GFAP+). Complementing these findings, a re-
cent study by Androutsellis-Theotokis and colleagues (Androutsellis-Theotokis et 
al., 2006) showed that fetal NSCs exposed to Notch ligands retain their multipo-
tency and have better survival, possibly through activation of a survival cascade 
downstream of the insulin receptor, which promotes survival by activating the 
phosphatidylinositol-3-OH kinase PI(3)K and serine/threonine kinase Akt/PKB-
mediated cytoplasmic phosphorylation events. Furthermore, activated Notch sig-
nalling supplemented with FGF2 increases the ratio of proliferating cells in the SVZ 
of rats with cerebral cortical ischaemia, in addition to increased regenerative re-
sponse as measured by improved motor skills (Androutsellis-Theotokis et al., 2006, 
Sutter et al., 2007). 
Activation of the Notch signalling pathway has been highlighted in glial and em-
bryonal tumours (Pahlman et al., 2004, Purow et al., 2005, Fan et al., 2006). Of 
particular interest is the study of Fan et al., (2006) where pharmacological block-
ade of the Notch signalling pathway, through inhibitors of α-secretase, in medul-
loblastoma cell lines increased the frequency of differentiated and apoptotic cells 
but did not affect the growth potential of these cells. However, the ability of these 
cells to form tumour xenografts upon injection into mice was reduced and the 
number of CD133 positive neoplastic cells with stem-like characteristics was re-
duced, suggesting that Notch signaling is required for maintenance of BTSC in the 
tumour bulk (Fan et al., 2006). In keeping with these findings, Notch signalling en-
hances nestin expression in gliomas (Shih and Holland, 2006), possibly implying an 
increase in the BTSC component in these neoplasms. 
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Interestingly, Hes1was found to be a target of Sonic Hedgehog in mesodermal and 
neural stem cells and smoothened function was found to be necessary for the up-
regulation of Hes1 in response to Sonic Hedgehog. However, the mechanism did 
not require -secretase-mediated cleavage of Notch receptors and appeared to 
involve transcription factors other than RBP-J , therefore implying a regulation of 
Hes1 in stem cells independent of canonical Notch signaling (Ingram et al., 2008). 
1.2.3 PTEN and PI3K  
The phosphatase and tensin homologue deleted on chromosome 10 (PTEN) is a 
tumour suppressor gene which was shown to be commonly mutated/deleted in 
various malignancies including brain tumours such as glioblastoma (Li et al., 1997, 
Stiles et al., 2004).  
The lipid phosphatase PTEN exerts its effects on the biological processes of cell 
proliferation, cell growth, cell migration and cell death mainly by antagonising the 
PI3K signalling through dephosphorylating one of its products namely phosphoti-
dylinosital-3,4,5-triphosphate (PIP3) (Sun et al., 1999). Activated PI3K converts the 
plasma membrane lipid phosphotidylinosital-4,5-triphosphate (PIP2) into PIP3 on 
the inner surface of the membrane, which, in turn, recruits Akt/PKB to the plasma 
membrane and alters its conformation to allow subsequent phosphorylation and 
thus activation by phosphoinositide-dependent kinase-1 (PDK-1) (Vazquez and 
Sellers, 2000, Song et al., 2005). The downstream targets of Akt/PKB kinase include 
the cell cycle regulators MDM2, p27 and p21, proapoptotic factor BAD, caspases 3 
and 9, and finally the kinase GSK-3 to name but a few among many important for 
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cellular events (Stiles et al., 2004). Other signalling molecules activated by PIP3 in-
clude phosphotidylinositol-dependent kinases (PDKs), S6 kinases and mTOR, small 
GTPases Rac1 and Cdc42 (Vivanco and Sawyers, 2002).   
A study by Fan et al., 2009, has found that nuclear PTEN functions are mediated by 
ways other that its phosphatase activity, at least in prostate cancer cell lines such 
as DU145 (Fan et al., 2009). Interestingly, though, the study showed that BMI1 co-
localizes with nuclear PTEN in primary prostate cancer tissue and that this atte-
nuates BMI1 function and reciprocally increases PI3K activity (due to lack of its in-
hibition by PTEN) (Fan et al., 2009).  
Conditional deletion of PTEN in nestin-positive progenitor cells resulted in in-
creased cell proliferation, enlarged cell size and decreased cell death in the em-
bryonic ventricular zone of the telencephalon, leading to mice with enlarged and 
morphologically abnormal brains (Groszer et al., 2001). In these mice, PTEN defi-
ciency increased neural stem cell proliferation and self-renewal without disrupting 
their capacity to differentiate into the three lineages of neurons, astrocytes and 
oligodendrocytes (Groszer et al., 2001, Groszer et al., 2006). Further analysis has 
shown increased expression of cell cycle and DNA replication related genes such as 
cyclin B1, cyclin B2, cyclin D1, cyclin E1, Ki-67 and DNA primases in these cells. In-
terestingly, fewer PTEN null NSC were shown to be in the quiescent (G0/G1A) phase 
of the cell cycle compared with controls, suggesting that PTEN negatively regulates 
NSC self-renewal potential by modulating G0–G1 cell cycle entry (Groszer et al., 
2006).  
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1.2.4 MAPKs 
The mitogen-activated protein kinases (MAPKs) are a family of intracellular signal-
ing molecules that play an essential role in a wide variety of cellular processes in-
cluding survival, growth, proliferation, differentiation, maintenance and self-
renewal (Tibbles and Woodgett, 1999). In mammals, three members of the MAPK 
family have been identified: extracellular signal-regulated kinase (ERK, including 
ERK1/2 and ERK5), p38 (including p38α, p38β, p38γ, and p38δ), and c-Jun N-
terminal kinase (JNK, including JNK1, JNK2, and JNK3) (Widmann et al., 1999, 
Johnson and Lapadat, 2002, White et al., 2007). Activation of ERK, p38 and JNK by 
phosphorylation through MAPK kinases (MEKs or MKKs), which are activated by 
MAPK kinase kinases (MEKKs), initiates a signaling cascade that transduce extracel-
lular stimuli into intracellular responses of transcriptional and non-transcriptional 
cell function regulation (Hazzalin and Mahadevan, 2002). 
MAPKs play an important role in connecting changes in cell surface receptors, such 
as integrins, to intracellular signals that may be important for maintenance of stem 
cells. A previous study has shown that NSPC express a number of β1 integrins 
(Jacques et al., 1999). Recently, a study by Campos et al., 2004 has shown that ac-
tivation of MAPK signaling, through activation of β1 integrin by ECM molecules, is 
required for maintenance of NSPC as assessed by neurosphere formation assay 
(Campos et al., 2004). A recent study has suggested that a downstream target of 
MAPKs may regulate activity of PcG gene family members, particularly of Bmi1 
(Voncken et al., 2005). The study by Voncken et al., (2005) has shown that 3pK, 
also known as MAPK-activated protein kinase 3 (MAPKAPK3), acts as a kinase for 
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Bmi1 in vivo and in vitro and that phosphorylation of Bmi1 by 3pK leads to 
PcG/protein dissociation from chromatin and de-repression of the Ink4a/Arf locus; 
thereby leading to increased p14ARF expression.  
1.3 Role of PcG genes in the regulation of stem cell functions 
The first Polycomb group (PcG) proteins were identified in Drosophila (fruitfly) as 
repressors of Hox genes (a family of transcription factors that are expressed in se-
quence along the anterior-posterior axis and involved in determination of axial 
identity), through studies of mutant phenotypes that had extra sex combs (esc) on 
the second and third legs of males rather only on the first leg (Ringrose and Paro, 
2004). In vertebrates, too, Polycomb mutants exhibit posterior transformation of 
body segments, where the identity of one body segment is transformed into the 
identity of another (van der Lugt et al., 1994). Moreover, the PcG proteins have 
been shown to regulate other cellular processes such as cell cycle, cellular senes-
cence and actin polymerization (Guney and Sedivy, 2006, Martinez and Cavalli, 
2006). More recently, however, some of the PcG proteins have been shown to be 
involved in regulation of proliferation, self-renewal and differentiation of specific 
stem cell types, including neural stem cells. In the next section I will describe the 
current findings about mode of action of PcG proteins and their involvement in 
regulation of neural stem cell self-renewal, maintenance and differentiation, with 
particular attention to the role of Bmi1.   
1.3.1 PcG proteins are epigenetic regulators 
The term epigenetics is broadly used to describe mechanisms that regulate herita-
ble establishment and maintenance of transcriptional states and thus cellular iden-
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tity, beyond the primary DNA sequence of a genome. The gene expression profile 
of a single genome may therefore be altered allowing for cellular and functional 
diversity (Richards, 2006, Bernstein et al., 2007). 
In eukaryotic cells the genetic information is packed into chromosomes, which are 
composed of lower order structures called chromatins. In turn, chromatins are 
formed by folding of lower order structures termed core histones wrapped with 
DNA helix; viewed in a sequence forming a structure referred to as ‘beads-on-a-
string’ (Figure 1.4). Core histones have ‘tails’ with specific amino acid sequences 
that when modified alter chromatin accessibility, which has important conse-
quences for many cellular processes ranging from chromosome segregation to 
DNA repair and transcription (Sparmann and van Lohuizen, 2006).   
Two of the most studied epigenetic regulatory factors, PcG group and Trithorax 
group (TrxG), act antagonistically in epigenetic regulation of cellular processes, 
where the former represses and the latter promotes gene expression through 
regulation of specific amino acid modifications in histone tails (Fisher and 
Merkenschlager, 2002). Histone tails contain specific amino acid sequences that 
are targets of covalent modifications such as acetylation, phosphorylation, 
poly(ADP)-ribosylation, ubiquitylation and methylation (Figure 1.4). Whereas 
trimethylation of lysine 4 (H3K4me3) or acetylation of lysine 14 of histone H3 
(H3K14ac) are associated with actively transcribed regions, the H3K9me3 or 
H3K27me3 are indicative of repressed chromatin state (Strahl and Allis, 2000, 
Sparmann and van Lohuizen, 2006). 
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1.3.2 Polycomb Repressive Complexes and epigenetic modifications 
In the nucleosome, DNA helix complexes loop around core histones and form 
higher order organisation termed chromatin, which undergo dynamic structural 
changes ensuing modifications to specific sequences in histone tails (Fisher and 
Merkenschlager, 2002). Biochemical purification and functional genetic studies 
have assigned the PcG components into one of the two functionally distinct mul-
Fig. 1.4 Organisation of genetic information in eukaryotic cells is shown at 
various levels such as chromosomes, chromatin and histones: Epigenetic 
modifications to the N-terminal of histone tails influence chromatin accesibility 
to transcription factors that regulate gene expression.  The figure was taken 
from Anke Sparmann and Marteen van Lohuizen (2006) Nat. Rev. Cancer. 
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timeric complexes termed the Polycomb repressive complex 1 or 2 (PRC1 or PRC2) 
(van Lohuizen, 1998). The PCR2 consists of the mammalian homologues of the 
Drosophila melanogaster proteins and are named as EED, EZH1, EZH2 and SUZ12 in 
mice (Figure 1.5 for a full list of vertebrate PRC2 members). These core compo-
nents initiate gene repression mainly by trimethylation of lysine 27 and lysine 9 of 
H3 (H3K27me3 and H3K9me3, respectively). The core components of the PCR1 are 
CBX2, 4 and 8 (mammalian homologues of Drosophila melanogaster chromodo-
main component named Polycomb (PC)); EDR1, 2 and 3; BMI1, MEL18 and ZNF134, 
and can recognise the H3K27me3 mark at promoter regions of genes and other 
sites on the DNA (Figure 1.5 for a full list of vertebrate PRC1 members). Binding of 
the PRC1 complex to recognition sites maintains a repressive state of transcription. 
This simplified description of hierarchical gene silencing by way of “initiation” and 
“maintenance” is being challenged by recent studies that showed continuation of 
PcG group proteins mediated gene silencing even in absence of N-terminal histone 
tails and depletion of specific binding sites (Francis et al., 2004, Papp and Muller, 
2006). Nevertheless, maintenance of stable gene silencing involves monoubiquiti-
nation of H2A (H2Aub1) recognition site by PCR1. Interestingly the latter modifica-
tion is stimulated by Bmi-1, a component of the PRC1 (Buchwald et al., 2006).  To-
gether these alterations contribute to a repressive chromatin state, which is 
thought to be important for stem cell maintenance and differentiation.  
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1.3.3 PcG genes and NSC maintenance and differentiation 
Several recent studies have highlighted a significant role for PcG proteins in main-
tenance of cellular identity, self-renewal and differentiation of not only embryonic 
but also postnatal and adult stem cells. Mice deficient in various components of 
PcG proteins were shown to have defects in embryonic stem (ES) cells (O'Carroll et 
al., 2001, Boyer et al., 2006), NSC (Molofsky et al., 2003), cerebellar progenitors 
(Leung et al., 2004), haematopoietic stem cells (HSC) (Lessard et al., 1999, Park et 
al., 2003a, Kim et al., 2004), and neural crest cells (Molofsky et al., 2003).    
Fig. 1.5 Representation of vertebrate components, not necessarily found in 
all cell and tissues, of PRC1 (a) and PRC2 (b):  PRC1 components include Bmi1, 
Mel18, Phc1 (2 and 3), and Cbx2 (4, 6, 7 and 8) whereas PRC2 is composed of 
Ezh1 (and 2), Eed1 (2, 3, and 4). Diagram was adopted from Tom K. Kerppola 
Trends in Cell Biology 2009.   
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Much of our understanding of role of PcG genes in stem cells, and particularly of 
Bmi1, derives from knockout studies. For example, the study by Park I.K. and co-
workers (2003) has shown that proto-oncogene Bmi1 is expressed by fetal and 
adult mouse and adult human HSC. It was noted that the number of HSC in the fe-
tal liver of Bmi1 deficient mice was comparable to normal levels. However, in the 
postnatal mice the number of HSC was markedly reduced and transplantation of 
fetal bone marrow and liver cells obtained from Bmi1 deficient mice were unable 
to restore haematopoiesis. In terms of the changes in gene expression they noted 
over-expression of Bmi1 targets such as p16Ink4a and p19Arf (Park et al., 2003a). 
Other studies have shown that the role of Bmi1 in regulating haematopoiesis in 
mice changes in relation to its interactions with other PcG genes. A study showed 
that the self-renewal capacity of murine HSC is severely impaired in absence of 
PcG genes Rae28 and Bmi1, while increased proliferation of HSC was observed in 
Eed deficiency, and also in absence of both Eed and Bmi1 (Lessard et al., 1999). 
This study suggests that Bmi1 is epistatic to Eed in regulating HSC proliferation in 
mice. Interestingly, these changes were not associated with changes in gene ex-
pression of p16Ink4a and p19Arf, further suggesting that a hierarchical mode of 
action exists between components of PcG genes.  
ES cells can be maintained in culture in a pluripotent state, and are imbued with 
self-renewal and multilineage differentiation capacity. These two opposing proper-
ties require on one hand a tight regulation of transcriptional state to maintain self-
renewal and on the other flexibility to allow differentiation during development. 
To determine the possible role of PcG proteins in regulating these functions in 
mouse ES cells, several studies have looked at the location of PcG proteins on large 
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segments of genome (Boyer et al., 2006, Bracken et al., 2006). PcG protein binding 
sites were enriched for homeodomain-containing transcription factors of Dlx, Irx, 
Lhx and Pax gene families, which are involved in regulation of neurogenesis, 
haematopoiesis and axial patterning (Hombria and Lovegrove, 2003). Among the 
targets were also the genes encoding for components of signalling pathways 
(TGFβ, BMP, Wnt and FGF) that were previously shown to be required for mainte-
nance and proliferation as well as differentiation of various tissue stem cells, in-
cluding neural stem cells (Boyer et al., 2006, Bracken et al., 2007). With regards to 
differentiation of NSC during cortical development, it was shown that inactivation 
of PcG genes Ring1B or Ezh2 or Eed, which repress the promoter of the proneural 
gene neurogenin1, prolonged the neurogenic phase and delayed the onset of the 
astrogenic phase in mice (Hirabayashi et al., 2009).   
1.3.4 Bmi-1 and the ink4a/arf locus  
Bmi-1 (B cell-specific Moloney murine leukaemia virus integration site 1) is a 
member of the Polycomb group (PcG) gene family of chromatin modifiers and 
transcriptional repressors (van Lohuizen et al., 1991). The murine Bmi-1 gene is 
located in chromosome two; consists of ten exons and encodes for a nuclear pro-
tein of 324 amino acids that take a position of fourty five-fourty seven kilodalton 
(kD) on SDS-PAGE (sodium dodecyl sulphate polyacrylamide gel electrophoresis) 
(Haupt et al., 1991, van Lohuizen et al., 1991, Alkema et al., 1993). Low levels of 
Bmi-1 mRNA are ubiquitously expressed in all tissues but higher levels are particu-
larly detected in thymus, heart muscle, brain, testis, ES cells, embryonic and post-
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natal CNS and peripheral nervous system (PNS) NSC throughout life (van der Lugt 
et al., 1994, Molofsky et al., 2003).  
The recent observation that Bmi-1 is highly expressed in NSC and is necessary for 
their self-renewal in both adult peripheral nervous system (PNS) and CNS suggests 
that Bmi-1 signalling plays a major role in their maintenance (Molofsky et al., 
2003). Indeed, reduced proliferation of Bmi-1-deficient SVZ NSC (quiescent) leads 
to their postnatal depletion, albeit the proliferation of neural forebrain progenitors 
is unaffected (Molofsky et al., 2003). However, inactivation of Bmi1 impairs prolif-
eration of postnatal granule cell progenitors leading to depletion of granule neu-
rons and consequently to ataxia (van der Lugt et al., 1994, Leung et al., 2004). 
The best-characterized downstream mechanism of Bmi1 function is through inhibi-
tion of the tumour suppressor locus Ink4a/Arf (Figure 1.6) (Jacobs et al., 1999a, 
Bruggeman et al., 2005). The mouse Ink4a/Arf locus encodes for two protein 
products, p16ink4a and p19arf (p16INK4a and p14ARF in human), both of which are in-
volved in cell cycle regulation (Quelle et al., 1995, Sherr, 2001). In the absence of 
Bmi-1, both products of the Ink4a/Arf locus are highly expressed (Quelle et al., 
1995). During the G1 phase of the cell cycle, p16
ink4a directly inhibits cooperation of 
cyclin D1 and cyclin D-dependent kinases 4/6 (Cdk4/6), which, when unblocked, 
form a complex that phosphorylates retinoblastoma protein (pRB) (Figure 1.6) 
(Sharpless and DePinho, 1999). Phosphorylated RB is unable to suppress E2F tran-
scription factors (E2Fs), the target genes of which (DNA polymerase II, cyclin E, p19 
myb and dihydrofolate reductase) are important for cell cycle progression (i.e. G1-S 
transition) (Vernell et al., 2003). In contrast, p19ink4a expression leads to p53-
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mediated cell cycle arrest and apoptosis (Figure 1.6) (Park et al., 2004). Association 
of p19ink4a with mouse double minute 2 (Mdm2) inhibits Mdm2-mediated ubiq-
uitin-dependent degradation of p53, which, when accumulating in the cell, leads to 
the induction of genes such as Wig1 and p21 that are involved in cell cycle arrest 
and apoptosis (Honda and Yasuda, 1999, Sutter et al., 2007). Taking into account 
that Bmi1 has been demonstrated to be downstream of Shh (Leung et al., 2004); 
this mechanism could at least in part mediate Shh function on NSC properties. 
Moreover, in primary cultures of mouse embryonic fibroblasts, induction of 
p16Ink4a and p19ARF leads to senescence whereas Bmi-1 over-expression prevents it 
by suppressing the Ink4a/Arf locus (Jacobs et al., 1999a, Dimri et al., 2002). In age-
ing mice, the decrease in SVZ NSC self-renewal and progenitor proliferation has 
been shown to correlate with physiological p16ink4a expression, and this effect 
could significantly be reversed by p16ink4a suppression alone (Molofsky et al., 
2005). As p16ink4a deficiency predisposes ageing mice to cancer (Sharpless et al., 
2001), it is intriguing to think that loss of p16ink4a expression noted in human 
glioblastoma can represent a powerful mechanism by which the NSC escape se-
nescence and possibly give rise to tumours.  
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1.3.5 New roles and targets of Bmi1 beyond Ink4a/Arf locus 
Role of Bmi1 in regulating self-renewal and differentiation of NSC, during devel-
opment and postnatal time points in mice, through regulated repression of 
Ink4a/Arf locus has been well established (Molofsky et al., 2003, Leung et al., 
Fig. 1.6 “Canonical” downstream targets of Bmi1: The red arrows indicate the 
possible cellular processes that maybe affected in absence of Bmi1 whereas 
the black arrows indicate the possible pathways activated and cellular proc-
esses that may occur when Bmi1 represses the Ink4a/Arf locus.  The diagram 
was adapted from Park et al., 2004.  
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2004). However, concomitant deletion/suppression of either p16Ink4a or p19ARF or 
both have reversed only partially the aforementioned defects in self-renewal of 
NSC and proliferation of granule cell progenitors derived from Bmi1-/- mice 
(Bruggeman et al., 2005, Molofsky et al., 2005). These observations suggest that 
whereas Ink4a/Arf locus is an important downstream target of Bmi1, other down-
stream target and mechanism may exist. Several studies have identified new tar-
gets and mechanisms of Bmi1 in regulating biological functions of NSC independ-
ent of the Ink4a/Arf locus.   
Adhesion and migration properties of SVZ NSC has been associated with specific 
expression and interaction pattern of extracellular matrix proteins and their recep-
tors such as collagens and Beta-1 integrin receptors (Campos, 2004, 2005).  
Bruggeman et al., 2009 has shown that Bmi1 deficient mouse NSC secrete a Colla-
gen-like extracellular matrix compound that they strongly adhere to in culture, in-
dependently of Ink4a/Arf locus. Moreover, Bmi1 has been shown to regulate self 
renewal of embryonic NSC located in VZ of the developing forebrain through inhi-
bition of a different cell cycle inhibitor, namely p21WAF1/Cip1 (Fasano et al., 
2007). Recently, a study by Fasano et al., (2009) has shown that Bmi1 cooperates 
with Foxg1, a forebrain specific transcription factor, in regulating self-renewal of 
NSC in vivo (Fasano et al., 2009). In this context it is interesting to suggest that 
Bmi1 acts in a developmental-stage-dependent manner: where suppression of 
Ink4a/Arf locus is more important for postnatal NSC as opposed to inhibition of 
p21 and/or cooperation with Foxg1 during development.  
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Lack of Bmi1 in HSC and thymocytes results in increased levels of reactive oxygen 
species (ROS), through de-repression of targets genes (other than Ink4a/Arf) in-
volved in ROS generation or regulation of mitochondrial function (Liu et al., 2009). 
Premature death or hypersensitivity to neurotoxic agents of Bmi1 deficient neu-
rons has been associated with increased p19Arf/p53 level (Chatoo et al., 2009). In-
deed, Chatoo et al., (2009) has shown that in Bmi1 deficient neurons, the accumu-
lation of p53 and co-repressors at promoter regions of antioxidant genes, results in 
a repressed chromatin state and antioxidant gene down-regulation that in turn 
leads to increased ROS levels and cell death.  
Furthermore, Bmi1 has recently been highlighted for its role in maintenance of 
GBM-initiating CD133+ stem cells, as well as in conferring resistance to apoptosis 
and radiotherapy of normal and cancerous NSC (Abdouh et al., 2009, Facchino et 
al., 2010). The study by Abdouh and coworkers (2009) has shown that ablation of 
BMI1 by shRNA, inhibits growth and clonogenic potential of GBM cell lines— ef-
fects that were independent of INK4A/ARF locus but rather related with depletion 
of CD133+ cells possibly through enhanced apoptosis and differentiation. A new 
role for BMI1 in DNA damage response has been proposed by the same group in 
the study by Sabrina Facchino et al., (2010), where the authors has shown that re-
sistance of tumour-initiating CD133+ NSC was due to BMI1 over-expression me-
diated “recruitment and activation” of DNA double-strand break response machi-
nery, including the ataxia-telangiectasia-mutated (ATM) kinase, and proteins of the 
non-homologous end joining (NHEJ) repair pathway such as histone H1. 
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1.4 Role of neural stem cells in the pathogenesis of glial tumours 
Traditionally, cancer has been viewed as a disease whereby differentiated cells ac-
quire mutations, leading to activation of proto-oncogenes and inactivation of tu-
mour-suppressor genes, together resulting in uncontrolled growth. However, it 
was puzzling that brain tumours with morphological features often recapitulating 
undifferentiated neural progenitor cells could arise from fully differentiated post-
mitotic cells, which could hardly accumulate enough genetic mutations to undergo 
neoplastic transformation. Much as the involvement of proto-oncogene activation 
in combination with tumour-suppressor gene inactivation may have significant 
contribution to tumourigenesis, our understanding about which cells can be trans-
formed to form tumours has reached a new level with experiments showing that 
normal NSC can give rise to brain tumours (Zheng et al., 2008, Jacques et al., 
2009).  
The study by Zheng H et al., (2008) has shown that GFAP-cre-mediated inactivation 
of PTEN and p53 in stem and progenitor cells during development results in forma-
tion of malignant astrocytomas and GBM in adulthood. More recently, Jacques et 
al., (2009) has provided interesting evidence that deletion of PTEN and p53 in 
GFAP positive adult SVZ NSC results in formation of gliomas. Studies by other 
groups has shown that inactivation/deletion of PTEN and p53, Nf1 or p53 in adult 
nestin-expressing progenitor cells results in formation of malignant gliomas 
(Alcantara Llaguno et al., 2009). Together these findings suggest that tumour-
suppressor gene inactivations in neural stem/progenitor cells are sufficient for 
their transformation into tumour inducing and maintaining cells.   
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In the next section I will i) describe the different types of brain tumour paying par-
ticular attention to gliomas; ii) describe possible cells of origin of brain tumours iii) 
highlight the similarities between normal and cancer stem cells in terms of biologi-
cal functions and molecular properties. 
1.4.1 CNS neoplasms 
Brain tumours are the second most common neoplasms in children and their inci-
dence is also relatively high in the adult population, especially in elderly people. In 
the world, 2-3 % of all benign and malignant primary tumours are those of the 
CNS. Their prevalence has been estimated to be 69 patients per 100,000 popula-
tion, whereas in the Western countries annual incidence is approximately 15 pa-
tients per 100,000 population (Ohgaki and Kleihues, 2005). The perception of brain 
tumours has changed substantially over the last two decades and significant new 
insights into the molecular mechanisms involved in their pathogenesis have been 
gained. However, little has changed in the clinical approach towards these neo-
plasms and they are still associated with very high morbidity and mortality.  
The most recent classification of brain tumours is the WHO classification of tu-
mours of the nervous system published in 2007, which is based on the consensus 
recommendations of an international WHO working group of experts (Kleihues and 
Cavenee, 2000, Louis et al., 2007). This classification provides criteria to distinguish 
between the various intrinsic brain tumours of neuroepithelial origin and several 
other groups of intracranial neoplasms not originating from the brain tissue itself. 
The WHO grading system provides histopathological criteria to estimate the bio-
logical behaviour of these tumours and represents a scale of malignancy to predict 
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the prognosis of a tumour. It ranges from grade I to IV, where slowly growing tu-
mours are grade I or II, grade III tumours grow faster and show anaplastic foci with 
atypical nuclei and mitotic activity, and grade IV tumours are characterised by 
anaplasia in a large portion of the tumour or the entire mass, microvascular prolif-
erations and areas of necrosis (Kleihues et al., 2002, Riemenschneider and 
Reifenberger, 2009a).  
In the last decade animal models have contributed significantly to our understand-
ing of the pathogenesis of human brain tumours. Genetically modified mice repre-
senting the common genetic alterations that occur in human tumours have been 
engineered using transgenic, conventional and conditional tissue-specific knockout 
technologies (Reilly and Jacks, 2001, Gutmann et al., 2003). Animal models are cur-
rently available for most of the major CNS tumour types, including glioma, oli-
godendroglioma, medulloblastoma, and meningioma (Weiss et al., 2002). 
Gliomas are the most common type of intrinsic tumours affecting the CNS and 
they comprise a variety of different tumour forms. Astrocytic tumours (WHO grade 
I to IV) are by far the most common and they comprise pilocytic astrocytoma, dif-
fuse astrocytoma, anaplastic astrocytoma and glioblastoma. Glioblastoma, the 
most common glioma is a WHO grade IV tumour and can arise either de novo (pri-
mary glioblastoma) or as a result of malignant progression of a low-grade glioma 
(Behin et al., 2003). The highest incidence is in the older population and the five-
year survival rate is only 3% (McCarthy et al., 2002). Primary and secondary 
glioblastomas carry mutations in multiple chromosomes and exhibit aberrations in 
different genetic pathways. Molecular and genetic analyses of the past years have 
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identified frequent aberrations in two different pathways that allowed distinguish-
ing of primary from secondary glioblastomas (Ohgaki and Kleihues, 2007). Accord-
ingly, primary glioblastomas exhibit frequent  EGFR amplification, homozygous de-
letion of CDKN2A and p14ARF, CDK4 amplification, MDM2 or MDM4 amplification, 
RB1 mutation/homozygous deletion, over-expression of epigenetic silencing gene 
NDGR2, monosomy 10 and PTEN mutation; whereas secondary glioblastomas 
arises from low-grade precursor lesions that typically carry mutations in TP53 and 
IDH1 (isocitrate dehydrogenase 1), promoter hypermethylation of the RB1 gene, 
and overexpression of PDGFR-α and epigenetic silencing genes MGMT and EMP3 
(Nakamura et al., 2001, Parsons et al., 2008, Riemenschneider and Reifenberger, 
2009b). Interestingly, though, the different molecular aberrations found in primary 
and secondary glioblastomas results in alterations in the same signalling pathways, 
namely p53, pRb1, PTEN/PI3K/AKT and MAPK (Riemenschneider and Reifenberger, 
2009a). This may explain why both types of glioblastomas share comparable histo-
logical features and poor outcome.     
1.4.2 Are NSC the cell of origin of brain tumours? 
A central issue in cancer biology is to understand the molecular mechanisms of 
tumour formation and the directly linked ontogeny of tumours. Over the past 80 
years, brain tumours were thought to originate from the cell types of the adult 
brain that they resembled most as assessed by comparison of histological features: 
for example, astrocytomas were thought to arise from astrocytes; oligodendro-
gliomas from oligodendrocytes; ependymoma from ependymal cells etc. (Louis et 
al., 2001, Louis, 2006). However, this concept is being increasingly challenged and 
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the role of NSC in brain tumour formation is currently being investigated, with re-
sults from several groups indicating both stem and progenitors as cells of origin of 
brain tumours.  
Radial glia cell-like stem cells defined by the expression of various markers CD133, 
Nestin, RC2 and BLBP have been shown to give rise to ependymomas, a subtype of 
glial tumours arising from different locations of the ventricular system along the 
craniospinal axis (Taylor et al., 2005). Despite the histological similarity of the tu-
mours originating from different locations, site specific alterations in signalling 
pathways such as upregulation of NOTCH in supratentorial and HOX family tran-
scription factors in spinal ependymomas, were shown. These data raise the possi-
bility that different populations of NSC are susceptible to neoplastic transforma-
tion through different molecular changes (Taylor et al., 2005).  
Two recently published papers have shown that medulloblastomas can also arise 
from stem cells when the Shh pathway was aberrantly activated in these cells dur-
ing embryonic development. However, they claim that a commitment to a granule 
cell lineage is needed for medulloblastoma to develop (Schuller et al., 2008, Yang 
et al., 2008). This is an interesting hypothesis, which however does not explain the 
occurrence of medulloblastoma in adult life when progenitors of granule cell line-
age are no longer present. 
Moreover, Jackson et al., (2006) have shown that PDGFR-α expressing quiescent 
adult rodent SVZ B cells, became highly proliferative and contributed to formation 
of atypical hyperplasia with features of gliomas when stimulated with surplus 
PDGF ligand (Jackson et al., 2006). This observation correlates well with the clinical 
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observation that over-expression of PDGF ligand and receptor is a common early 
change in low-grade gliomas (Behin et al., 2003) and suggested that SVZ NSC might 
be involved in the formation of these tumours. 
CNS-specific deletion of p53 and an allele of Pten in GFAP expressing neural stem 
and progenitor cells, using the transgenic mouse model hGFAP-
Cre+;p53lox/lox;Ptenlox/+,  results in formation of gliomas (anaplastic astrocytomas) 
between 15 to 40 weeks of ages (Zheng et al., 2008). In this study, it could not be 
fully determined whether the tumours originated from NSC per se, but the similari-
ties in biological properties (self-renewal) and expression profile (positive for 
Nestin, GFAP and Olig2 but negative for mature neuronal and oligodendrocyte 
markers such as NeuN and Mbp) between the gliomas and NSC was suggestive.  
However, the GFAP-Cre model used in this study targets all GFAP expressing cells 
during development and cells arising thereby.   
In a more recent study by Jacques et al., specific targeting of adult GFAP positive 
cells confined to periventricular region was achieved, using a transgenic mouse 
model bearing conditional alleles of PTEN and p53 (Jacques et al., 2009). Concomi-
tant deletion of PTEN and p53 in GFAP-expressing adult stem cells (type B cells) 
gave rise to gliomas (anaplastic astrocytomas).  
Recently, somatic cells have been reprogrammed into pluripotent stem (iPS) cells 
through viral transduction of four transcription factors, c-Myc, Oct4, Sox-2 and Klf4 
(Takahashi and Yamanaka, 2006, Nakagawa et al., 2008) and more recently even 
by means of expression of only Oct-4 and either Klf-4 or c-Myc in NSC (Kim et al., 
2008). These are exciting findings opening tremendous opportunities for future 
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stem cell-based therapies, but they also raise the possibility that terminally differ-
entiated cells such as glia and neurons can revert to a more undifferentiated state 
through genetic mutations and contribute to tumour formation. Interestingly, 
Moon et al., showed that mouse astrocytes cultured under NSC conditions upon 
overexpression of Bmi1 gave rise to NSC-like cells (NSCLC) (Moon et al., 2008). 
These NSCLC were shown to express NSC marker genes including nestin, CD133 
and Sox2; could self renew and, differentiate into neuronal and glial lineage in vitro 
(Moon et al., 2008). Whether these cells could initiate tumourigenesis is to date 
unknown. However, BMI1 copy numbers are increased in gliomas, especially in 
high-grade astrocytomas, suggesting that overexpression of BMI1 may contribute 
to brain tumour pathogenesis (Hayry et al., 2008a).   
1.4.3 NSC and BTSC: What do they have in common?  
A subpopulation of cells termed BTSC has been isolated from several tumours in-
cluding gliomas (Ignatova et al., 2002, Hemmati et al., 2003, Lee et al., 2006), me-
dulloblastomas, astrocytomas (Hemmati et al., 2003, Singh et al., 2003) and 
ependymomas (Taylor et al., 2005). These cells express stem cell markers, among 
others Musashi-1, Sox2, nestin, MELK and CD133 (Galli et al., 2004, Singh et al., 
2004a) and were shown to be able to re-initiate tumourigenesis; in fact as few as 
100 of these cells gave rise to tumours when injected into immunodeficient mice 
and retained their tumour phenotype upon serial transplantation (Singh et al., 
2004a). 
In the light of these findings, a brain tumour can be viewed as a renewing system 
with a defined cell hierarchy, in which quiescent but indefinitely self-renewing 
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BTSC give rise to a limited number of transit-amplifying neoplastic progenitors that 
have a limited proliferation potential, which eventually will give rise to terminally 
differentiated neoplastic cells (Alvarez-Buylla and Temple, 1998, Reya et al., 2001). 
This hypothesis, so called hierarchical model of tumourigenesis, predicts that the 
bulk of the tumour is composed of functionally heterogeneous cells; some with a 
limited proliferative capacity; others with the ability to proliferate extensively and 
initiate new tumours.  
The similarities between normal NCS and BTSC has led to the hypothesis that a 
causal link might exist between the two and that endogenous NSC might give rise 
to brain tumours possibly through transformation into BTSC (Figure 1.7). Further-
more, it is also conceivable that BTSC are tumour cells regaining stem cell-like 
properties without being directly derived from NSC (Figure 1.7).  
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Fig. 1.7 Schematic representation to show the relationship between NSPC 
and BTSC, and brain tumour formation: a) Transformed NSC give rise to BTSC, 
which give rise to and maintain tumours; b) Progenitors or differentiated cells 
may be the origin of brain tumours that harbour BTSC. Dotted arrows indicate 
possible de-differentiation of cells that may occur before tumourgenesis 
whereas grey semi-circles signify self-renewal capacity of NSC and BTSC alike. 
The figure was adapted from Sutter et al., Biochim. Biophys. Acta. 2007. 
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1.5 Bmi1, neural stem cells and brain tumour pathogenesis   
The PcG gene Bmi1 has been demonstrated to be required for stem cell self-
renewal and maintenance in mice. In addition, Bmi1 over-expression has been 
shown in human gliomas. Here I will describe the landmark findings that have 
shaped a role for Bmi1 in regulating neural stem cell functions and that have sug-
gested a role for this gene in brain tumour pathogenesis. 
1.5.1 Bmi1 and neural stem cells 
 Bmi1 is required for self-renewal and maintenance of peripheral and central nerv-
ous system NSC, and that the extend of its requirement increases over time, both 
in vitro and in vivo (Molofsky et al., 2003). NSC isolated from Bmi1 deficient mice 
at developmental time points of E14.5, P0 and P30 have been shown to form sig-
nificantly less and smaller neurospheres (Molofsky et al., 2003). Moreover, to as-
sess the effects of Bmi1 deficiency on proliferation of NSC, the authors have exam-
ined the rate of BrdU incorporation of SVZ cells at P0 and P30. They concluded that 
the rate of proliferation of Bmi1 deficient SVZ cells was significantly lower com-
pared with normal mice. In addition, the reduced self-renewal capacity of Bmi1 
deficient SVZ NSC leads to their postnatal depletion. Reduction in the rate of pro-
liferation and self-renewal of Bmi1 deficient NSC were attributed in part to in-
creased expression of the cylin-depended kinase inhibitor gene p16ink4a as its inhi-
bition partly reversed the previously noted self-renewal defects. Further, it was 
suggested that Bmi1 deficiency does not perturb differentiation and survival of 
PNS and CNS NSC. A study by Bruggeman et al., (2005) has looked at the relative 
contribution of de-repression of p16ink4a and p19Arf in various cell types of Bmi1 de-
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ficient mice, particularly the NSC (Bruggeman et al., 2005). Importantly, this study 
has found that not only inhibition of p16ink4a but also that of p19Arf in Bmi1 defi-
cient NSC was sufficient to partly reverse proliferation and self-renewal defects 
observed at various time points studied. Moreover, restoration of long-term self-
renewal capacity (five of weekly passages- in this study) of Bmi1 deficient NSC was 
achieved through concomitant deletion of either p19Arf alone or in combination 
with p16ink4a in these cells. In addition to previously stated importance of p16ink4a in 
conveying Bmi1 function, the significance of p19Arf as a downstream target of Bmi1 
in regulating proliferation and self-renewal of NSC was therefore stressed by this 
study (Bruggeman et al., 2005). Moreover, Bruggeman et al., (2005) has also high-
lighted that Bmi1 deficient neurospheres are multipotent but with a reduced effi-
ciency compared with control spheres.  
In contrast to the effects of Bmi1 deficiency on the proliferation and self-renewal 
of postnatal NSC through repression of Ink4a/Arf locus, it was noted that embry-
onic NSC did not seem to depend on Ink4a/Arf locus repression (Fasano et al., 
2007). Together these findings and observations did show the possibility that Bmi1 
function in neural stem cells must be mediated through other developmental time 
point dependent downstream targets. Indeed, Fasano et al., (2007) have identified 
repression of p21-Rb cell cycle regulatory pathway by Bmi1 as an important 
mechanism for regulation of proliferation and self-renewal during embryonic de-
velopment. In their study Fasano et al., (2007) have used lentiviral-mediated RNA 
interference at different developmental stages in vivo and in vitro.  One striking 
observation was that acute reduction of Bmi1 expression by way of shRNA inter-
ference resulted in impairment of proliferation and self-renewal, in addition to in-
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creased apoptosis of cortical NSPC as early as E11, and at E14 and E16. Interest-
ingly, the expression levels of p16ink4a and p19Arf were unchanged at 48 hours post-
treatment. Their analysis showed up-regulation of a member of the Cip/Kip family 
of cyclin-depended kinase inhibitors namely, p21/Clip1 upon shRNA mediated si-
lencing of Bmi1 expression in cortical NSPC. Further gene expression analysis of 
these cells, particularly at E11, has shown that Bmi1 knockdown leads to changes 
in expression of genes such as Tcf4 and Id2, which can affect Rb function (Tetsu 
and McCormick, 1999, Lasorella et al., 2005). The authors have thus concluded 
that acute knockdown of Bmi1 in cortical NSPC induces apoptosis, reduces prolif-
eration and self-renewal by altering the p21/Rb pathway, in a developmental stage 
specific manner (Fasano et al., 2007).  
The same authors have shown the role of Foxg1 in mediating p21 dependent role 
of Bmi1 in embryonic NSC. The transcription factor Foxg1 is a member of the 
winged-helix gene family that is expressed incrementally in forebrain progenitors 
from development to adulthood, and is thought to be important for regional main-
tenance of NSC (Dou et al., 1999, Shen et al., 2006). In the study by Fasano et al., 
(2009) Bmi1 was over-expressed in SVZ NSPC by means of transduction with lenti-
viral vector (Bmi1 Over), in vitro and in vivo. NSPC isolated at E11, E14, E16, P0 and 
adult were transduced with either Bmi1 Over or empty (EV) lentiviral ventor. Then, 
plated in neurosphere-forming conditions and assessed for secondary neurosphere 
formation. They found that secondary neurosphere-formation frequency between 
Bmi1 Over and EV transduced NSPC were increased with advancing developmental 
stages, and with each passage (Fasano et al., 2009). Further, the authors examined 
whether Bmi1 over-expression in vivo by injecting Bmi1 Over into E14 mouse lat-
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eral ventricles in utero and electroporating into the developing cortex would 
stimulate progenitor proliferation. Whereas the Ev control transduced cells had 
followed the normal pattern of development with most cells migrating to cortical 
plate (CP) and acquiring a neuronal morphology, those transduced with Bmi1 Over 
remained in VZ and SVZ and a fewer had migrated into CP. These findings suggest 
that Bmi1 over-expression in vivo increases proliferation of VZ and SVZ NSPC and 
inhibit production of migration and neuronal differentiation, at least in comparison 
with the normal developmental pattern observed in controls (Fasano et al., 2009). 
Expression analysis of Bmi1 Over transduced LeX positive cells (a surface marker 
that labels NSC and proliferative progenitors but not differentiated cells (Capela 
and Temple, 2006)) showed that Foxg1 expression is significantly increased. Con-
versely, knockdown of Foxg1 by shRNA reduces secondary neurosphere formation 
potential of Bmi1 Over transduced NSPC, suggesting that Foxg1 expression in-
creased in parallel to Bmi1 expression and that it is required for Bmi1 regulated 
self-renewal of stem cells (Fasano et al., 2009).     
1.5.2 Bmi1 and brain tumour pathogenesis  
The first line of evidence that identified Bmi1 as an oncogene came from studies of 
Eµ-Bmi1 transgenic mice, which developed T and B cell lymphomas (Haupt et al., 
1993). Development of lymphomas was accelerated by concomitant over-
expression of c-Myc mainly due to inhibition of Myc-mediated induction of p19Arf 
and apoptosis, thus highlighting Bmi1 as an oncogene and establishing collabora-
tion between the two oncogenes (Jacobs et al., 1999b).  
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Studies in acute myeloid leukaemia (AML) have reinforced the role of Bmi1 as an 
oncogene and its role in maintenance of the cancer stem cells in these tumours. 
Lessard et al., showed that BMI1 is required for self-renewal and proliferation of 
leukaemic stem cells, which is the fraction of the tumour that retains the ability to 
generate AML in the primary host in absence of BMI1, but fails to initiate tumour 
in secondary recipient without expression of BMI1 (Lessard and Sauvageau, 2003). 
Interestingly, Bmi1 over-expression or/and gene amplification has been reported 
in several brain tumours such as medulloblastomas and gliomas (Leung et al., 
2004, Phillips et al., 2006, Hayry et al., 2008b). Over-expression refers to increased 
expression of a gene beyond physiological levels whereas amplification is a genetic 
aberration manifesting itself as increased copy number in the DNA. The study by 
Leung C et al., (2004) showed that Bmi1 is over-expressed in cerebellar precursor 
cells during postnatal expansion of external granular layer (EGL) in mice and hu-
man. Moreover, BMI1 over-expression was noted in a substantial number of pri-
mary human medulloblastomas, a tumour thought to originate from aberrantly 
proliferating progenitor cells (Leung et al., 2004).  
A study by Hayry V et al., (2008) investigated the genetic status of 100 low and 
high grade primary or recurrent gliomas for expression patterns of BMI1 using 
chromogenic in situ hybridisation (Hayry et al., 2008a). Interestingly some of the 
tumours had BMI1 deletion but most particularly astrocytomas had increased copy 
number (3-5 copies). The authors reported that there were no significant differ-
ences in prognosis of cases where BMI1 gene was deleted or amplified. More re-
cent studies have shown that BMI1 is required for maintenance and self-renewal 
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of GBM stem cells (Abdouh et al., 2009). The study by Abdouh et al., (2009) 
showed that CD133 positive stem cells isolated from glioblastomas expresses high 
levels of BMI1 and EZH2. Moreover, ablation of either of these oncogenes in GBM 
cell lines cultured as neurospheres inhibited their proliferation and self-renewal 
potential, independent of INK4A/ARF locus. Indeed, gene expression analysis of 
the shRNA treated GBM cell lines (using replication-incompetent lentiviruses) 
showed significant reduction in expression of stem cell associated genes such as 
CD133, MUSASHI, SOX2 and LHX2. Moreover, some of the transduced cell lines 
exhibited extensive apoptosis and differentiation, suggesting further that BMI1 is 
required for maintenance of CD133 positive GBM stem cells, through mechanisms 
independent of INK4A/ARF locus (Abdouh et al., 2009).  
A study by Bruggeman et al., (2007) examined the role of Bmi1 in development 
and phenotype determination of gliomas, using an orthotopic model for gliomas 
where deficiency for Ink4a/Arf in combination with constitutively active mutant of 
EGF receptor (*EGFR) was induced either in NSPC or astrocytes (Bruggeman et al., 
2007). Primary astrocytes transduced with Ink4a/Arf-/- *EGFR vectors produced 
tumours immediately when stereotactically intracranially injected into mice brain, 
where Bmi1-/-;Ink4a/Arf-/- *EGFR cells went through a lag phase. Both tumours re-
sembled human gliomas and developed into grade III-IV (oligo)astrocytomas or 
GBM. However, there were differences in the cellular composition and differentia-
tion of tumours: the majority of Ink4a/Arf-/- tumours were positive for progenitor 
marker Nestin, neuronal marker TuJ1, and astrocytic marker GFAP, whereas only 
half of Bmi1-/-;Ink4a/Arf-/- tumours were positive for Nestin and only one expressed 
TuJ1 (Bruggeman et al., 2007). These observations suggest that Bmi1 controls de-
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velopment and composition of differentiated cells in gliomas through mechanisms 
independent of Ink4a/Arf locus. On the other hand, NSPC transduced with *EGFR 
and Bmi1-/-;Ink4a/Arf-/-  did not produce any GBM but only low grade gliomas. 
While all Ink4a/Arf-/- tumours were positive for Nestin, only few of the Bmi1-/-
;Ink4a/Arf-/- tumours stained positive for Nestin (Bruggeman et al., 2007). Together 
these findings suggest that malignant transformation of NSPC depends on Bmi1.  
CD133+ BTSC isolated from GBM are resistant to all known therapies including ir-
radiation, mainly because of DNA repair mechanisms through activation of DNA 
double strand response machinery (e.g., ATM) and nonhomologous end joining 
proteins (e.g., histone gamma-H2AX).  The study by Facchino et al., (2010) has 
shown that BMI1 co-localises with DNA damage response components in CD133+ 
BTSC, especially after gamma irradiation, thus boosting their resistance to therapy 
(Facchino et al., 2010). Conversely, inactivation of BMI1 in these cells renders them 
more radiosensitive. These results may suggest that down-regulation of Bmi1 ex-
pression may be a viable approach to increase radiosensitivity of BTSC. 
1.6 Transgenic mouse models and conditional control of gene expression 
Developments in molecular biology have provided us with powerful tools to turn 
genes on and off at our discretion. Ability to alter genomic loci or insert foreign 
transgenes into mouse genome has facilitated the study of many complex biologi-
cal processes such as embryogenesis and cancer. In the next section I will describe 
some of the strategies used to generate transgenic mouse models, and highlight 
the advantages of the Cre/loxP based system we have used in this study to analyse 
roles of Bmi1 in biological functions of embryonic and postnatal NSPC. We have 
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also used previously generated tumour prone conditional transgenic mice 
(PTENLoxP/LoxP and p53LoxP/LoxP), in combination with Bmi1 over-expression, to study 
effects of Bmi1 over-expression in brain tumour formation. 
Conditioned by the availability of the technologies and purpose of study, different 
kinds of transgenic animals (knockout, conditional knockout, knock-in etc.) can be 
generated. A knockout mouse is derived from embryonic stem (ES) cells that have 
integrated a knockout construct (non-functional DNA sequence of the targeted 
gene) by homologous recombination, which is a method in which the native and 
foreign nucleotide sequences are exchanged. The construct is cloned into ES cells 
by using the recombinant DNA technology. With this technology the targeting con-
struct replaces a specific segment of DNA in the ES cells, thereby replacing the 
functional allele. The knockout ES cells are then microinjected into normal mouse 
blastocysts where they mix with cells from the normal embryo to form a chimeric 
mouse which contains cells derived from both the host embryo and knockout ES 
cells. In principle, up to 100 percent of the resulting mouse chimera can be formed 
from cells derived from knockout ES cells.  However, it is sufficient if the gonads of 
the chimeric mice are derived from knockout ES cells, as in this case mating the 
chimeric mice with wild-type mice would produce offspring with all cells heterozy-
gous for the homologous recombination. Thereafter the knockout allele can be 
transmitted in a Mendelian fashion. However, not all biological processes can be 
studied by gene knockout or transgene expression strategies as many genes have 
different roles during embryogenesis and adulthood, and may result in embryonic 
lethality and preclude an analysis of its function in late development or adulthood. 
Moreover, it becomes impossible to determine roles of specific genetic alterations 
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on tissues and cells of interest as the resultant phenotypes from such genetic 
modifications could be due to cell autonomous, non-cell autonomous or systemic 
effects in the whole animal; or even a combination of these at various degrees of 
importance. One way to overcome these limitations is to use a binary genetic sys-
tem, in which gene expression is controlled by the interactions of an ‘effector’ 
transgene and ‘target’ transgene. Such binary system is based on Cre/loxP, where 
Cre enzyme acts as the effector and the loxP recognition sequences are on the tar-
get transgene. This system allows for spatial and temporal control of gene activa-
tion in transgenic mice. In conditional transgenic mice, the conditional control of a 
particular gene is based on Cre enzyme, whose expression can be controlled by cell 
specific promoters.  
1.6.1 Adenovirus-mediated Cre delivery is an efficient method to recombine 
loxP sites in NSPC in vitro 
Since its discovery as a part of normal life cycle of P1 bacteriophage by Henderson 
and Hamilton (Sternberg and Hamilton, 1981, Sauer and Henderson, 1988), the 
Cre/loxP system has been extensively used to manipulate the cellular genome in 
cell culture systems, mice and other organisms. The Cre/loxP system consists of 
two components; the Cre enzyme and the loxP sites. The latter are introduced into 
the DNA of the organism of interest by conventional cloning strategies followed by 
electroporation or calcium precipitation into ES cells where homologous recombi-
nation will integrate the modified genetic sequence into the host DNA (Nagy, 
2000). The Cre gene encodes for a 38 kD protein, Cre recombinase, that catalyses 
recombination between two loxP sites. loxP sites consists of a specific 34-base pair 
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(bp) sequences that can be divided into three functional regions; a central 8bp se-
quence, where recombination takes place, and two flanking palindromic 13 bp se-
quences (Nagy, 2000). At the molecular level, a single recombinase binds to palin-
dromic halves of a loxP site and forms a tetramer by bringing two loxP sites to-
gether, mediating recombination at the central 8bp sequence (Figure 1.8) 
(Voziyanov et al., 1999, Yu and Bradley, 2001). Whether this recombination results 
in a deletion, inversion or chromosomal translocation of intertwining sequences is 
determined by the orientation, location and copy number of loxP sites (Figure 1.9) 
(http://cre.jax.org/introduction.html).  
Delivery of Cre into the cells of interest can be achieved by several means both in 
vivo and in vitro. Previous studies have shown that Cre/loxP system functions effi-
ciently in eukaryotic organisms and mammalian cells (Smith et al., 1995). Among 
other systems, adenoviral vectors constructed to express Cre recombinase have 
previously been used to mediate loxP-dependent recombination in various tissues 
and cells in vitro (Anton and Graham, 1995). Adenoviruses with deleted E1 and 
therefore defective in replication could be propagated in Human Embryonic Kidney 
293 (Hek293) cells and grown to high titres, and yet retain their properties to in-
fect a wide variety of cells (Addison et al., 1997). These recombinant Adenoviruses 
can infect both proliferating and quiescent cells and once in the cytoplasm, release 
their virions, which are transported into nucleus and replicate using the host’s rep-
lication machinery (Anton and Graham, 1995).  
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loxP site 
C R E  
Fig 1.9 Three possible outcomes of a Cre-lox recombination: A) Inver-
sion of the floxed segment, when the LoxP sites are oriented in opposite 
directions, B) Chromosomal translocation when the LoxP sites are lo-
cated on different chromosomes, C) Deletion of the floxed segment 
when the LoxP sites are oriented in the same direction on a chromo-
some segment. Diagram was adopted from the site, 
http://cre.jax.org/introduction.html, in July 2010.  
 
 
Fig 1.8 Schematic representation of Cre/loxP system: One Cre recombi-
nase binds to 13 bp inverted repeat sequences of LoxP sites and cataly-
ses recombination at the core region. The modified figure was originally 
adopted from Yuejin Yu & Allan Bradley Nat. Rev. Genetics, 2001. 
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1.7 Hypothesis 
Bmi1 is a member of the Polycomb group (PcG) gene family of chromatin modifiers 
and transcriptional repressors, the essential role of which in development and 
homeostasis of the CNS was first highlighted by studies on knockout mice. Bmi1-/- 
mice displayed impaired self-renewal and maintenance of SVZ NSC leading to their 
postnatal depletion.  The molecular mechanisms of Bmi1 function in postnatal NSC 
are mediated in part by transcriptional repression of the ink4a locus. This locus en-
codes two cell cycle inhibitors, p16Ink4a and p19ARF, the activities of which increase 
with postnatal age and have been linked to cellular senescence. However, con-
comitant deletion/suppression of p16Ink4a or p19ARF or or both does not completely 
rescue the above mentioned defects in self-renewal of NSC derived from Bmi1-/- 
mice.  
Another cell cycle inhibitor, namely p21WAF1/Cip1, contributes to mediating Bmi1 
function in developmental contexts. Other NSC functions, such as migration, have 
also been shown to be controlled by Bmi1 in an ink4a independent manner.   
Increased expression of BMI1 has been demonstrated in humans, not only in hae-
matological malignancies, such as high grade lymphomas, but also in neural tu-
mours, e.g. medulloblastomas and neuroblastomas. A tight regulation of Bmi1 ex-
pression might therefore not only be crucial for maintaining a balance between 
self renewal and differentiation or senescence of NSCs, but it may also play a role 
in CNS tumourigenesis, when deregulated.  
By taking into account the essential roles of Bmi1 in NSC, I hypothesised the fol-
lowing: 
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1) Over-expression of Bmi1 in NSC will increase their proliferation and self-
renewal capacity through suppression of cell cycle inhibitors such as 
p16Ink4a, p19ARF and p21WAF1/Cip1.  
2) Over-expression of Bmi1 in NSC will confer resistance to apoptosis by re-
ducing Mdm2-mediated ubiquitin dependent degradation of p53 (possibly 
because of reduced p19ARF expression).  
3) Bmi1 over-expression mediated increased proliferation and self-renewal 
together with resistance to apoptosis makes NSC a potential origin of brain 
tumour(s) in mice. 
4) Bmi1 over-expression in NSC will reveal novel gene targets involved in 
regulation of stem cell function in vitro and in vivo.   
 
1.8  Aims 
 To determine whether Bmi1 over-expression in NSPC at different devel-
opmental time points would alter their biological properties such as self-
renewal, apoptosis and differentiation. 
 To identify molecular changes associated with Bmi1 over-expression in 
NSPC. 
 To determine whether Bmi1 over-expression in SVZ NSC is sufficient for 
tumourigenesis in mice. 
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Chapter 2— Materials and Methods 
2.1 Generation, maintenance, breeding and genotyping of genetically modi-
fied mice 
2.1.1 Conditional Transgenic Mouse Model with Double Reporter System 
The Cre/loxP system takes advantage of the P1 bacteriophage Cre recombinase, a 
38 kDa enzyme that catalyses specific excision of DNA between 34 base pair (bp) 
recognition sequences called loxP and consecutive ligation of the remaining DNA 
(Hamilton and Abremski, 1984, Nagy, 2000).  
A modified version of the the pccall2 construct (Lobe et al., 1999), where the hu-
man placental alkaline phosphatase gene was replaced with enhanced green fluo-
rescent protein (EGFP) (pCCALL2 vector (Novak et al., 2000), was chosen to drive 
conditional expression of Bmi1. The pCCALL2-Bmi1 plasmid  contains pCCAG pro-
moter region (Niwa et al., 1991) composed of CMV (cytomegalovirus) enhancer 
and β-actin promoter sequences; the first reporter βgeo (a fusion of LacZ and 
neomycin coding sequances) followed by three copies of the SV40 polyadenylation 
sequence, which are flanked by LoxP sites; the cloning site , which is separated 
from the second reporter EGFP by the intermediate internal ribosome entry site 
(IRES) sequence, followed by three copies of the SV40 polyadenylation sequence 
(Figure 2.1). The full-length murine Bmi-1 cDNA was cloned into the cloning site of 
this modified version of the pCCALL plasmid. 
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Briefly, the pCCALL2-Bmi1 vector was electroporated into TC-1 mouse embryonic 
stem cells. Selection for neomycin resistance was applied and resistant clones 
were selected and expanded (Figure 2.2, A). Clones  with high level LacZ expression 
were further screened for single transgene integration using Southern Blot analysis 
(Figure 2.2, B), a method widely used to detect specific DNA sequences in DNA 
samples. Four ES cell clones that had single copy integration were selected for fur-
ther analysis and electroporated with a Cre recombinase expression vector 
(pOG231) carrying a puromycin resistence gene to test whether Bmi1 over-
expression could be induced. Upon antibiotic selection, resistant clones were cho-
sen, amplified and further screened for β-galactosidase activity. LacZ negative 
clones were further analysed by Western blot and the level of Bmi1 expression 
was assessed as compared to the baseline level prior to recombination and to the 
expression level of a medulloblastoma sample (Figure 2.2, C).  
Clones IB5 and IE1 were selected for injection into blastocysts to generate chimeric 
mice. Germline transmission and line establishment was achieved for the clone 
IB5, from now on defined STOPFloxBmi1.  
Fig. 2.1 Schematic representation of the pCCALL2-Bmi1 construct: 
The STOPFloxBmi1 mouse line was generated by electroporation of 
this construct into TC-1 mouse embryonic stem cells.   
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The expression pattern of STOPFloxBmi1 mice was assessed by LacZ expression 
analysis both in embryonic and postnatal brains. At embryonic day 16.5 (E16.5) 
robust LacZ expressions was seen in most tissues (Figure 2.2, D), but interestingly 
in  all layers of the developing neocortex, in the external granular layer of the 
cerebellum and in scattered cells in the deep cerebral and cerebellar white matter 
(Figure 2.2, E). At postnatal day 7 (pd7) and p20 (not shown), LacZ expression was 
seen in the cerebral cortex, in the hippocampus, in the basal ganglia and in the 
subventricular zone (SVZ) (Figure 2.2, F). LacZ expression in the ventricular zone 
(VZ) at E16.5 of STOPFloxBmi1 was also analysed by X-gal staining (Figure 2.2, G). 
And that crossing between NestinCre and STOPFloxBmi1 mice generates double 
transgenic embryos (NestinCre;STOPFloxBmi1) that have no LacZ expression in the 
VZ at E16.5; indicating successful recombination of lox-P sites and loss of the first 
reporter gene (Figure 2.2, H).  
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Fig. 2.2 Verification of the pCCALL2-Bmi1 vector integration into ES cells, and 
assessment of its functionality in vitro and in vivo: A) Neomycin resistant ES 
cells with LacZ expression B) Confirmation of single copy integration (Southern 
Blot) C) Over-expression of Bmi1 in ES cells upon Cre-mediated recombination 
(Western Blot). D) LacZ expression in all tissues of the STOPFloxBmi1 whole 
embryo cross section at E16.5 E) LacZ expression throughout the developing 
cortex and VZ at E16.5 F) LacZ expression in the SVZ at P7 G) High magnification 
showing LacZ expression in the VZ of STOPFloxBmi1 embryo at E16.5 H) Loss of 
LacZ expression in the VZ of NestinCre;STOPFloxBmi1 embryo at E16.5. These 
experiments were performed by Olga Shakhova. 
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2.1.1.1     Nestin Cre mediated recombination of LoxP sites in NSPC 
The Cre/loxP system has been used in transgenic mouse lines to enable tar-
geted/conditional gene activation or deletion in specific tissues and cells in vivo 
taking advantage of the specificity of a given promoter (Ray et al., 2000, 
Lewandoski, 2001, Dubois et al., 2006). Briefly, the system requires cross-breeding 
between two transgenic animal lines: one line carries an allele of interest flanked 
at the 5’ and 3’ ends by loxP sequences whereas the other line carries a Cre trans-
gene, the expression of which is regulated by a heterologous promoter. Recombi-
nation of the loxP sites in the littermates is determined by the expression pattern 
of the Cre transgene. 
To activate Bmi1 expression in NSPC in vivo we have used a Nestin-Cre transgenic 
mouse line where Cre mediated recombination of loxP sites occurs in all cells ex-
pressing nestin (Dubois et al., 2006). Nestin is an intermediate filament protein 
first identified in neuroepithelial stem cells, which is widely used as a marker for 
NSPC during development and adult tissues (Wiese et al., 2004). The transgenic 
construct (Nes-Cre) used to generate this line consists of the rat nestin gene ex-
cluding the transcriptional start site, followed by modified Cre gene carrying a nu-
clear localization signal and actin-polyA sequence, and finally the complete intron 
2 of the rat nestin gene (Figure 2.3, Dubois et al, 2006). 
In order to study the efficiency and spatiotemporal expression pattern of Nes-Cre, 
Dubois and co-workers crossed Nestin-Cre males with R26R females (Dubois et al., 
2006). The latter line is a commonly used reporter line, where the LacZ gene is ex-
pressed upon Cre mediated deletion of a floxed stop cassette. During embryonic 
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development, Cre expression and therefore recombination was detected in the 
neuroectoderm as early as day E7; at E12 it became detectable in the VZ where it 
reaches its peak by day E14.5 and E15.5 (Figure 2.4) (Kawaguchi et al., 2001, 
Dubois et al., 2006). Similarly, expression of Cre driven by the Nestin promoter was 
shown from E11.5 onwards in the developing neocortex (Dubois et al., 2006).  
Indeed, although nestin is expressed in a variety of cell types during development 
and in adult tissues, it is widely recognised as a marker for NSPC (Wiese et al., 
2004). The second intron of both rat and human nestin gene has been shown to be 
sufficient for both midbrain and general CNS expression (Dubois et al., 2006).  
In this study, this line will be used to generate embryonic and postnatal NSPC 
which have been exposed to over-expression of Bmi1 since E11.5 of embryonic 
development. 
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Fig. 2.3 Schematic representation of the Nes-Cre construct: The 
mouse line termed Nestin-Cre, which was used in this study to acti-
vate over-expression of Bmi1 in STOPFloxBmi1 transgenic line, carry 
this construct. (Adopted from Dubois et al., 2006) 
Fig. 2.4 Nes-Cre mediated recombination pattern during late em-
bryogenesis: Compound hemizygous embryos carrying paternally in-
herited Nes-Cre and Z/AP (the latter has the expression of LacZ before, 
and alkaline phosphatise (AP) after loxP recombination (Lobe et al., 
1999). Whole mount AP staining of embryo section shows that Nes-
Cre mediated recombination of LoxP sites occur in lateral ventricles 
(LV) and midbrain (Mb) in addition to other sites (Adopted from Du-
bois et al., 2006).  
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2.1.2 Maintenance of Mice  
The full range of genetically modified (GM) mouse lines and normal mouse bred 
for use in in-vitro and in-vivo experiments throughout this project include; STOP-
FloxBmi1, Nestin-Cre, Rosa26Lac-Z, PTENLoxP/LoxP, p53LoxP/LoxP, NOD/SCID and normal 
C57Bl/6 mice. All mice were maintained at the Biological Sciences Unit (BSU), and 
animal care and procedures were carried out in accordance with guidelines and 
protocols approved by the United Kingdom Home Office. Standard polymerase 
chain reaction (PCR) methods were used to determine the genotype of compound 
litter mates/embryos produced from different crossings made between the above 
mentioned mouse lines.  
The genetic background of the mice selected for breeding is always important es-
pecially in the case of knockout and transgenic mice. For genetic experiments, as in 
the case in this study, failure to choose breeders of the appropriate genetic back-
ground would eventually result in unwanted although often subtle changes in the 
characteristics of the mice. A strain is defined as inbred if it was obtained by sibling 
matings for more than 20 generations, after which all offspring are considered ge-
netically identical. With inbred mice, the goal is to preserve genetic uniformity in 
the colony. With most strains, this involves nothing more than mating males and 
females of the same strain. The only precaution is to avoid generation of a sub-
strain or genetic drift, which occurs when a closed colony of inbred mice is isolated 
for many generations. A substrain may differ genetically from the original inbred 
strain and may yield different results when used in research. To avoid this, it is suf-
ficient to introduce outsiders from the same inbred strain on a regular basis.  
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C57BL/6 is the most widely used inbred strain. It is commonly used as a general 
purpose strain and background strain for generation of transgenic mice. Although 
this strain is refractory to many tumours, it provides a permissive background for 
maximal expression of most mutations. C57BL/6 mice breed well, are long-lived 
and are used in a variety of research areas including developmental biology, diabe-
tes and obesity, immunology and neurobiology. For convenience and advantages 
aforementioned C57BL/6 mice were used for production of STOPFloxBmi1 condi-
tional transgenic mice.   
2.1.3 Breeding and Time mating 
The following compound genotypes were used: NestinCre/STOPFloxBmi1; 
PTENLoxP/LoxP/STOPFloxBmi1 and p53LoxP/LoxP/STOPFloxBmi1. Compound mice were 
kept homozygous for all alleles and in-bred within the same colony.   
Depending on the project’s progress, mice from E16.5, p7 and p70 were used for 
experiments. Timed mating between NestinCre male and STOPFloxBmi1 female 
mice was set up to obtain embryos at the desired developmental timepoint. Every 
morning each female was examined for presence of a vaginal plug, which is com-
posed of coagulated secretions from male sex glands, and indicates that coitus and 
ejaculation had occurred. Then the female is placed in a separate cage and consid-
ered pregnant for 0.5 day. 16 days later, female mouse is sacrificed and embryos 
removed; decapitated and brains placed in ice cold HIB buffer, while tail tipping 
performed for isolation of genomic DNA. Brains were individually treated: men-
inges removed and whole telencephelon processed for isolation of neural stem 
and progenitor cells, which were plated at clonal density in culture medium. 
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Meanwhile, PCR is performed on genomic DNA using primers for EGFP and Cre to 
identify compound and single transgenic embryos. This allowed for selection of the 
cultures to be used in our experiments. While NSPC from single transgenic em-
bryos (STOPFloxBmi1 or Nestin-Cre) were used as control, those of compound 
transgenic (NestinCre;STOPFloxBmi1) were treated as experimental material.   
2.1.4 Genotyping: From DNA Isolation to Amplification of Gene of Interest 
A local anaesthetic, EMLA cream (supplied by the BSU), was applied to tails of P5 
litter mates, or ears of P70 mice for 15 minutes before they were excised (ap-
proximately 0.5 millimetres) using a sculpture for the former and a sharp scissors 
for the latter, whereas for E16.5 embryos the tail samples were taken post-
decapitation. As their processing and use in the rest of the procedure is the same, 
tail or ear samples will be referred to as tissue samples hereafter.  
Tissue samples were digested in 500 microlitres (µl) of lysis buffer (50 mM Tris, pH 
8.0, 100 mM EDTA, 100 mM NaCl and 1% SDS) and Proteinase K (Biolabs) on a 
thermomixer compact (Eppendorf), for two-three hours at 55o C and mixing at 
1000 units per minute (upm). Upon full digestion, samples were centrifuged 
(Thermo Scientific, Heraeus Fresco 17) at 13000 (13k) revolutions per minute 
(rpm) for ten minutes at room temperature (RT), and the supernatant (SN) was 
transferred into correspondingly labelled eppendorfs tubes containing 500 µl iso-
propanol-2 (Fisher Scientific) to precipitate deoxyribonucleic acid (DNA). Samples 
were then centrifuged again under the same conditions as above, supernatants 
decanted and tubes drained inverted on a paper towel. To remove salts away from 
the pelleted DNA, a final wash with 70% ethanol was performed before DNA was 
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dissolved in 50-100 µl of TE buffer (10 mM Tris,1 mM EDTA, pH 8.0), on the ther-
momixer compact for 30 minutes at 55o C and mixing at 1000 upm. Dissolved DNA 
was stored at 4o C. 
Standard PCR methods based on denaturation, annealing and extension were used 
to amplify DNA segment(s) of interest (amplicon), so that genetically modified 
mice could be distinguished from non transgenic littermates.  
Table 2.1 provides predominantly used pipetting scheme and range of final con-
centration(s) for Taq polymerase based PCR procedure, though minor changes 
were applied whenever required: 
 
 
A list of primer sequences used is given below in Table 2.2, some of which were 
commercially available, whereas others were designed (*) de novo. Primers were 
designed using both the mouse genomic sequence provided online at 
Reagent 
Quantity (µl), 
 25µl reaction volume 
Final  
concentration 
H2O 13.65 -14.15  
Enzyme Buffer Thermo Pol (10 x conc.) 2.5 1X 
dNTP mix (4mM) 2.5 0.4 mM of each 
Upstream primer (10 pM/µl) 2.5 0.1 µM 
Downstream primer (10 pM/µl) 2.5 0.1 µM 
Taq DNA polymerase (5 u/ml) 0.35 1.75 U 
Template DNA (µg/µl) 0.5 - 1  
Table 2.1: Pipetting scheme for PCR-assay for genotyping 
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http://www.ensembl.org/Mus_musculus/index.html and the program named 
primer3 available online at http://frodo.wi.mit.edu/. Criteria used for primer selec-
tion were based on length, sequence and melting temperature: the primer length 
between 18-24 nucleotides; the Guanine (G)/Cystine (C) content ratio between 
50% and 50%; the 3’ ends free of secondary structures, repetitive sequences, 
complementary sequences, palindromes and highly degenerate sequences; and 
similar melting temperatures between  55o C and 65o C.  
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Company Name Sequence (5’-3’) Species 
o C 
(Tm
) 
bp 
MWG-
Biotech 
LZ 1* -CGTCACACTACGTCTGAACG- 
Mus mus-
culus 
58 500 
MWG-
Biotech 
LZ 2* -CGACCAGATGATCACACTCG- 
Mus mus-
culus 
58 500 
MWG-
Biotech 
EGFP* 
Fwd 
-CCTACGGCGTGCAGTGCTTCAGC- 
Mus mus-
culus 
65 300 
MWG-
Biotech 
EGFP* 
Rev 
-CGGCGAGCTGCACGCTGCGTCCTC- 
Mus mus-
culus 
65 300 
MWG-
Biotech 
TAG-83F -GGAGGAGAGAGACCCCGTGAAA- 
Mus mus-
culus 
65 500 
MWG-
Biotech 
TAG-82B -ACACGAAGTGACGCCCATCCGT- 
Mus mus-
culus 
65 500 
MWG-
Biotech 
Cre 
Fwd* 
-CTATCCAGCAACATTTGGGCCAGC- 
Mus mus-
culus 
65 700 
MWG-
Biotech 
Cre Rev* -CCAGGTTACGGATATAGTTCATGAC- 
Mus mus-
culus 
65 700 
Table 2.2: Primer sequences used for genomic DNA 
Table 2.3: PCR programs used for genotyping 
Table 2.2: Primer sequences used for genomic DNA 
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The PCR amplification products were run according to standard agarose electro-
phoresis methods and visualised by ultraviolet (UV) light:  1.5 µl 4X loading dye 
(Sigma) were added to each reaction, they were run on a 2 % TAE (Tris-Acetate-
EDTA) agarose gel containing 0.01 % ethidium bromide (EtBr) at 120 volts for 30 
minutes. Furthermore, the PCR programs given above in Table 2.3 were optimised 
for each primer and reactions were run on a standard PCR machine (eppendorf). 
2.2. Isolation and culturing of murine embryonic and postnatal NSPC 
The isolation and culturing of NSPC was undertaken essentially in accordance with 
previously described methodologies  (Lois and Alvarez-Buylla, 1993)  (Gritti et al., 
1999). Here, I will describe essential details of how NSPC were isolated, cultured 
PCR Pro-
grams Op-
timised for 
Primers 
     
 
Denaturation 
(o C) 
Primer anneal-
ing (o C) 
Extension (o C) 
Number 
of Cycles 
Final Ex-
tension (o 
C) 
EGFP 94 for 5 min 65 for 5 min 72 for 1 min 35 
72 for 5 
min 
CRE 94 for 5 min 65 for 5 min 72 for 1 min 35 
72 for 5 
min 
TAG 94 for 5 min 65 for 5 min 72 for 1 min 40 
72 for 5 
min 
LZ 94 for 5 min 58 for 5 min 72 for 50 sec 35 
72 for 5 
min 
Table 2.3: PCR programs used for genotyping 
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and expanded in preparation for functional assays to characterise their growth and 
differentiation properties in vitro.  
2.2.1 Dissection of the developing neocortex at E16.5 and of the subventricular 
zone at P7 and P70.  
 E16.5 embryos and P7/P70 mice were culled by decapitation and heads placed 
immediately in a Petri dish containing ice cold HIP buffer. For E16.5 embryos, the 
fibrocollagenous skull structures were removed with forceps, the brain was re-
leased and the neocortex was dissected and placed in a Petri dish containing ice 
cold HIP buffer. For P7/P70 mice, the skin was removed from the head using small 
scissors. A superficial coronal cut was made at the junction between the nasal and 
frontal bones using small scissors. Curved scissors were used to gain access to the 
brain, via a longitudinal cut through the skull along the sagittal suture. The skull 
was then peeled off using curved forceps. The head was inverted and, optic and 
trigeminal nerves as well as hypophisis/hypothalamus stalk were cut using forceps 
to allow the brain to be detached. The brain was then placed in a Petri dish con-
taining ice cold HIP buffer. An approximately 2-3 mm thick frontoparietal slice was 
obtained, as depicted in Figure 2.5, A and B. In brief, the olfactory bulbs rostral to 
incision (a) were removed as well as the brain regions caudal to incision (b). The 
SVZ, which is located in the lateral wall of the lateral ventricles from the crossing of 
the anterior commissure to the rostral opening of the third ventricle, was isolated 
by cutting a strip of tissue approximately 1-2 mm wide and 2-4 mm long along the 
lateral wall of the lateral ventricle underneath the corpus callosum.  
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The tissue of interest, embryonic neocortex or SVZ region, were then homogenised 
using a tissue chopper before further processing.  
 
 
2.2.2 Isolation of NSPC 
The Papain Dissociation System (PDS) (Worthington) based on the proteolytic 
properties of the enzyme papain (sulfhydryl protease from Carica papaya latex), 
was used to isolate NSPC from the brain homogenate.  Tissue homogenate was 
placed in a Petri dish containing papain solution at 37o C for 40 minutes (embry-
onic neocortex) or 1 hour (postnatal SVZ). The homogenate mixture was further 
dissociated into single cell suspension by trituration using a 1 ml syringe with 21 
gauge (21G) needle. The cell suspension was transferred into a 15 ml falcon tube 
and centrifuged at 600 rpm for 6 minutes. Supernatant was removed and pellet 
Fig 2.5 Dissection of the SVZ from postnatal brains A) Schematic rep-
resentation of the cut up strategy to isolate SVZ from the rest of the 
brain. B) Macroscopical view of the adult brain slice obtained,   dotted 
square indicate the area used for NSPC preparation. 
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immediately re-suspended in DNase dilute albumin-inhibitor solution which, in 
turn, was carefully transferred into a 15 ml tube containing albumin-inhibitor solu-
tion that formed the discontinuous density gradient. Following centrifugation for 
five minutes at 500 rpm, dissociated NSPC and other cells formed the pellet, 
whereas the membrane fragments and debris remained at the interface between 
the two layers of the gradient. Supernatant was removed and pellet re-suspended 
in 1 ml DMEM/F12 (Invitrogen) supplemented with 1X B27 (Invitrogen), and the 
mitogens epidermal growth factor (EGF, 20 ng/ml) and fibroblast growth factor 
(FGF, 20 ng/ml).  
2.2.3 Trypan Blue exclusion test to determine number of cells in the cell suspen-
sion 
Number of cells was determined by Neubauer’s improved counting chamber 
(VWR). 10µl sample of the cell suspension obtained was mixed with 10µl of Trypan 
Blue Solution (dye). 10µl of this mixture was applied to Neubauer’s improved 
counting chamber, and all viable cells (trypan blue negative) in each of the outer 
primary squares (4 × 1mm2) were counted at the light microscope. 
Cell number was determined using the formula below: 
Number of cells in suspension = mean no. of cell count × 2 (dilution factor) × 104 
ml-1 
2 × 104 ml-1 cells (postnatal SVZ) and 3 × 104 ml-1 cells (embryonic neocortex) were 
seeded in each well of a 6-well plate (9.6 cm2) in two ml culture medium. The rela-
tionship between the growth area and plating densities for postnatal and embry-
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onic NSPC is then 4000 and 6000 per cm2 respectively, in keeping with  what com-
monly described in the literature  (Ferron et al., 2007). 
2.2.4 Culturing of NSPC with the neurosphere assay.    
In agreement with previously described work (Reynolds and Weiss, 1992), free-
floating clusters of stem cells and progeny (so called neurospheres) arose between 
5 and 7 days in culture (DIC) in growth factor supplemented medium. These pri-
mary neurospheres (approximately 180-200 micrometers in diameter) were trans-
ferred into a 15 ml falcon tube and centrifuged at 500 rpm for 3 minutes. Super-
natant was removed, and the pellet was re-suspended in 1 ml fresh culture me-
dium. Neurospheres were dissociated by gentle trituration approximately 20 times 
using a 1 ml syringe with 21G needle. Cell number was determined as described 
above and cells were plated at the same density under the same culture conditions 
to allow for formation of secondary neurospheres. Similar procedure was used for 
dissociation and replating of secondary NS to tertiary NS, etc. (sequential pas-
sages).  
Both embryonic and postnatal NSPC were dissociated and replated for at least two 
passages before assessment of cellular properties were carried out to ensure 
elimination of cellular debris and of differentiated cells.  
2.3 Adenoviral Vectors and the induction of Bmi-1 Overexpression in vitro 
Two different replication-defective adenoviruses were used: one expressing green 
fluorescent protein (GFP) and other expressing Cre recombinase. Both viruses 
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Adeno-GFP (A-GFP) and Adeno-CRE (A-CRE) were gifts of Professor Anton Berns, 
Molecular Genetics, The Netherlands Cancer Insitute, Amsterdam.  
2.3.1 Amplification and titre determination of Adenoviruses 
The batches of adenovirus that were available in the laboratory (stock Adeno-CRE 
1 × 109 pfu/ml and Adeno-GFP 1 × 108 pfu/ml) could be expanded using Human 
Embryonic Kidney 293 cells (Hek-293) (Clonetech #C3202-1). Hek-293 cells were 
plated in 150 cm2 Petri dishes, in DMEM (high glucose)/10% FCS/1% penicillin 
streptomycin/2 mM Glutamine, 24 hours before infection at a density to ensure 
that the monolayer of cells reach 50-70% confluent on the day of infection. Cell 
number has been estimated to be 2x107 per dish. Cells were infected with M.O.I. > 
5 of both viruses. Cells were then incubated for 90 minutes at 37° C, 5% CO2, and 
dishes were briefly swirled every 30 minutes to ensure maximum contact between 
virus and cells. Virus-containing media was then discarded in a bottle containing 
1% virkon, and 20 ml fresh growth media added. Cells were incubated for 2-3 days 
at 37° C, 5% CO2 until cytopathic effect (detachment of approximately 50% of cells) 
was observed. The rest of the cells were dislodged by gentle agitation and all were 
pulled in 50 ml conical tubes. Cell suspension was centrifuged at 1500 g, for 5 min-
utes at RT. Pellet was re-suspended in 1 ml PBS and cells were lysed with 3 con-
secutive freeze-thaw cycles. After the third cycle, cells were briefly centrifuged to 
pellet debris, and aliquots of suspension containing virus was prepared.  
Next, Plaque Assay was performed to determine the plaque forming unit (pfu) of 
each virus. For this, Hek-293 cells were plated in 6 well plates at a density of 4x105 
cells/ml, 24 hours before the procedure. 5 % agarose was prepared by dissolving 
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2.5 gram Seaplaque Agarose in 50 ml Dulbecco’s Phosphate Buffered Saline (DPBS) 
(pH 7). Serial dilutions, from 10-1 to 10-10, of the virus were prepared with sterile 
DPBS. When the cell density had reached 80-90 % confluency, growth media was 
removed and 0.2 ml adenovirus dilutions of interest (10-3 to 10-10) were added to 
wells. Cells were incubated for 1 hour at 37° C, 5% CO2 to allow viral infection. 
Meanwhile, 0.5 % agarose solution was prepared by mixing 45 ml pre-warmed 
growth media with 5 ml of 5 % stock agarose. The virus inoculum was removed 
and 2 ml of 0.5 % agarose solution was added to each well. Agarose was allowed to 
set for about 5-10 minutes at RT before the plate was incubated for 5-7 days at 37° 
C, 5% CO2. Then, 1 ml of neutral red solution (0.03 %) was added to each well, and 
the plate was incubated for 2-3 hours. Neutral red is taken up by the healthy cells, 
and therefore plaques appear as clear circles against red or pink background. 
Number of plaques for each well was counted using the aid of a custom made grid. 
The viral titre, a quantitative biological activity of the virus expressed as pfu/ml is 
calculated using the following formula: 
Pfu/ml= no of plaques/ (dilution factor) x (volume of virus dilution added to each 
well) 
The plaque forming unit (pfu), which is a measure of the strength or concentration 
of a component/particle in a given volume, was calculated to be 2.5 × 109 pfu/ml 
and 1.5 × 108 pfu/ml for A-CRE and A-GFP respectively.  
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2.3.2 Determining the Multiplicity of Infection (MOI) of virus needed for opti-
mal lox-P recombination in NSPC 
The plaque forming unit (pfu), which is a measure of the strength or concentration 
of a component/particle in a given volume, was estimated to be 2.5 × 109 pfu/ml 
and 1.5 × 108 pfu/ml for Adeno-Cre and Adeno-GFP respectively.  
NSPC were infected on the next day following dissociation of primary neuro-
spheres either with A-CRE, to enable Bmi1 over-expression by Cre-mediated re-
combination or A-GFP, to provide a control for infection. Optimization tests for use 
of adenoviruses were performed to obtain both highest infection efficiency and 
viability. The following formula was used to calculate amount of virus needed to 
infect a given number of cells to achieve the desired MOI:  
Amount of virus (µl) = Cell number x MOI of interest / Virus (pfu/µl). 
 Our trials demonstrated that the optimal multiplicity of infection (MOI), defined as 
the average number of phage particles that infect a single bacterial cell in a specific 
experiment, and therefore referring to the infectious efficiency of a virus, was 
eight for both Adeno-Cre and Adeno-GFP viruses. 
2.4. In vitro NSPC assays 
I have chosen and optimised several assays to assess effects of Bmi1 over-
expression on NSPC properties such as proliferation, self-renewal, differentiation 
and apoptosis. In the next section, I will describe the experimental procedures of 
the assays used in this study to explore NSPC properties in vitro. 
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2.4.1  Serial dilution assay for self-renewal 
Tertiary neurospheres were dissociated by triturating and 4000 cells were sus-
pended in a 15 ml falcon tube containing 2 ml culture media. Serial dilutions (1:2) 
were prepared from this as follows; 1 ml of cell suspension from the initial tube 
was transferred to another 15 ml tube, which already contained 1 ml of media. 
From the second tube 1 ml of cell suspension was transferred to yet another tube 
containing 1 ml media. This operation was repeated for the next 4 tubes sequen-
tially producing a range of cell concentrations from 2000 (first tube) to 64 cells 
(sixth tube). Then each tube was supplemented with 1 ml culture media to obtain 
a total volume of 2 ml in each tube. From these tubes 500 µl was transferred into 
four wells of a 24-well plate, which had then received 500 µl of culture media next 
day. This was repeated for each tube in the series producing four replicas for a se-
rial dilution of a range of cell concentrations from 500 ml-1 to 16 ml-1. After 6-8 
days the newly formed neurospheres (with diameter greater than 40 µm) were 
counted in each well and the mean of four technical replicas was plotted against 
the initial number of cells.  
2.4.2 Long-term propagation of NSPC 
Another way of assessing self-renewal capacity is in vitro long-term propagation of 
NSPC. Primary neurospheres were mechanically dissociated and 125 cells/well 
were plated in technical quadruplicates in 96-well plates. The number of neuro-
spheres arising in each well was counted within 4-6 days using a light microscope. 
Neurospheres were dissociated by triturating and re-plated under the same condi-
tions. These two procedures were repeated for 10 passages. The number of neuro-
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spheres arising from experimental and control NSPC was plotted against number 
of passages, providing an independent measure of ability of self-renewal over 
time.     
2.4.3  Proliferation  
Proliferation ability of NSPC from postnatal and embryonic mice was measured by 
quantitation of Alamar Blue (a dye which is reduced by metabolic intermediates 
produced in proliferating cells) reduction in normal culture conditions. Cells (1.0 × 
104) were seeded in replicas in wells of a 96-well flat bottom culture plate. Alamar 
Blue solution (10% final concentration v/v) was added to each well (except the 
blank/medium only wells) and the plate was incubated for 2 hours at 37°C before 
the first measurement was taken. Dye reduction was measured at 2 different 
wavelengths (570nm and 595nm) using a standard spectrophotometer. Measure-
ments were taken at 12 hour intervals over 72 hours.  
In addition, in an independent experiment, actual size of neurospheres was de-
termined as an indirect measure of proliferation (data not shown- as there was no 
difference between the experimental and control neurospheres).   
2.4.4 Click-iT™ EdU based proliferation assay 
The Click-iT™ EdU assay is a more accurate method for assessment of proliferation 
as it directly measures DNA synthesis. Tertiary neurospheres we dissociated 16 
hours prior to incubation to ensure that differentiated and progenitor cells are 
eliminated before addition of EdU, allowing measurement of proliferation of neu-
ral stem cells. A 2X working solution of EdU was prepared in the culture media 
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from the 10 mM stock solution. NSC were incubated with 10 µM EdU solution for 3 
hours at 37°C, 5% CO2.  After incubation, media was removed and 100 µl/well of 
3.7% formaldehyde in PBS added for 15 minutes at RT. The fixative was removed 
and cells were washed twice with 3% BSA in PBS (100 µl/well). Wash solution was 
removed. And 0.5% Triton X-100 in PBS (100 µl/well) was added for 20 minutes at 
RT. The Triton X-100  was removed and cells were incubated with 1X Click-iT™ EdU 
reaction cocktail (1X Click-iT™ reaction buffer, CuSO4, Click-iT™ Alexa Fluor 488, 
and Reaction buffer additive) for 30 minutes, protected from light. Reaction cock-
tail was removed and cells were washed once with 3% BSA in PBS (100 µl/well). 
Propidium Iodide (PI- excitation wavelength 647 nm) (20 µg/ml-1) was added to 
cells, and assessment of proliferation and cell cycle was performed using LSR II 
(Becton Dickinson) flow cytometer. Cells from the same population without the 
EdU treatment was used as negative staining control. Thirty thousand cells were 
recorded in each analysis.    
2.4.5  Apoptosis and Live Cell Cycle Analysis 
Neurosphers were incubated with Hoechst 33342 (10 µg/ml-1) for 45 minutes at 
37°C in advance for cell cycle analysis. They were then dissociated into single cells, 
collected by centrifugation at 700 rpm for five minutes, washed once with PBS, 
and collected in an eppendorf by centrifugation at 300 × g for 10 minutes. Super-
natant was removed and approximately 1 x 106 cells per assay were re-suspended 
in 100 μL 1X Annexin Binding Buffer (BioSource™). And then Hoechst 33342 (10 
µg/ml-1) was added again, after 5 minutes supplemented with Annexin V-Alexa 647 
conjugate (2.5 µg/ml-1) for 10 minutes at RT. For NSC that had been infected with 
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A-GFP, 4-6-Diamidino-2-phenylindole (DAPI; 200ng/ml-1) was then added. How-
ever, for NSC from E16.5, PI (20µ/ml-1) was used.  All apoptosis and cell cycle (G1, S 
and G2m phases) experiments were analysed by LSR II (Becton Dickinson) flow cy-
tometer. Thirty thousand cells were recorded in each analysis. 
2.4.6 Neurosphere differentiation 
Neurospheres were plated onto cover slips coated with 25µg/ml laminin in serum 
free Neurobasal medium containing 1X B27 to differentiate over 5, 7 or 9 days. Dif-
ferentiated neurospheres were fixed in 4% PFA for 15 minutes at room tempera-
ture and immunostained with primary antibodies including mouse monoclonal 
anti-βIII-tub (1:500, Abcam); rabbit polyclonal anti-GFAP (1: 500, DakoCytomation); 
mouse monoclonal anti-O4 (1:500, Chemicon International); mouse monoclonal 
anti-Nestin (1:500, Chemicon); rabbit polyclonal anti-NG2 (1:100, Chemicon); 
mouse monoclonal anti-A2B5 (1:200; Chemicon); rabbit polyclonal anti-Musashi-1 
(1:500, Chemicon); mouse monoclonal antibody raised against Bmi-1 (1:400, Up-
state); mouse monoclonal/rabbit polyclonal antibody raised against glial fibrillary 
acidic protein (GFAP, 1:500, Molecular Probes); mouse monoclonal antibody rec-
ognizing β-tubulin Isotype III (1: 500, Abcam); mouse monoclonal antibody raised 
against O4 (1:500, Chemicon International), rabbit polyclonal antibody recognizing 
Green Fluorescent Protein  (GFP, 1 :400; Abcam). Secondary antibodies used were 
Alexa Fluor 596-conjugated anti-rabbit IgG or anti-mouse IgG (1:500, Invitrogen); 
Alexa Fluor 488-conjugated anti-mouse IgG or anti-rabbit IgG (1:500, Invitrogen).  
The ratio between positive cells and the total number of cells (DAPI) were com-
puted from 10 successive fields chosen around the epicentre of the neurospheres.   
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2.4.7 Expression analysis in neurospheres 
Neurospheres from control and transgenic animals were studied for expression of 
a variety of genes and reporter genes, antigens and proteins. In the next section I 
will describe the methods and materials used for these assays.  
2.4.8 X-gal Staining 
For X-gal staining, neurospheres from STOPfloxBmi1 mice were fixed in 4 % for-
maldehyde (PFA)/PBS for 10 minutes before they were incubated at the ratio 1:25 
with 25 mg/ml X-gal/PBS (Calbiochem) and X-gal staining solution comprising 5 
mM K3[Fe(CN)6], 5 mM K4[Fe(CN)6], 2 mM
 MgCl2, at 37
o C and overnight. After 
staining, neurospheres were post-fixed in 70 % ethanol/PBS and stored at 4°C. 
2.4.9 Immunocytochemistry on cells and neurospheres 
10-15 neurospheres were plated onto Laminin (20 ng/ml-1) coated cover glass (18 
mm) in 12 well plates, and incubated in Neurobasal medium without EGF or FGF 
but B27. The cells were differentiated for 6 days and then fixed in 4 % PFA for 15 
minutes at RT. Following rinses with PBS and permeablisation with 0.5% Triton X-
100 for 30 minutes at RT, the cultures were blocked with 5 % Normal Goat Serum 
(NGS) for 40 min at RT. Primary antibodies (see below) were diluted in NGS (5 %) / 
Triton X-100 (0.5 %) and applied overnight at 4°C or 2 hours at RT. After repeated 
rinses in PBS, they were further incubated with secondary antibodies diluted in 
PBS (see below) for 2 hours, in dark and at RT. Following further rinses in PBS, cells 
were counterstained with DAPI (200ng/mL) for 10 minutes, in dark and RT, and 
mounted on slide using DAKO fluorescence mounting medium. Controls with omis-
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sion of primary antibodies were made, with no positive signals detected.  The pri-
mary antibodies used were: mouse monoclonal antibody raised against Bmi-1 
(1:400, Upstate); mouse monoclonal/rabbit polyclonal antibody raised against glial 
fibrillary acidic protein (GFAP, 1:500, Molecular Probes); mouse monoclonal anti-
body recognizing β-tubulin Isotype III (1: 500, Abcam); mouse monoclonal antibody 
raised against O4 (1:500, Chemicon International), rabbit polyclonal antibody rec-
ognizing Green Fluorescent Protein  (GFP, 1 :400; Abcam). Secondary antibodies 
used were Alexa Fluor 596-conjugated anti-rabbit IgG or anti-mouse IgG (1:500, 
Invitrogen); Alexa Fluor 488-conjugated anti-mouse IgG or anti-rabbit IgG (1:500, 
Invitrogen). 
To study neurosphere composition using immunohistochemistry, 12 µm cryostat 
sections were prepared from pre-fixed (in 4% paraformaldehyde overnight at 4° C) 
and cryo-protected (in 30 % sucrose solution (w/v)) tertiary neurospheres embed-
ded in OCT (TissueTek-Sakura). Sections were dried overnight at room tempera-
ture and used for immunohistochemistry: blocked in PBS (0.06% Triton X-100 or 
0.1% Tween-20) containing 5% normal goat serum and incubated overnight with 
primary antibodies (rabbit polyclonal anti-GFAP (1:500, DakoCytomation); mouse 
monoclonal anti-GFAP (1:500, Chemicon International); rabbit polyclonal anti-NG2 
(1:100, Chemicon); mouse monoclonal anti-A2B5 (1:200, Chemicon International); 
rabbit polyclonal anti-Dlx2 (1:200, Chemicon International) at room temperature. 
The application of appropriate secondary antibodies and counter staining with 
DAPI (2 µg/ml, Sigma) was followed by picture acquisition using a Zeiss LSM 510 
confocal microscope.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
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2.4.10 Neurosphere composition and flow cytometry. 
To study neurosphere heterogeneity using flow cytometry, neurospheres were 
harvested by centrifugation, mechanically dissociated into single cells and washed 
once with PBS. The cell suspension for experimental and control samples were 
parted in two, where one part was incubated (1 hour, RT) with the primary anti-
bodies (anti-GFAP, 1:500; anti-NG2, 1:100; anti-A2B5, 1:200 or combination of 
these) and other with control antibodies to obtain background fluorescence (rab-
bit IgG for GFAP and NG2; mouse IgG for GFAP; IgM for A2B5) both antibodies di-
luted in 1 % PBS/ 0.5 % BSA. Cells were washed twice with 1 % PBS/ 0.5 % BSA. 
Both cell parts were then incubated (30 minutes, RT) with secondary antibodies ( 
goat anti-rabbit IgG Alexa Flour 488, 1:500; goat anti-mouse IgG Alexa Flour 488, 
1:500; goat anti-mouse IgM Alexa Flour 488, 1:500; goat anti-rabbit IgG Alexa Flour 
596, 1:500). Cells were washed once with 1 % PBS/ 0.5 % BSA and re-suspended in 
PI (20µ/ml-1) before being analysed the LSR II (Becton Dickinson) flow cytometer.  
2.4.11 Western blotting 
Proteins were extracted using Ripa buffer (25 mM Tris•HCl pH 7.6, 150 mM NaCl, 
1% NP-40, 1% sodium deoxycholate, 0.1% SDS) containing protease inhibitors 
(Complete mini, Roche Diagnosis). Protein concentration was determined using 
the BCA assay. Equal amount of protein (10-20µg) for each condition was loaded 
into a 12% BisTris gel, separated by SDS-PAGE and electroblotted onto nitrocellu-
lose membranes (Proteigene). Membranes were blocked with 5% non-fat dry milk 
for 1 hour at room temperature and incubated overnight, in 2% milk/Tris-buffered 
saline containing 0.1% Tween-20 (TBST), with the following primary antibodies at 
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4°C : mouse monoclonal anti-Bmi-1(1:200; Millipore); rabbit polyclonal anti-p16 
(M-156) (1:200; Santa Cruz Biotechnology); rabbit polyclonal anti-p19ARF (1:500, 
abcam); mouse monoclonal anti-p21 (1:200; Calbiochem); and mouse monoclonal 
anti-α-Tubulin (1:5000; Sigma). Membranes were incubated with appropriate per-
oxidise-conjugated secondary antibodies at 1:5000 for one hour at room tempera-
ture prior to visualization of immunoreactive proteins on a film using the ECL kit 
(Amersham).   
2.4.12 RNA extraction and cDNA synthesis 
Large quantities of fresh or frozen tertiary neurospheres were suspended in Trizol® 
Reagent (Invitrogen, Paisley, UK) and vigorously shaken and incubated for 5 min-
utes at room temperature (RT) to permit a complete dissociation of nucleoprotein 
complexes. Subsequently 0.2 ml of chloroform was added per 1ml of Trizol re-
agent. After vigorous shaking for 15 seconds the samples were incubated at RT for 
3 minutes and centrifuged at 12,000 x g for 5 minutes. Following centrifugation the 
colourless upper aqueous phase was transferred into a new tube which was mixed 
with 0.5 ml of Isopropyl alcohol per 1 ml of Trizol reagent. Then, after incubation 
at RT for 10 minutes, the RNA samples were centrifuged for 10 minutes at 13,000 x 
g at RT.  Following the phenol-chloroform RNA extraction, isopropanol precipita-
tion and the RNA pellet formation by centrifugation, the RNA samples were 
washed using 300 ml of 75% ethanol and dissolved in RNase-free water. The RNA 
concentration was determined spectrophotometrically at 260 nm, and the quality 
of RNA was assessed based on the ratio of absorbance at 260 and 280 nm with a 
NanoDrop (ND-1000, NanoDrop Technologies, USA). 1-2 µg of RNA was imme-
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diately treated with DNaseI (Invitrogen) to minimize genomic contamination. 1ug 
of DNase-treated RNA was then retrotranscribed by SuperScript III (Invitrogen) and 
resultant cDNA used as template for quantitative real time PCR.  
2.4.13 Real-Time quantitative PCR and data analysis 
SYBR green reactions were performed with SYBR Green Jump Start Taq Ready Mix 
(Sigma Aldrich) and run on ABI PRISM7500 Sequence Detection System. Expression 
of genes of interest was determined following normalization to the level of a 
housekeeping gene, GAPDH, in each sample. A standard curve was generated by 
real-time PCR analysis from triplicates of five ten-fold dilutions of cDNA generated 
from 1 ng of control sample RNA. As a negative control mRNA measurements were 
performed on samples treated with DNase but not with reverse transcriptase en-
zyme on each single run. The relative expression level of the gene of interest was 
computed from each experimental sample by calculating the ratio between the 
gene of interest (ng/reaction) and the GAPDH gene (ng/reaction).  
Taqman (Invitrogen) assays were performed with FAM labeled probes in 96 well 
plates using the Applied Biosystems 7500 RT PCR machine. Amplification condi-
tions for both Taqman and SYBR Green assays were as follows:  95° C for15 min 
followed by 40 cycles of 95° C for 10 seconds; 60° C for 15 seconds; 72° C 20 sec-
onds. The cDNA content was normalized against the expression of the housekeep-
ing gene GAPDH. All results represent the mean of at least three biological samples 
and each reaction has been performed in triplicates.  
Primers sequences designed to analyze mRNA expression of selected genes by 
real-time PCR are shown in Table 2.4: 
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Genes Sequence (5’-3’) 
GAPDH 
 
F: GCACAGTCAAGGCCGAGAAT 
R: GCCTTCTCCATGGTGGTGAA 
Col1a1 
 
F: GACCCCAAGGCCCCCGTGGT 
R: GACCCTTTATGCCTCTGTCA 
Col 9a1 
 
F: TACCAAAACTGGGGCAAAGC 
R: ATTTGGCTAAAGAGAAATTG 
Neurog2 
 
F: CAATTACATCTGGGCGCTC 
R: ACGCCGGGCTGTTGGTGCAG 
Foxg1 
 
F: GTGAGGATTTGTGATCTGTGTG 
R: ACGAGTGGGTAGCTTGTAATTC 
Bcan 
 
F: CCGAGGTAGGCAGCATAGAG 
R: AAGGTCAAAGGGGTCGTCTT 
Neurocan 
 
F: TCAGAGGCCCTAAGTGCTGT 
R: GTGGGACTGGGGTCATATTG 
Ncam1 
 
F: GGTGACCCCTGATTCAGAAA 
R: GGATGGAGAAGACGGTGTGT 
Cspg4 (NG2) 
 
F: GAAGATGATGCGAGGTGGAT 
R: AGCTGATGCTGGAGGTGTCT 
Col4a1 
 
F: CCAAAGGATCAGTTGGAGGA 
R: CTCCTTTGGCTCCCTTCTCT 
Col4a2 
 
F: ACCAGATGGCTTCCTGTTTG 
R: ACATTGGCAGTCTCCAGCTT 
Table 2.4: Primer sequences of selected genes 
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2.4.14 Administration of adenoviruses 
Viral infection of SVZ NSPC was achieved by unilateral stereotaxic injections of 5 µl 
of A-Cre and A-GFP (2.5 x 109 pfu/ml and 1.5 x 108 pfu/ml respectively) into 
anaesthetized adult mice placed in a steriotaxic frame. Viruses were administered 
with a Hamilton syringe (26G), using coordinates of 0.5 mm lateral to coronal su-
ture and a depth of 2mm.  
2.5 Statistics 
Statistical analysis was performed using SPSS 15.0 software. Statistical significance 
was determined by Student’s t-test, paired test. All results in the graphs and 
tables, where it applies, are indicated as the mean ± standard deviation of the 
mean (SD) where p < 0.05 is considered as statistical significance. Degree of signi-
ficance is denoted by asterics where * incates p < 0.05; ** indicates p < 0.01 and 
*** indicates p < 0.001. The Welch correction is used to provide a valid t-test in 
the presence of small sample size and unequal population variances.  
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CHAPTER 3 — RESULTS 
3.1 In vitro assays to assess self-renewal, proliferation, apoptosis and differentia-
tion of neural stem/progenitor cells. 
The availability of robust in vitro culturing conditions for NSPC provided an ex-
perimental platform to develop a variety of experimental procedures to study dif-
ferent aspects of their biological properties such as self-renewal, proliferation, dif-
ferentiation and apoptosis (Conti and Cattaneo 2010). Here, I will describe; 1) the 
optimisation of the assays I have chosen to study the biological properties of these 
cells in vitro and 2) the experimental approach I have taken to efficiently deliver 
Cre recombinase to NSPC in vitro.  
3.1.1 Self-renewal 
I have chosen to study self-renewal capacity of NSPC using; 1) a serial dilution 
method (Campos et al., 2004) and 2) a repeated passaging method (Hitoshi et al., 
2002; Deleyrolle and Reynolds 2009).  
Serial dilution method: This method allowed us to assess the number of cells con-
tained in a neurosphere which was capable of giving rise to neurospheres upon 
dissociation. The initial experiments were designed to determine the most appro-
priate well size and the most appropriate number of cells to be plated in a given 
volume of culture media to obtain a number of neurospheres which could be accu-
rately and reproducibly counted with a light microscope. I have chosen to use 24 
well plates and a range of concentrations between 16 cells ml-1 and 500 cells ml-1 
in each well. The number of neurospheres originating from any given concentra-
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tion was assessed with a light microscope and the aid of a custom made grid at 6-7 
days in vitro (DIV). In our hands, 16 cells per well would generate a range of 4 to 12 
neurospheres while 500 cells per well would produce between 104 and 269 (Figure 
3.1A). This method allowed us to assess clonogenicity of NSPC while  taking into 
account the notion  that neurospheres are motile and can merge when plated at 
high density  (Singec et al., 2006). Moreover, this method allowed us to simultane-
ously monitor the effects of cell density on the self-renewal capacity of NSPC. 
Repeated passaging method: A cardinal feature of stem cells is that they can be 
passaged over a long period of time. To test self-renewal ability of NSPC over an 
extended period of time and its effects on neurosphere forming capacity with each 
passage, I employed the repeated passaging method. Briefly, primary neuro-
spheres were mechanically dissociated and 125 cells/well were plated in technical 
quadruplicates in 96 well plates. Before each subculture passage (every 4-6 days 
for 10 passages) total number of neurospheres was counted using 5x objective of a 
light microscope. On average there were found to be between 20 and 59 neuro-
spheres at each passage (Figure 3.1B). 
In addition, at each subculture passage the total number of live cells from com-
bined neurospheres of technical replicates were counted using Trypan blue exclu-
sion method.  In combination, the number of neurospheres and the combined cell 
number obtained at each subculture passage provided us an indication of the 
growth characteristics of NSPC contained within neurospheres and of their self-
renewal capacity.   
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A 
B 
Fig. 3.1 A) Assessment of self-renewal capacity of control NSPC using 
serial dilution method: The column chart exemplifies the typical number 
of neurospheres arising from a range of NSPC cultured for 6-7 DIV in 
media containing mitogens EGF and bFGF-2, and B27 supplement. B) 
Assessment of self-renewal capacity of control NSPC using repeated 
passaging method: The scatter chart shows the typical number of neu-
rospheres arising from 125 NSPC cultured for 4-6 DIV.   
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3.1.2 Proliferation  
Briefly, tertiary neurospheres were dissociated into single cells 24 hours before the 
procedure and then replated in normal culture conditions. The following day, cells 
were incubated with 10 mg/ml of Click-iT™ EdU for 2 hours –as recommended by 
the manufacturer’s protocol- or for 4 hours –to account for the predicted slow pro-
liferation rate of NSPC. The number of EdU positive cells was assessed by means of 
flow cytometry. The 3 hours incubation time was clearly superioras it consistently 
and reproducibly allowed me to detect a proliferation rate of circa 5-10 % in the 
cultures as compared to 1-3 % I detected when the cells were incubated with EdU 
only for 2 hours. 
 Alamar Blue assay: This is a dye which is widely used to quantify both prolifera-
tion and viability (Ahmed et al., 1994) of cells in vitro. Alamar blue is reduced by 
metabolic intermediates produced in metabolically active cells, and the rate of re-
duction as measured spectrophotometerically at 2 different wavelengths (565nm 
and 595nm) is proportional to the rate of proliferation and viability of the cells. 
Initial experiments were designed to determine the smallest number of cells re-
quired to detect a detectable change in Alamar Blue reduction over time.  
Having tried a range of cells from 1000 to 30 000 per/well, we found that the 
changes in proliferation were best observed if we plated 10 000 cells per well of a 
96 well plate. Tertiary neurospheres were dissociated by trituration and cells were 
plated in media containing non-toxic water soluble Alamar Blue dye. Measure-
ments were taken with a spectrophotometer at 12 hour intervals over 3 days. This 
timescale was chosen to ensure death of more differentiated cells  (up to 90 per-
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cent of progenitors and other cells die off 24 hours after plating (Reynolds and 
Rietze, 2005) and formation of small neurospheres from proliferating NSPC. Tech-
nical and biological replicas confirmed consistency and reproducibility of this as-
say. Differences in Alamar Blue reduction by experimental and control cells could 
be due to innate differences in proliferation and apoptosis (or other types of cell 
death) or their combinations at different rates; features that cannot be distin-
guished from spectrophotometric readout. Therefore, use of Alamar Blue alone 
does not provide sufficient evidence to clearly distinguish between changes in cul-
ture that could arise from differences in proliferation and/or viability/cell death. 
Nonetheless, quantitative assessment of proliferation and viability over time pro-
vides invaluable insight into dynamics of neurosphere formation, which is tightly 
associated with proliferation from a heterogeneous population of cells.      
3.1.3 Apoptosis  
Tertiary neurospheres were dissociated by trituration. This was followed by addi-
tion of Annexin Binding Buffer and conjugated Annexin V. DAPI or PI was used in 
parallel to exclude dead cells. Percentage of Annexin V positive cells were assessed 
by means of flow cytometric analysis (Figure 3.2). This analysis allowed me to 
quantify the rate of apoptotic cell population contained in the neurospheres.    
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Fig. 3.2 Quadrant dot plot analysis of control neurospheres with An-
nexin V and DAPI: The table provides quantitative information about the 
quadrants of the dot plot, where sum of Q1 and Q2 represents the dead 
cells (20.4 %), Q3 live cells (64.5 %) and Q4 apoptotic cells (15.1 %). 
 
Dead 
Live Apoptotic 
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Fig 3.3 Assessment of differentiation capacity of control neurospheres 
in absence of mitogens on laminin coated coverglass for 6-7 DIV. Neu-
rospheres contain multipotent NSPC as GFAP + astrocytes, O4 + oli-
godendrocytes, and βIII Tub + neurons are generated upon differentia-
tion. Images were taken with Zeiss LSM510; Magnifications 40X, and 
scale bar (50 µm) is indicated on image A. 
 
3.1.4. Differentiation  
For these studies, I have used the in vitro differentiation method for NSPC essen-
tially as described by Doetsch and co-workers (1999). NS were plated onto laminin 
coated coverslips and cultured in Neurobasal medium containing B27 supplement 
while growth factors EGF and FGF were withdrawn. We found that 5-6 DIV differ-
entiation under these conditions is sufficient to obtain cells that are positive for 
βIIITub (neurons), O4 (oligodendrocytes) and GFAP (astrocytes) (Figure 3.3), at a 
ratio comparable to those commonly quoted in the field (Singec et al., 2006). To 
study changes in nestin expression NS were allowed to differentiate for 9-10 DIV.   
 
 
 
 
3.1.5 Cre-mediated recombination of loxP sites in NSPC 
NSPC from postnatal control mice were cultured, as previously described. After 
two passages NSPC were infected with Adeno-GFP at a range of MOI (2-12) and 
were allowed to form neurospheres. Neurospheres were examined using a fluo-
O4 βIII Tub 
B C 
GFAP 
A 
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rescent microscopy. The efficiency of infection, as assessed by GFP positivity in the 
neurospheres, was almost 100% (Figure 3.4). 
Next, I set out to determine what MOI of Adeno-CRE virus would be most efficient 
to recombine loxP sites in NSPC. In order to test this, I took advantage of the es-
tablished Cre-loxP system in R26R mice; where cells of the R26R mice permanently 
express LacZ upon Cre-mediated recombination. Briefly, SVZ NSPC of adult R26R 
mice were isolated and cultured for two passages. Secondary neurospheres were 
mechanically dissociated and re-plated overnight before infection with Adeno-CRE 
virus using a range of MOI (2-12). X-gal staining was performed on tertiary neuros-
pheres and they were analyzed using a light microscopy. Results for the MOI of 
Adeno-CRE virus that produced the most efficient recombination in terms of least 
toxicity and greatest spread of LacZ staining in all cells of the neurospheres are 
shown in Figure 3.5.  
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A B 
X-gal 
A B 
Fig 3.4 Testing efficiency of infection of Adenoviruses in NSPC: A) Light 
microscopy image of the Adeno-GFP infected neurospheres. B) High in-
fection efficiency in neurospheres arising from Adeno-GFP infected NSPC 
is visible under a fluorescent microscopy. Note that almost all cells of all 
neurospheres are green. Magnifications 40X. Scale bar 200 µm. 
 
Fig 3.5 Testing efficiency of infection of Adenoviruses in NSPC: A) Con-
trol neurospheres are not positive for LacZ. B) High infection efficiency in 
neurospheres arising from Adeno-CRE infected R26R NSPC. All cells of all 
neurospheres were blue. Magnifications 20X (A) and 40X (B). Scale bar 
200 µm in (A), and 100 µm in (B).  
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3.1.5.1 Adenovirus mediated expression of GFP and CRE in NSPC has similar ef-
fects on their biological properties 
To control for non specific effects of infection and over-expression of any exoge-
nous proteins, NSPC were isolated from control (non transgenic) littermates and 
infected in parallel with Adeno-CRE and Adeno-GFP. Self renewal assays, prolifera-
tion and apoptotic assays as well as induction of differentiation were carried out as 
previously described on these cultures. I carried out the experiments for the self 
renewal and apoptotic assays while a colleague in the laboratory, Dr. Reto Sutter, 
carried out the proliferation and differentiation assays.  
Self-renewal 
Normal (non transgenic) NSPC from SVZ of postnatal mice was isolated and cul-
tured for three passages.  Tertiary neurospheres were mechanically dissociated 
into single cells and infected with either Adeno-GFP (MOI 8) or Adeno-CRE (MOI 8), 
and serially diluted from 500-16 cells per well. The neurospheres arising from 
normal NSPC infected with different viruses were counted 6 days later, and results 
are shown in Figure 3.6.  
In conclusion, we found that NSPC infected with either Adeno-CRE or Adeno-GFP 
viruses gave rise to similar number of neurospheres (Fig 3.6). The experiment was 
performed twice and two technical replicas were analysed for each experiment.   
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Apoptosis 
A small population of cells are known to undergo apoptosis in neurospheres. 
Whether Adeno-CRE and Adeno-GFP viruses differentially contribute to induction 
of apoptosis in the NS is unknown and we set out to analyse this as follow. Normal 
tertiary neurospheres arising from cells infected either with Adeno-CRE or Adeno-
GFP were mechanically dissociated and processed for Annexin V based apoptosis 
test. The number of Annexin V positive cells was assessed by FACS analysis, while 
DAPI positive dead cells were excluded from the analysis. No difference in the 
Fig 3.6 Testing possible differential effects of adenoviruses on self-
renewal of normal NSPC: Clonogenic assay was performed on normal 
NSPC infected with either Adeno-CRE or Adeno-GFP viruses. Note that 
similar number of NS originate from equal number of plated cells (n=2). 
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apoptotic rate of these two cultures was observed (Figure 3.7, Q4) and a specific 
toxicity of either of the Adeno-viruses used could be excluded.  
Similarly, comparable results were found in proliferation and differentiation assays 
carried out on cultures infected either with Adeno-CRE or Adeno-GFP (data not 
shown). 
 
             
                      
                                                                               
 
 
 
 
 
Fig 3.7 Assessment the effect of adenoviruses on apoptotic proper-
ties of neurosphere cells: The experiment was performed on normal 
NSPC cells infected with either Adeno-GFP (left panel) or Adeno-CRE 
(right panel). For each experiment 30 000 events were recorded and 
the quadrant 4 (Q4) both in the table and the dot plot represents An-
nexin V positive cells, that is apoptotic cells. The number of Annexin V 
positive cells in both experiments is approximately the same; 22.3 % 
for Adeno-GFP infected cells and 21.8 % for Adeno-CRE infected cells. 
n= 2   
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3.2.1 Analysis of expression of the transgenic construct in embryonic and postna-
tal NSPC 
The first reporter gene contained in the construct -the LacZ gene- encodes for the 
β-galactosidase enzyme. The enzymatic activity of this protein can be exploited to 
trace cells expressing the construct both in vitro and in vivo. Indeed, if the pro-
moter is active in a specific cell, β-galactosidase enzyme will be synthesised and 
the cells will turn blue when incubated with X-gal, a dye which is converted into an 
insoluble blue product by the β-galactosidase enzyme. We therefore set out to 
analyse whether the transgene was expressed in embryonic and postnatal NSPC 
obtained from STOPFloxBmi1 by means of X-gal staining.  
NSPC were isolated from the developing neocortex at E16.5 or from the SVZ at P7 
or P70 and cultured as neurospheres in the presence of B27 and mitogens (EGF 
and FGF2b) for three passages as previously described. We found strong and ho-
mogeneous blue staining in all cells contained within the neurospheres at 5-6 DIV 
(Figure 3.8, B), as compared to a complete lack of β-galactosidase activity in con-
trol neurospheres (Figure 3.8, A).   
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Next, we set out to analyse whether infection with Adeno-CRE would efficiently 
recombine the floxed sequence of the construct and therefore remove the LacZ 
gene. Embryonic and postnatal NSPC were infected on the next day following dis-
sociation of tertiary neurospheres with Adeno-CRE and X-gal staining was per-
formed on NS at 5-7 DIV (Figure 3.9). 
Lack of X-gal positivity demonstrated efficient Cre mediated recombination of the 
floxed LacZ/neomycin fusion gene. 
We therefore conclude that the transgene is active in NSPC and in all cells derived 
thereof regardless of age of isolation and that Adeno-CRE infection of the cultures 
efficiently removes the floxed sequence from the STOPFloxBmi1 construct. 
 
 
 
Fig 3.8 Assessment of the transgene activity in NSPC isolated from 
STOPFloxBmi1 mice embryos. A) Neurospheres derived from control 
(wt) NSPC do not stain for X-gal. B) X-gal staining showing expression 
of transgene in all cells of neurospheres derived from NSPC of STOP-
FloxBmi1 mice at E16.5. Magnifications 20X. Scale bar is 200 µm. n=2 
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Fig 3.9 Assessment of the efficiency of A-CRE mediated recombina-
tion of the LoxP sites using X-gal staining: A) Neurospheres derived 
from STOPFloxBmi1 NSPC (control) are blue, indicating activity of the 
reporter gene. B) Loss of X-gal positivity in all cells of neurospheres 
derived from A-CRE infected NSPC demonstrates permanent recombi-
nation of Lox-P sites. Magnifications 20X. Scale bar is 200 µm. n=2  
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3.2.2 Activation of Bmi1 over-expression in NSPC 
Two experimental settings were used to activate Bmi1 expression in NSPC: 
A)  Adenovirus mediated Cre delivery in NSPC isolated from STOPFloxBmi1 at 
E16.5, P7 or P70, from now on referred to as “acute activation of Bmi1 expression” 
B) Nestin promoter driven Cre expression in the developing neocortex of STOP-
FloxBmi1 mice followed by isolation of NSPC from double transgenic embryos at 
E16.5, from now on referred to “chronic activation of Bmi1 expression”.   
We reasoned that the combination of these two approaches would allow us to dis-
criminate between the impacts of an acute up-regulation of Bmi1 expression on 
NSPC properties versus the impact of a protracted over-expression of Bmi1 in 
these cells.  
3.2.2.1 Acute activation of Bmi1 expression   
Tertiary neurospheres originating from E16.5 NSPC were mechanically dissociated, 
replated at clonal density and infected on the following day with Adeno-CRE, to 
enable activation of Bmi1 over-expression.  To assess whether adenoviral medi-
ated Cre recombination of the STOPFloxBmi1 construct resulted in Bmi1 over-
expression, immunofluorescent staining for Bmi1 was carried out on NS originating 
thereof. Confocal analysis of this staining showed higher levels of Bmi1 expression 
in Adeno-CRE infected neurospheres as compared with non infected controls (Fig-
ure 3.10). As it is difficult to estimate an upregulation on the baseline expression of 
an endogenous protein with an immunohistochemical staining, which is essentially 
a non quantitative method, we set out to assess also expression of GFP, the sec-
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ond reporter gene which should be expressed only upon activation of the con-
struct. We show that GFP is also expressed in the experimental neurospheres as 
compared to controls. Co-localisation of the two markers is shown in double im-
munofluorescent staining analysed with a confocal microscope.  
Similar results were obtained also in experiments on NSPC isolated from the post-
natal subventricular zone (data not shown). We therefore conclude that adenovi-
rus mediated Cre delivery is highly efficient and resulted in recombination of loxP 
sites with removal of β-galactosidase expression and activation of Bmi1 expression 
driven by the chicken β-actin promoter.  
 
Fig 3.10 Activation of Bmi1 expression in vitro: Assessment of Bmi1 
over-expression in neurospheres derived from tertiary NSPC infected 
with Adeno-Cre (bottom panel). Note that upper panel does not ex-
press EGFP (green) and has lower level of Bmi1 (red). Scale bar is 200 
µm. n=2   
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3.2.2.2 Chronic Activation of Bmi1 expression    
NSPC were isolated from the developing neocortex of single transgenic embryos 
(STOPFloxBmi1 or Nestin-Cre) and of compound transgenic mice (Nestin-
Cre;STOPFloxBmi1) and cultured as previously described .     
X-gal staining of tertiary neurospheres derived from compound transgenic NSPC 
revealed lack of β-galactosidase activity as compared to controls isolated from 
STOPFloxBmi1 mice (Figure 3.11).   
 
 
These data show that Nestin-driven Cre expression is an efficient method to re-
combine loxP sites in embryonic NSPC.  
Next we set out to assess and quantify the level of Bmi1 expression upon Nestin-
Cre induced recombination. NSPC were isolated from E16.5 embryos of Nestin-
Fig 3.11 Successful in vivo recombination of loxP sites and removal 
of β-geo expression in NestinCre;STOPFloxBmi1 compound mice: A) 
X-gal positive neurospheres from NSPC of STOPFloxBmi1 mice (con-
trol). B) In vivo loss of floxed LacZ/neomycin fusion gene is permanent 
as NSPC from compound mice give rise to neurospheres that are nega-
tive for X-gal staining.  Magnifications 20X. Scale bar is 200 mµ. n=2 
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Cre;STOPFloxBmi1 and STOPFloxBmi1, and cultured as previously described. Pro-
tein lysate and RNA were isolated from tertiary neurospheres and Western blot-
ting or SYBR green RT-PCR were performed to assess Bmi1 over-expression.  
Reverse-transcription of the RNA into cDNA was simultaneously performed for the 
control and experimental samples. SYBR green RT-PCR was performed and expres-
sion of Bmi1 was determined for each sample following normalisation to the level 
of housekeeping gene, ribosomal 18S. All experiments have shown that Nestin-
Cre;STOPFloxBmi1 samples express approximately 1.8 fold more of Bmi1 mRNA 
compared with controls (Figure 3.12).  
Next, I performed Western blotting experiments to determine whether the in-
creased mRNA expression in NestinCre;STOPFloxBmi1 samples is translated into 
protein. All Western blotting experiments performed showed a two fold increase 
in Bmi1 protein level in NestinCre;STOPFloxBmi1 neurospheres as compared to 
single transgenic cultures. Equal protein loading was assessed by reprobing the 
membrane with an antibody against tubulin, while specificity of the antibody was 
confirmed by lack of staining in the negative control lane which contained protein 
homogenates extracted from Bmi1-/- brain (Figure 3.13). 
In conclusion, I found that efficient activation of the transgene is achieved by both 
Adeno-Cre infection and nestin driven cre expression in NSPC and their progeny 
isolated from STOPFloxBmi1 transgenic line.  
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Fig 3.12 SYBR green RT-PCR measurement of mRNA for Bmi1: Meas-
urements expressed in arbitrary units shows that Bmi1 expression is 
increased approximately by two fold in the NestinCre;STOPFloxBmi1 
neurospheres, compared with those of control (STOPFloxBmi1). n=2 
 
Fig 3.13 Assessment of activation of Bmi1 over-expression using 
Western blotting:  monoclonal antibody against Bmi1 shows ap-
proximately two fold increase in expression in the Nestin-
Cre;STOPFloxBmi1 neurospheres (middle lane), compared with those 
of control (left panel). Tubulin was used as loading control. n=2 
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3.3 Analysis of the impact of Bmi1 over-expression on cellular properties of NSPC 
in vitro 
3.3.1 Bmi-1 over-expression increases self-renewal of NSPC 
A cardinal feature of stem cells is their ability to self-renew by either symmetrical 
or/and asymmetrical cell division (Lois and Alvarez-Buylla, 1994). Previous studies 
on Bmi-1 null mice had shown that Bmi-1 is an essential component of neural stem 
cells’ self-renewal machinery (Park et al., 2003b). We set out to determine 
whether Bmi1 over-expression increases NSPC self-renewal capacity using two 
methods: 1) assessment of the number of neurospheres arising from serially di-
luted NSPC (Campos et al., 2004) and 2) assessment of long term passaging 
(Reynolds and Rietze, 2005). These two methods complement each other in the 
assessment of self-renewal as the former measures the percentage of cells with 
the ability to give rise to neurospheres in a given culture at a given time point 
whereas the latter determines the capability to give rise to neurospheres over 
time. 
3.3.1.1 Serial Dilution  
NSPC were isolated from STOPFloxBmi1 and NestinCre;STOPFloxBmi1 telencepha-
lon at E16.5 and subcloned three times before they were serially diluted from 500 
to 16 cells per well. After 7 DIV the neurospheres in each well were counted at 20x 
magnification using a grid for accuracy and the results are shown in Figure 3.14. 
The number of neurospheres arising from cells plated across the density range 
from 16, 32, 64, 125, 250 and 500 in experimental and control samples is 12 vs 4, 
23 vs 8, 42 vs 16, 79 vs 27, 149 vs 52, 269 vs 104, respectively. Two-tail Student’s t-
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test with Welch correction revealed that there is a significant difference in self-
renewal capacity between Bmi-1 over-expressing and controls cells at all cell den-
sities used (p values in order for cell densities from 16 to 500 are 0.001, 0.001, 
0.001, 0.001, 0.001, 0.001).  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Next, we wanted to determine whether a similar difference in self-renewal was 
also achievable when activation of Bmi-1 over-expression was induced acutely by 
adenoviral infection. We repeated the same experiments and took the same 
measurements using NSPC cells infected with Adeno-CRE or Adeno-GFP. The re-
Fig 3.14 Comparison of self-renewal capacity between the Bmi1 over-
expressing tertiary telencephalic NSPC derived from STOPFlox-
Bmi1;NestinCre and control STOPFloxBmi1 mice at E16.5: Note that 
more neurospheres are produced from Bmi1 over-expressing NSPC at 
all densities tested. ***= p<0.001, n= 4. 
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sults are shown in Figure 3.15. Similarly, activation of Bmi1 expression in tertiary 
NSPC cells resulted in formation of significantly more number of neurospheres at 
all densities plated from 16 to 500 per well (p values are 0.001, 0.001, 0.001, 
0.001, 0.001 and 0.001 respectively). 
 
These results show that over-expression of Bmi1 in NSPC maintain a higher pro-
portion of cells in a developmental stage where they can give rise to neurospheres, 
regardless of the route of over-expression; ‘acute’ induction of Bmi-1 expression 
by Adeno-Cre infection or ‘chronic’ by crossing STOPfloxBmi-1 mice with Nestin-
CRE mice. To determine whether cell density would have an impact on Bmi1-
Fig 3.15 Acute activation of Bmi1 expression in STOPFloxBmi1 NSPC 
increases their self-renewal capacity. ***= p<0.001, n= 4. 
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induced clonogenic activity, we compared the ratio (Adeno-Cre/Adeno-GFP; 
NestinCreSTOPFloxBmi1/STOPFloxBmi1) of the neurospheres formed at each “cell 
dilution plated” for both acute and chronic activation of Bmi1 expression (Table 
3.1).  
 
RATIO (experimental/control)       
Cell density 500 250 125 64 32 16 
STOPFloxBmi1;A-GFP/STOPfloxBmi1;A-
CRE 
2.3 2.3 2.5 2.2 1.9 3.3 
STOPFloxBmi1/STOPfloxBmi1;NestinCre 2.6 2.8 2.9 2.6 2.8 3.3 
 
The ratio of the neurospheres arising from plating of 500 NSPC infected with 
Adeno-GFP and Adeno-Cre is 1:2.3, whereas that of single and compound trans-
genic cells is 1:2.6. Similar results were obtained at all cell densities (see Table 3.1), 
in keeping with the interpretation that Bmi1 over-expressing NSPC give rise to 
more neurospheres independently of their original cellular density and route of 
activation of Bmi1 over-expression.  
Next, I set out to study effects of activation of Bmi-1 expression by means of Cre-
mediated recombination, on the biological properties of postnatal and adult NSPC, 
in a similar fashion to that of embryonic cells. 
Table 3.1 Comparison of the R of neurospheres obtained from plat-
ing different number of NSPC: Cell density or route of activation of 
Bmi1 in NSPC does not influence the increment in ratio of spheres 
generated, compared with controls, in 5-7 DIV.  
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NSPC obtained upon dissociation of tertiary NS derived from SVZ of P7 and P70 
STOPFloxBmi1 mice were infected with Adeno-CRE or Adeno-GFP. The resulting 
neurospheres were dissociated and plated as previously described. Neurospheres 
arising from each of these were counted and the results are shown in Figure 3.16. 
 
 
 
As seen in Figure 3.16, “acute” activation of Bmi-1 over-expression in postnatal 
NSPC has similar effects as observed in embryonic NSPC.  
In conclusion, these results show that overexpression of Bmi1 in NSPC increases 
self renewal/clonogenic activity of these cells in vitro independently of whether 
Fig 3.16 Serial dilution based assay showing that Bmi1 over-
expression in postnatal NSPC by means of “acute” activation leads 
to a greater clonogenic activity. **= p<0.01, ***= p<0.001, n=3. 
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the cells were isolated from the developing neocortex during embryonic develop-
ment or the postnatal SVZ.  
3.3.1.2 Long-term passaging  
NSPC can be perpetuated for a long time in culture, a property which is used as a 
measure to assess their self-renewal capacity (Reynolds and Rietze, 2005).   
Therefore, I set out to further assess the impact of Bmi1 overexpression on the 
self-renewal capacity of NSPC by repeatedly dissociating neurospheres and replat-
ing cells for 10 rounds. Tertiary NS of E16.5 NestinCre;STOPFloxBmi1 mice were 
dissociated, 125 cells were plated in 96 well dishes and cultured for 4-6 days untill 
small neurospheres of the size of 80µm diameter originated (data not shown). 
These NS were counted as previously described and results plotted into a graph 
(Figure 3.17). The number of neurospheres arising from equal number of plated 
cells for nine sequential passages is 36 vs 24, 28 vs 21, 37 vs 24, 33 vs 18, 35 vs 23, 
30 vs 23, 31 vs 21, 32 vs 20, 32 vs 21 and 32 vs 21 in NestinCre;STOPFloxBmi1 mice 
and controls respectively (Figure 3.18). The same experiment was performed for 
P7 NSPC where Bmi1 expression was activated through infection with Adeno-Cre 
and similar results were obtained. The number of neurospheres arising from equal 
number of plated cells for nine sequential passages 44 vs 28, 42 vs 27, 43 vs 27, 44 
vs 26, 42 vs 29, 43 vs 26, 43 vs 27, 43 vs 27, 42 vs 29, 43 vs 29 and 42 vs 28 respec-
tively. 
These experiments provided an independent confirmation of the increased self 
renewal of NSPC overexpressing Bmi1, independently of the develomental time-
point analysed. 
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Fig 3.17 Repeated passaging assay showing that Bmi1 over-
expression in postnatal NSPC by means of “acute” activation leads 
to a greater clonogenic activity. n=3 
 
 
Fig 3.18 Repeated passaging assay showing that Bmi1 over-
expression in embryonic NSPC by means of “chronic” activation 
leads to a greater clonogenic activity. n=3 
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3.3.2 Over-expression of Bmi1 increases proliferation and viability of NSPC 
NSPC are thought to have both a low proliferation rate (Morshead et al., 1994) and 
a finite number of mitotic divisions (Shay and Wright, 2000). Their proliferation is 
regulated by several pathways  (Sutter et al., 2007) including Bmi1 mediated inhi-
bition of Ink4a/Arf locus. In ageing mice, a decrease of both the self-renewal and 
proliferation potential of the SVZ NSPC have been shown to correlate with in-
creased p16ink4a expression, and that these effects could significantly be reversed 
by suppression of p16ink4a (Molofsky et al., 2006). Given the role of Bmi-1 in re-
pression of p16ink4a expression, I set out to assess whether Bmi-1 over-expression 
induces increased proliferation of NSPC. Assessment of proliferation was per-
formed by means of a colorimetric assay- Alamar Blue- and EdU (5-ethynyl-2´-
deoxyuridine) incorporation and detection, as previously described.   
Tertiary neurospheres arising from NSPC isolated from Nestin-Cre;STOPFloxBmi1 
and STOPFloxBmi1 were mechanically dissociated and 10 000 cells were plated in 
each well. Measurements of Alamar Blue reduction were carried out at 12 hour 
intervals for 72 hours at 2 different wavelengths (570nm and 595nm) using a spec-
trophotometer (BioTek SIAFR Synergy HT microplate reader with KC4 v3.4 soft-
ware).  Percentage of Alamar Blue reduction over time is plotted in a line graph for 
experimental cells and controls (Figure 3.19).  
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We found increased proliferation/ viability in NSPC overexpressing Bmi1. It is im-
portant to note that the proliferation rate of Bmi-1 over-expressing NSPC reaches 
its peak at 36 hours with 75% reduction of Alamar Blue, followed by a phase of pla-
teaux when reduction of the Alamar Blue reaches 87%. The proliferation rate of 
control cells reaches a plateaux when Alamar Blue is reduced by approximately 
60%. Indeed proliferation/viability of NSPC could be impaired by the size of the 
neurospheres they are imbedded in and by exhaustion of mitogens and nutrients 
in the culture media (Mori et al., 2006).  
Fig 3.19 Alamar Blue dye based assessment of prolifera-
tion/viability of E16.5 NSPC. Increased proliferation/viability is 
seen in NestinCre;STOPFloxBmi1 NSPC as compared with controls, 
at all time points analysed. *= p<0.05, **= p<0.01, n=4. 
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These results suggest that Bmi1 over-expression confers increased viability to 
NSPC as assessed by their increased metabolic rate. This, in turn, raises the possi-
bility that over-expression of Bmi1 increases the proliferation of these cells. To 
provide further support to this interpretation I used a complementary approach to 
assess proliferation of NSPC, the EdU incorporation and detection assay (Figure 
3.20). 
 
 
 
 
 
 
 
 
 
 
 
The average percentage of experimental NSPC incorporating EdU, e.i. actively syn-
thesising DNA, is 8.3, whereas that of control is 4.9. The difference is significant at 
95% significance level.   
Fig 3.20 EdU based assessment of proliferation of E16.5 NSPC rev-
eled increased rate of DNA synthesis in NestinCre;STOPFloxBmi1 
samples. **= p<0.01 n=3  
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The Alamar Blue dye showed that activation of Bmi1 expression in embryonic 
NSPC increases their metabolic rate, an event which may be linked either to in-
creased proliferation or to increased cellular viability. However, assessment of pro-
liferation by means of EdU incorporation and detection conclusively shows that 
activation of Bmi1 expression in NSPC results in an increase of their proliferation. 
Similar results were obtained when these experiments were performed on P7 
NSPC (Figure 3.21), in keeping with this being an effect of Bmi1 overexpression in-
dependent of the developmental timepoint analysed. 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.21 Alamar Blue assay shows increased proliferation of P7 
NSPC upon activation of Bmi1 expression by Adeno-Cre as com-
pared to controls. *= p<0.05 **= p<0.01, ***= p<0.001, n=3. 
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3.3.3 Bmi1 over-expression differentially affects apoptosis of progenitor cells 
contained in neurospheres in a temporal dependent manner.  
Bmi1 is involved in regulation of apoptosis of NSC via direct inhibition of the 
Ink4a/Arf tumour suppressor locus, particularly of the protein product p19ink4a   
(Sutter et al., 2007) . It was therefore conceivable that Bmi1 over-expression could 
induce resistance to apoptosis in NSPC. We set out to test this hypothesis by study-
ing the apoptotic rate upon induction of Bmi1 over-expression.  
Tertiary neurospheres derived from E16.5 NSPC of NestinCre;STOPFloxBmi1 and 
STOPFloxBmi1 mice were mechanically dissociated into single cells at 6-7 DIV and 
processed for Annexin V apoptosis assay, as previously described. Flow cytometry 
analysis showed increased apoptosis in Bmi-1 over-expressing cultures (mean= 
24.9%, n=4) as compared with control (mean=16.6%, (Figure 3.22)). 
 As the vast majority of progenitor cells contained in the neurospheres are com-
mitted progenitors, these findings suggest that these cells are more susceptible to 
apoptotic death induced by protracted culturing upon activation of Bmi1 expres-
sion. 
Intriguingly, when I performed the same experiment on neurospheres derived 
from NSPC isolated from the postnatal SVZ at P7, different results were obtained.  
On average, Annexin V positive cells in neurospheres obtained from postnatal 
NSPC constituted 7.9% of the total whereas they represented 13% in the controls 
(Figure 3.23).  
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We conclude that activation of Bmi1 expression confers resistance to apoptosis in 
progenitor cells contained within neurospheres originating from postnatal NSP in 
our culture conditions.  
Taken together these data imply that intrinsic, developmental stage dependent 
factors play a crucial role in determining the apoptotic response of Bmi1 over-
expressing NSPC. 
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Fig 3.22 Increased apoptosis in Bmi1 over-expressing neuro-
spheres as detected by Annexin V assay. *= p<0.05, n=4 
Fig 3.23 Reduced apoptosis in NSPC upon “acute” Bmi-1 over-
expression at P7. *= p<0.05, n=4. 
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3.3.4 Effects of Bmi-1 over-expression on differentiation 
3.3.4.1 Analysis of the cellular composition of neurospheres over-expressing 
Bmi1 
Neurospheres consists of a heterogeneous population of cells. In fact, only a small 
number of cells of the neurosphere are capable of stem cell properties, such as 
self-renewal. To begin to characterise the impact of activation of Bmi1 over-
expression on the differentiation potential of NSPC, I analysed the cellular compo-
sition of NS over-expressing Bmi1 as compared with controls. I have chosen to 
evaluate cellular composition of neurospheres using previously reported neural 
stem and progenitor cell markers namely glial fibrillary acid protein (GFAP), type-1 
transmembrane proteoglycan protein (NG2), and ganglioside epitope (A2B5). GFAP 
is a marker commonly associated with astrocytes and yet most of NSPC, isolated 
from neurogenic sites of postnatal and adult mouse brain, express it. A previous 
study has demonstrated that GFAP positive SVZ cells give rise to neurons terminat-
ing at the olfactory bulb in mice (Doetsch et al., 1999a). Another study by Doetsch 
et al., has shown that upon deletion of transit amplifying cells and neuroblasts in 
the SVZ of mice with the arabinofuranoside (Ara C), GFAP positive astro-
cytes/NSPC, which are spared by Ara C, were sufficient for regeneration of the SVZ 
(Doetsch et al., 1999b). Moreover, primary GFAP positive astrocytes cultured with 
media containing EGF and FGF-2, form neurospheres and act as multipotent NSPC. 
However, whether GFAP-positive cells within neurospheres represent NSPC and/or 
astrocytes is unclear.  
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The NG2 proteoglycan is a type 1 transmembrane protein, previously considered 
to be expressed in oligodendrocyte precursor cells that exclusively gave rise to oli-
godendrocytes. Recent findings have shown that NG2 expressing cells generate 
not only oligodendrocytes but also protoplasmic astrocytes and in some instances 
neurons in vivo. Moreover, NG2 positive cells are thought to contribute to gliomas 
formation and glioma angiogenesis (Chekenya et al., 2002a, Chekenya et al., 
2002b). Recently, NG2 positive neurosphere forming cells were isolated from em-
bryonic murine cortex, striatum and adult spinal cord (Chekenya and Pilkington, 
2002, Dromard et al., 2008). Interestingly, the same study has found that NG2 
negative embryonic spinal cord cells gave rise to neurospheres containing NG2 
positive cells. Moreover, NG2-positive cells isolated from neurospheres by flow 
cytometry and plated in media containing EGF and FGF2, were capable of generat-
ing neurospheres (Dromard et al., 2008). Interestingly, these cells have been 
shown also to be positive for A2B5, another marker classically thought to be exclu-
sively expressed in oligodentrocyte precursors in vivo.  
A) Flow cytometry analysis 
To dissect the cellular composition of NS, simultaneous detection of multiple anti-
gens by means of incubation with fluorescence labelled specific antibodies fol-
lowed by flow cytometric quantification was used (as in Figure 3.24).  
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NS derived from Bmi-1 over-expressing NSPC displayed a significantly higher per-
centage of cells co-expressing GFAP and NG2 (79%), GFAP and A2B5 (73%), NG2 
and A2B5 (54%) compared with control neurospheres, respectively 41%, 13% and 
17% (Figure 3.24 p<0.001 and p<0.01). Quantification of three independent bio-
logical replicas is plotted below in Figure 3.25. 
Fig 3.24 FACS dot plots showing the percentage of A2B5 (x-axis) 
and NG2 (y-axis) positive cells, and their non-immune controls (top 
and bottom left), control (top panel) and experimental (bottom 
panel) neurospheres. The upper right quadrants, of the right top 
and bottom plots respectively, show that experimental NS had 
66% double positive cells as compared to 13.5% in control NS. n=3 
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Cells expressing NG2+ and A2B5+ in neurospheres have previously been shown to 
be self-renewing and multipotent (Dromard et al., 2008). Our data show that over-
expression of Bmi-1 in NSPC results in expansion of the pool of self-renewing and 
NS-forming cells in vitro and they are compatible with the results we obtained with 
the self renewal assays.  
B) Immunohistochemical analysis 
In order to verify these findings with an independent method, neurospheres de-
rived from NestinCre;STOPFloxBmi1 and controls NSPC were embedded in OCT, 
Fig 3.25 Bmi1 over-expressing cells contain more cells positive for 
early progenitor markers such as NG2, A2B5, GFAP and NG2, GFAP 
and A2B5, and NG2 and A2B5. **= p<0.01, ***= p<0.001, n=3.  
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cryo-sectioned and immunostained against either non immune controls (IgG 
or/and IgM) or with anti-NG2, anti-A2B5, anti-GFAP or combinations of these anti-
bodies and analysed by confocal microscopy. Bmi1 over-expressing NSPC give rise 
to NS that have a greater number of cells positive for NG2 and A2B5 (bottom left- 
see inset), GFAP and NG2 (bottom middle), and more GFAP and A2B5 positive cells 
(bottom right- see inset), all compared with control NS (Figure 3.26). Note that the 
results seen in Figure 3.26 are in agreement with those obtained from flow cy-
tometric analysis.  
 
 
 
Fig 3.26 OCT sections showing the cellular composition of NS: 
Note that Bmi1 over-expressing neurospheres have more double 
positive cells for all antigens studied compared with controls. DAPI 
was used for counterstaining. Magnifications 20X, insets 40X, Scale 
bar is 200 µm, n=3. 
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We have further analysed Bmi1 over-expressing neurospheres for expression of 
markers associated with neuronal differentiation such as the homeobox gene Dlx2. 
This marker was chosen as its role in the acquisition of neuronal fate has been de-
scribed in the developing forebrain (Petryniak et al., 2007). Immunolabelling of 
OCT embedded NS revealed a reduced number of cells expressing Dlx2 in Bmi1 
overexpressing cultures compared with controls (Figure 3.27).  
 
 
These results are in keeping with the data of Petryniak et al., (2007) who have 
shown that deletion of Dlx1 and Dlx2 homeobox transcription factors in oligoden-
drocyte progenitor cells results in inhibition of neuronal differentiation and pro-
Fig 3.27 Immunostaining for Dlx2 on OCT sections of NS: A) Con-
trol NS contain Dlx2 positive cells both in the centre and the pe-
riphery, B) Bmi1 over-expressing NS have less cells positive for 
Dlx2 and they are focused mainly on the periphery of the sphere. 
DAPI was used for counterstaining. Magnifications 40X, Scale bar is 
100 µm, n=3. 
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motion of myelinating oligodendrocyte differentiation in vivo. Together, these re-
sults suggest that over-expression of Bmi1 in NSPC increases the number of undif-
ferentiated cells contained within NS, and that neuronal differentiation may be 
impaired.  
 
3.3.4.2 Analysis of the impact of Bmi1 overexpression on the differentiation po-
tential of progenitor cells.  
Next, I analysed the impact of increased Bmi1 expression on the differentiation 
capacity of NSPC contained in NS derived from Nestin-Cre;STOPFloxBmi1 com-
pared with controls. Induction of differentiation was carried out as previously de-
scribed.  Fluorescent immunolabelling against specific antigens as detailed below 
was performed at DIV5 and DIV9 and DAPI was used for counterstaining. For each 
experiment 10 random image fields were taken at 40X magnification using a con-
focal microscopy, and cells were counted by image2 software.  
A)  Neuronal differentiation is delayed at DIV5  
The percentage of cells expressing nestin is higher (36% vs 13%) at DIV5 in Bmi1 
over-expressing cultures (Fig 3.28 A and F, p<0.01). Moreover, the expression of 
Musashi, another marker of undifferentiated/uncommitted NSPC (Kaneko et al., 
2000), was retained in a significantly higher number of cells (50% vs 28%) in the 
transgenic cultures (Fig 3.28 B and G p<0.001). While the percentage of GFAP posi-
tive astrocytes and O4 positive oligodendrocytes was similar in both cultures, a 
significant reduction in the number of βIII-tubulin positive neurons was noted in 
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Nestin-Cre;STOPFloxBmi1 cultures (Fig. 3.28 E and J, p<0.01). The percentage of 
cells expressing markers of immature glial and oligodendroglial progenitors such as 
A2B5 (28% vs 10%) and NG2 (19% vs 10.9%) as well as co-expressing GFAP and 
A2B5 (20% vs 3.5 %) and GFAP and NG2 (17% vs 10.5%) was significantly higher in 
cultures over-expressing Bmi1 (Fig.3.28 C and H and D and I, p<0.001 or p<0.01). 
The results for immunostaining experiment are shown in Figure 3.28. Their quanti-
fication is shown in Figure 3.29. 
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The reduced number of neuronally differentiated cells is surprising and may sug-
gest that increased levels of Bmi1 expression in differentiating neural progenitors 
mantains cells in an undifferentiated state or alternatively favours glial versus neu-
ronal differentiation. 
 
 
Fig 3.29 Quantification of the immunocytochemistry analysis of 
differentiation properties Bmi1 over-expressing NSPC compared 
with controls: Increased number of undifferentiated (Nestin and 
Musashi positive cells) and glial differentiated progenitors (GFAP 
and NG2; GFAP and A2B5 positive cells) and reduced number of 
βIII Tubulin positive neurons. Note that there is no difference in 
the number of O4 positive oligodendrocytes. **= p<0.01, n=3. 
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B) Complete differentiation is achieved at later stages with an increased number 
of neurons and oligodendrocytes produced from Bmi1 over-expressing NSPC 
Similar analysis performed at DIV9 showed higher number of O4 positive oli-
godendrocytes (Fig 3.30, A&E, 10% vs 6.5%), but also a higher number of βIII-
tubulin positive neurons (Figure 3.36 B&F, 8.5% and 5.4%) in Bmi1 over-expressing 
cultures compared with controls (Figure 3.30).  
 
 
 
 
 
 
 
Fig 3.30 Neurosphere differentiation on laminin coated coverslips 
for 9DIV, and immunostaining with antibodies against antigens 
βIII tubulin and O4 to identify neurons and oligodendrocytes re-
spectively: Bmi1 over-expressing NS give rise to more neurons and 
oligodendrocytes after 9 DIV differentiation. n=3 
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In addition, I have performed co-immunostaining labelling against antigens GFAP 
and A2B5, GFAP and NG2 and lastly NG2 and A2B5, following 9 DIV differentiation 
of neurospheres (Figure 3.31). Note that there are no NG2 and A2B5 positive cells 
in the control cultures.  Interestingly, the percentage of differentiated cells gener-
ated from Bmi1 over-expressing NS compared with controls, that is positive for 
A2B5 and GFAP (20.5 % vs 10.4 %), NG2 and GFAP (9.1 % vs 2.9 %), NG2 (11 % vs 
3.2%) were significantly different (Figure 3.32 for quantification of immunostain-
ing).  
 
                                                                       
 
 
 
Fig 3.31 Neurosphere differentiation on laminin coated coverslips 
for 9DIV, and co-immunostaining with antibodies against anti-
gens GFAP and A2B5, GFAP and NG2, and NG2 and A2B5 for glial 
cell progenitors: More undifferentiated and early progenitor cells 
are seen in Bmi1 over-expressing cultures even after 9 DIV differ-
entiation. n=3  
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This analysis of the effects of activation of Bmi1 expression on differentiation sug-
gests that Bmi1 maintains NSPC in an undifferentiated state longer. This is evident 
from the reduced number of terminally differentiated cells and the high number of 
progenitor cells in Bmi1 over-expressing cultures at DIV5. However, at 9 DIV a 
higher number of βIII-tubulin positive neurons and O4 positive oligodendrocytes 
were seen. Taken together these findings suggest that Bmi1 over-expression de-
lays but does not hamper trilinage differentiation of progenitor cells.   
Fig 3.32 Quantification of 9 DIV differentiation assay: Neuro-
sphere differentiation on laminin coated coverslips for 9DIV, and 
co-immunostaining with antibodies against antigens GFAP and 
A2B5, GFAP and NG2, and NG2 and A2B5 for glial cell progeni-
tors: More undifferentiated and early progenitor cells as well as 
more neurons and oligodendrocytes are seen in Bmi1 over-
expressing cultures. **= p<0.01, ***=p<0.001, n=3.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 rise to more neurons and oligodendrocytes after 9 DIV differentia-
tion. n=3 
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Similar experiments carried out on postnatal NSPC and NS derived thereoff dem-
onstrate that Bmi-1 overexpression in postnatal progenitors does not alter their 
differentiation potential (Figure 3.33), as they can give rise to neurons (βIIITub), 
oligodendrocytes (O4) and astrocytes (GFAP). Moreover, it shows that their mor-
phology is unaffected. Next, I tested whether Bmi-1 overexpression changed the 
relative distribution of these cell types in our culture conditions.  However no dif-
ference was found in their relative distribution in comparison with control cells 
and the obtained figures were comparable to the figures commonly quoted in the 
field (Singec et al., 2006), (Figure 3.34 for quantification of data).  
 
 
 
 
 
 
 
 
Fig 3.33 Bmi-1 over-expression does not alter postnatal NSPC dif-
ferentiation potential and the morphology of their progeny, n=3. 
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In summary, the impact of Bmi1 over-expression on the differentiation potential of 
NSPC differs at different developmental timepoints. 
 
 
 
 
 
Fig 3.34 Quantification of differention assays performed on Bmi-1 
over-expressing and control NS: relative distribution of cell types 
(neurons 8.1 % vs 10.6 %, astrocytes 54.6 % vs 51.1 %, oligoden-
drocytes 4.2 % vs 4.6 %) are similar to those commonly quoted in 
the literature. n=3. 
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3.3.5 Analysis of the molecular mechanims mediating the observed effects of 
Bmi-1 over-expression on the biological properties of NSPC in vitro.  
3.3.5.1 Canonical downstream targets of Bmi1.  
Bmi1-/- mice displayed impaired self-renewal and maintenance of SVZ NSC leading 
to their postnatal depletion (Molofsky et al., 2003, Park et al., 2003a). The molecu-
lar mechanisms of Bmi1 function have been shown to be mediated in part by tran-
scriptional repression of the ink4a locus (Jacobs et al., 1999a). This locus encodes 
two cell cycle inhibitors, p16Ink4a and p19ARF (Sherr, 2001), the activities of which 
increase with postnatal age and have been linked to cellular senescence (Molofsky 
et al., 2003). 
Recently Bmi1 has been shown to regulate self renewal of embryonic NSC located 
in ventricular zone (VZ) of the developing forebrain through inhibition of a differ-
ent cell cycle inhibitor, namely p21WAF1/Cip1 (Fasano et al., 2007). A more recent pa-
per by the same group has extended our knowledge of Bmi-1 and p21WAF1/Cip1 as-
sociation in regulation of embryonic NSPC self-renewal, by including into the equa-
tion also Foxg1. Foxg1 is winged-helix gene family member a gene previously 
known to be expressed by forebrain progenitor cells during development and 
throughout adulthood (Dou et al., 1999, Shen et al., 2006).  
The respective contribution of the Ink4aArf and Foxg1-p21 axes to mediation of 
Bmi1 function in the biological properties of embryonic and postnatal NSPC is still 
unclear. We set out to analyse how overexpression of Bmi1 in NSPC would influ-
ence the expression of key members of these two molecular axes. To this end we 
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perform protein analysis by means of Western blotting for p16Ink4a, p19ARF, 
p21WAF1/Cip1, and quantitative RT-PCR for Foxg1. 
We set out by testing whether activation of Bmi1 over-expression by “acute” and 
“chronic” methods would make a difference in functions of Bmi1 on suppression of 
p16Ink4a, p19ARF, p21WAF1/Cip1 (Figure 3.35).  
 
 
 
 
 
 
 
 
 
 
Fig 3.35 Western blotting showing the effects of “acute” and 
“chronic” activation of Bmi1 over-expression on expression of “ca-
nonical” downstream effectors of Bmi1. Suppression of expression 
of p16, p19 and p21 are achieved in both systems. Protein lysate 
obtained from STOPFloxBmi1 neurospheres was used as control. 
Actin was used as loading control. n=3 
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Reduced levels of p16Ink4a, p19ARF, p21WAF1/Cip1 was seen in neurospheres derived 
from NestinCre;STOPFloxBmi1 or STOPFloxBmi1;A-Cre as compared to controls. 
This finding suggests that Bmi1 represses expression of these cell cycle inhibitors 
simultaneously and independent of whether Bmi1 expression was activated 
chronically during embryonic development in vivo or acutely in vitro. 
Western Blotting analysis was performed also on neurospehres originating from 
NSPC isolated at p7 and p70 and similar results were obtained (Figure 3.36). 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.36 Western blotting performed on protein isolated from 
postnatal and adult NSPC showing the effects of “acute” and 
“chronic” activation of Bmi1 over-expression on expression of “ca-
nonical” downstream effectors of Bmi1. Suppression of expression 
of p16, p19 and p21 are achieved in both systems. Protein lysate 
obtained from STOPFloxBmi1 neurospheres was used as control. 
Actin was used as loading control. n=3 
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Furthermore, in keeping with recent data supporting a correlation between the 
expression of Bmi1 and Foxg1 (Fasano et al., 2009) we also show increased levels 
of Foxg1 (p<0.01), independently of whether Bmi1 activation occurred during em-
bryonic development in vivo or acutely in vitro.  
In keeping with published literature (and that of Fasano et al., 2009) over-
expression of Bmi1 in embryonic neurospheres revealed downregulation of the 
expression of Foxg1, independently on whether Bmi1 activation was induced dur-
ing embryonic development in vivo or acutely in vitro (Figure 3.37). However, no 
changes in the expression of this gene were found in P7 and P70 neurospheres. 
 
 
Fig 3.37 Showing the relative expression of Foxg1 gene in Bmi1 
over-expressing and control neurospheres: Expression of Foxg1 
gene in Bmi1 over-expressing embryonic neurospheres is approxi-
mately 5 fold greater that those of control. There is no difference 
in expression of Foxg1 in postnatal and adult neurospheres. **= 
p<0.01, n=3. 
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3.3.5.2 Gene expression profiling using microarray technology 
So far, we have shown that Bmi1 over-expression in embryonic NSPC increases 
their proliferation and apoptosis as well as their self renewal capacity while it de-
lays differentiation in neurospheres, and that these changes are associated with 
down-regulation of Bmi1’s known/recently identified downstream targets. The 
molecular mechanisms of Bmi1 function in all biological properties of NSPC exam-
ined above have been shown to be mediated in part by transcriptional repression 
of the ink4a locus (Jacobs et al., 1999b).   
However, concomitant deletion/suppression of either p16Ink4a or p19ARF or or both 
did not completely rescue the above mentioned defects in self-renewal of NSC de-
rived from Bmi1-/- mice (Molofsky et al., 2003, Bruggeman et al., 2005, Sparmann 
and van Lohuizen, 2006). Other NSPC functions, such as for example migration, 
have also been shown to be controlled by Bmi1 in an ink4a independent manner 
(Bruggeman et al., 2009). Moreover, it is interesting that the developmental stage 
of NSPC influences the preferential downstream targets of Bmi1. Indeed, Bmi1 has 
been shown to regulate self renewal of embryonic NSC located in ventricular zone 
(VZ) of the developing forebrain through inhibition of a different cell cycle inhibi-
tor, namely p21WAF1/Cip1 (Fasano et al., 2007).  
In this context, we set out to study which other novel genes might be involved in 
the changes noted post Bmi-1 over-expression in biological functions of NSPC. 
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3.3.5.2.1 Illumina Expression Array analysis  
To establish genome-wide expression profiles of NestinCre;STOPFloxBmi1 and con-
trol neurospheres, total RNA was isolated from tertiary neurospheres (n=2). Gene 
expression profiling was carried out at the Genome Centre in Charterhouse 
Square. The Illumina BeadChip arrays, which are high-density photolithographic 
oligonucleotide microarrays, were used. This system allows accurate measurement 
of relative concentration of an RNA sequences in a complex mixture of nucleic ac-
ids. Each platform represents approximately 46 000 genes (Illumina Expression Ar-
ray). 
We initially checked whether the control genes are present on the scatter plot, 
which shows the overview and clustering of gene expression. Indeed, we could see 
CRE on one side of the distribution and CV40 and NeoR on the other, as well as  
most of the genes of experimental and control samples clustered closely together 
suggesting that the number of differentially expressed genes was low (Figure 3.38).    
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Next, we set a cutting point at 95% significance for selection of most differentially 
expressed genes between experimental and control samples. This application was 
performed on the BeadStudio (Illumina) software. Statistical analysis revealed that 
1600 genes were significantly (P<0.05) differentially expressed between the ex-
perimental and control samples. However, only 700 of these genes were anno-
tated (Figure 3.39). 
 
 
NestinCre;STOPFloxBmi1 vs. STOPFloxBmi1 
Fig 3.38 The scatter plot showing the distribution of gene expres-
sion of NestinCre;STOPFloxBmi1 and STOPFloxBmi1 neuro-
spheres: Note that most of the genes are closely distributed ex-
cept the reporter genes for samples (arrows).  
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3.3.5.2.2 Validation of Target Genes Using Real-Time Quantitative PCR- embry-
onic 
Genes with highest expression profiles were selected for verification processes. 
These genes included transcription factors (Dlx2, Dbx2, and Irx2) and others (Ng2, 
Ncan, Ncam and Bcan) potentially involved in regulation of neurogenesis and dif-
ferentiation, and cell adhesion molecules (Col9a1, Col1a1, Col4a1 and Col4a2) 
regulating cell to cell contact, as well as other cellular processes, in neurospheres.  
Both TaqMan probe based-assays and SYBR Green Jump Start Taq Ready Mix as-
says were performed and run respectively on Applied Biosystems 7500 RT PCR and 
ABI PRISM7500 Sequence Detection System machines. 
Fig 3.39 Selection process for differentially expressed genes that 
are further studied using MetaCore or RT-PCR 
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qPCR expression profiling of NS isolated from Nestin-Cre;STOPFloxBmi1 and con-
trol mice revealed significant differences in the expression of transcription factors 
involved in neuronal specification – Dbx2, Neurog2, Dlx2 and Irx2 (p<0.001 or 
p<0.01 or p<0.05) (Figure 3.40). Moreover, several members of the collagen fam-
ily-Collagen Ia1, IVa1 and IVa2 and IXa1- as well as cell adhesion molecules Ng2, 
Ncam, Ncan and Bcan were deregulated in the double transgenic NS (p<0.001 or 
p<0.01 or p<0.05) (Figure 3.40).  
 
 
 
 
 
 
Fig 3.40 qRT-PCR arrays results show deregulation of cell adhesion 
molecules and down-regulation of transcription factors involved in 
neurogenesis in NS over-expressing Bmi1. *= p< 0.05; **= p<0.01; 
***= p<0.001; n=3.  
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Increased expression of Bmi1 results in upregulation of the expression of several 
members of the collagen family cell adhesion molecules such as Collagen Ia1, IVa1 
and IVa2 and IXa1, as well as cell adhesion molecules Ng2, Ncam, Ncan and Bcan. 
Note that reduced expression of members of the Collagen IV family and changes in 
expression of cell adhesion molecules may have functional consequences on mi-
gration of NSPC as Bmi1 has been previously shown to be regulating this process in 
vitro (Bruggeman et al., 2009). Moreover, upregulation of NG2 in Bmi1 over-
expressing neurospheres may account for increased number of oligodendroglial 
progenitors identified upon induction of differentiation. Reduced expression of 
Dlx2 in Bmi1 over-expressing neurospheres is in keeping with previous immunohis-
tochemistry studies. Moreover, Bmi1 over-expressing neurospheres have signifi-
cantly lower expression of a series of transcription factors - Dbx2, Neurogenin2, 
Irx2 (and Dlx2)- all of which play an important role in neuronal fate commitment 
(Ahn et al., 2004, Lacin et al., 2009, Roybon et al., 2009). Dlx2 in particular is 
known to regulate the balance between neurogenesis and oligodendrogenesis in 
the developing forebrain (Petryniak et al., 2007). A Bmi1- mediated downregula-
tion of Dlx2 may therefore explain the delayed neuronal differentiation and in-
creased number of oligodendroglial progenitors observed in Bmi1 overexpressing 
cultures.  
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3.3.5.2.3 Validation of differentially expressed genes by quantitative real-time 
PCR-in postnatal and adult NSPC 
Next we set out to study changes in gene expression profile of P7 and P70 (latter 
for only expression of Foxg1) neurospheres derived from tertiary NS/P cells in-
fected with Adeno-Cre virus. Briefly, we wanted to test whether “acute” activation 
of Bmi1 expression in postnatal NS/P cells would produce similar changes in gene 
expression profile observed in embryonic stage. 
 To perform this, SVZ NS/P cells were isolated from P7 and P70 STOPFloxBmi1 mice 
and cultured for three passages before infection with Adeno-Cre virus. RNA was 
isolated from tertiary neurospheres and cDNA was derived as previously described 
and used as template for quantitative RT-PCR analysis performed using SYBR 
Green Jump Start Taq Ready Mix and Taqman assays. 
We have assessed expression of transcription factors Dlx2 and Irx2, genes which 
are potentially involved in neurogenesis, and Ng2, Col4a1, Col4a2, Ncan, Bcan and 
Ncam, which are members of collagen family and cell adhesion molecules poten-
tially involved in self-renewal and cell-to-cell contact in neurospheres- some of 
those that we had studied in embryonic neurospheres.  
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Both TaqMan probe based-assays and SYBR Green Jump Start Taq Ready Mix as-
says were performed and run respectively on Applied Biosystems 7500 RT PCR and 
ABI PRISM7500 Sequence Detection System machines. I found that only Col4a1 
significantly differentially expressed by the NSPC over-expressing Bmi1. All other 
genes; Col4a2, Ng2, Ncan, Bcan, Ncam, Dlx-2, Foxg1 and Irx-2, that were differen-
tially expressed in the embryonic NSPC were not significant at the postnatal time 
point (Figure 3.41). 
 
 
Given that we have found similarities and in some cases differences in the biologi-
cal properties of embryonic compared with postnatal Bmi1 over-expressing NS/P 
cells as assessed by functional tests for self-renewal, proliferation, differentiation 
Fig 3.41 qRT-PCR results showing that only Col4a1 gene is differen-
tially expressed (p<o.oo1) upon Bmi1 over-expression. n=3.  
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and apoptosis, it seemed reasonable to investigate and determine the degree of 
difference in gene expression levels in postnatal NSPC compared with those of 
embryonic. In terms of changes in biological properties we have found that Bmi-1 
over-expression in postnatal and adult NSPC leads to increased resistance to apop-
tosis, makes no difference in differentiation potential, however self-renewal and 
proliferation are increased. In a similar fashion, the changes in gene expression 
profile in the Bmi1 over-expressing postnatal NSPC, as presented above in Figure 
3.41, points to a differential affect of acute Bmi1 over-expression between embry-
onic and postnatal time points studied. Indeed, in the Bmi1 over-expressing post-
natal neurospheres only one gene namely, Col4a1 is significantly differentially ex-
pressed. These findings suggest that Bmi1 acts through different sets of down-
stream targets in regulation of NSPC properties in the postnatal time point com-
pared with that of embryonic.  
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3.3.5.2.4 KEGG PATHWAY 
We then took two approaches in analysing these genes further. First, we uploaded 
these genes into KEGG PATHWAY database, which is a regularly updated collection 
of pathway maps and their interactions, to have a fast and reliable glance at possi-
ble pathways and cellular processes that may be altered upon Bmi-1 over-
expression. Indeed we found that several pathways, their components and the cel-
lular processes that they are most likely to alter in the experimental samples were 
significantly affected. These included MAPK signalling pathway, Insulin signalling 
pathway and Wnt signalling pathway. On the other hand, several core cellular 
processes and functions were also affected. These included focal adhesion, regula-
tion of actin cytoskeleton, ECM-receptor interactions, Cell adhesion molecules 
(CAMs), Adherens junctions, and axon guidance (Table 3.2).  
 
Table 3.2 showing changes in the cellular processes and functional pathways ob-
served in Bmi1 over-expressing NSPC. 
mmu04010 
MAPK signaling 
pathway 
 
14182   Fgfr1; fibroblast growth factor receptor 1 
14186   Fgfr4; fibroblast growth factor receptor 4 
17762   Mapt; microtubule-associated protein tau 
18218   Dusp8; dual specificity phosphatase 8 
19042   Ppm1a; protein phosphatase 1A, magnesium dependent, 
alpha isoform 
192176  Flna; filamin, alpha [SP:FLNA_MOUSE] 
19252   Dusp1; dual specificity phosphatase 1 
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20130   Rras; Harvey rat sarcoma oncogene, subgroup R 
23882   Gadd45g; growth arrest and DNA-damage-inducible 45 
gamma 
240168  Rasgrp3; RAS, guanyl releasing protein 3 
26414   Mapk10; mitogen-activated protein kinase 10 
26921   Map4k4; mitogen-activated protein kinase kinase kinase 
kinase 4 
26971   Pla2g2f; phospholipase A2, group IIF 
56613   Rps6ka4; ribosomal protein S6 kinase, polypeptide 4 
70686   Dusp16; dual specificity phosphatase 16 
 
mmu04512 
ECM-receptor 
interaction 
 
11603   Agrn; agrin 
12826   Col4a1; collagen, type IV, alpha 1 
12827   Col4a2; collagen, type IV, alpha 2 
15529   Sdc2; syndecan 2 
16403   Itga6; integrin alpha 6 
16780   Lamb3; laminin, beta 3 
243816  Gp6; glycoprotein 6 (platelet) 
 
mmu01430 Cell 
Communication 
 
11465   Actg1; actin, gamma, cytoplasmic 1 
12826   Col4a1; collagen, type IV, alpha 1 
12827   Col4a2; collagen, type IV, alpha 2 
16403   Itga6; integrin alpha 6 
16780   Lamb3; laminin, beta 3 
 
mmu04514 Cell 
adhesion mole-
cules (CAMs) 
 
15000   H2-DMb2; histocompatibility 2, class II, locus Mb2 
15529   Sdc2; syndecan 2 
16403   Itga6; integrin alpha 6 
18417   Cldn11; claudin 11 
56863   Cldn9; claudin 9 
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mmu04520 Ad-
herens junction 
 
11465   Actg1; actin, gamma, cytoplasmic 1 
14182   Fgfr1; fibroblast growth factor receptor 1 
16001   Igf1r; insulin-like growth factor I receptor 
17127   Smad3; MAD homolog 3 (Drosophila) 
19263   Ptprb; protein tyrosine phosphatase, receptor type, B 
 
mmu04360 
Axon guidance 
 
12631   Cfl1; cofilin 1, non-muscle 
13845   Ephb3; Eph receptor B3 
18481   Pak3; p21 (CDKN1A)-activated kinase 3 
235611  Plxnb1; plexin B1 
 
mmu04910 In-
sulin signaling 
pathway 
 
13684   Eif4e; eukaryotic translation initiation factor 4E 
18709   Pik3r2; phosphatidylinositol 3-kinase, regulatory subunit, 
polypeptide 2 (p85 beta) 
18746   Pkm2; pyruvate kinase, muscle [EC:2.7.1.40] 
18762   Prkcz; protein kinase C, zeta 
26414   Mapk10; mitogen-activated protein kinase 10 
 
mmu04310 Wnt 
signaling path-
way 
 
17127   Smad3; MAD homolog 3 (Drosophila) 
20319   Sfrp2; secreted frizzled-related protein 2 
20377   Sfrp1; secreted frizzled-related protein 1 
22415   Wnt3; wingless-related MMTV integration site 3 
26414   Mapk10; mitogen-activated protein kinase 10 
93960   Nkd1; naked cuticle 1 homolog (Drosophila) 
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Of these pathways and processes that are altered upon Bmi-1 over-expression the 
most significantly and highly altered was that of MAPK signalling pathway, as as-
sessed by the sheer number of components that are altered (15) and their fold dif-
ference in expression being more than two fold. Moreover, the MAPK signalling 
pathway has been highlighted as an important component of NSPC self-renewal 
regulation, and proliferation and apoptosis in other cell types. The similarities and 
correlations drawn between roles of MAPK signalling pathway portrayed in the lit-
erature and the changes we have observed in NSPC functions upon Bmi-1 over-
expression has made a strong case for us to study changes in MAPK signalling 
pathway components in our experimental and control neurospheres.  
In order to study expression of MAPK signaling pathway components protein lys-
ate was isolated from experimental and control tertiary neurospheres. 10ng/µl 
protein was used to perform Western blotting experiments.  
We initially looked at the total MAPK (ERK1/2) levels using antibodies against ERK 
and P-ERK, and found that there is no significant difference in protein levels be-
tween experimental and control neurospheres (Figure 3.42). 
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This finding suggested that the changes in expression of components of MAPK 
pathway could be more subtle and requires a more specific examination of the 
pathway. Independent studies of the other three main branches of the pathway, 
namely p38, SAPK/JNK and Jun were carried out. Indeed, the MAPK pathway re-
lated differentially expressed genes seen in the KEGG PATHWAY database analysis 
were pointing towards a possible change in the p38 branch of the pathway. West-
ern Blotting analysis was performed for p38, SAPK/JNK and Jun branches of the 
MAPK pathway and the results are shown in Figure 3.43. 
Fig 3.42 Western Blot analyses reveal that Bmi1 over-expression 
does not change levels of ERK and P-ERK in neurospheres. Tubulin 
was used as loading control. n=3 
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No changes in protein levels of neither of the branches of MAPK pathway were 
found in Bmi1 over-expressing neurospheres.  
 
 
 
 
Fig 3.43 Western Blot analyses show that three main branches of 
MAPK pathway do not alter in neurospheres over-expressing Bmi1. 
Tubulin was used as loading control. n=3 
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3.3.5.2.5 MetaCore  
In the next stage of microarray data analysis, we applied a further filter, which in 
principle oblige a minimum of 1.5 fold difference, as a requirement for accepting a 
gene as a potential target for advanced analysis. This application reduced the total 
number of differentially expressed genes to 450, some of which were either down-
regulated more than 2 fold or up-regulated more than 2 fold, though a majority of 
the gene population in the list were clustered around a two fold expression differ-
ence.  
Here we used MetaCore, a manually curated software suite, which is based on 
regularly updated database of protein-protein, protein-DNA and protein-RNA in-
teractions published in peer reviewed journals, transcription factors, signalling and 
metabolic pathways and the effects of bioactive interactions. MetaCore is used for 
functional analysis of microarray data using enrichment analysis. Briefly, enrich-
ment analysis consists of matching gene IDs of possible targets for the "common", 
"similar" and "unique" sets with gene IDs in functional ontologies in MetaCore. The 
probability of a random intersection between a set of IDs the size of target list with 
ontology entities is estimated in p-value of hypergeometric intersection. The lower 
p-value means higher relevance of the entity to the dataset, which shows in higher 
rating for the entity. The ontologies include GeneGo Pathway Maps, GeneGo Proc-
ess Networks, GO Processes, GeneGo Diseases (by Biomarkers). The degree of 
relevance to different categories for the uploaded datasets is defined by p-values, 
so that the lower p-value gets higher priority.  
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Differentially expressed genes (P<0.05 and expression > 1.5 fold) were uploaded to 
begin the analysis. Metacore allowed us to visualise what pathways, networks and 
biological processes our differentially expressed genes in Bmi1 overexpressing 
neurospheres relates to and involved in, in the up-to-date knowledge about pro-
tein-protein interactions and their pathways.  
Canonical pathway maps represent a set of about 650 signaling and metabolic 
maps covering human biology (signaling and metabolism) in a comprehensive way. 
All maps are drawn from scratch by GeneGo annotators and manually curated and 
edited. Experimental data is visualized on the maps as blue (for downregulation) 
and red (upregulation) histograms. The height of the histogram corresponds to the 
relative expression value for a particular gene/protein.  
These are about 110 cellular and molecular processes whose content is defined 
and annotated by GeneGo. Each process represents a pre-set network of protein 
interactions characteristic for the process. Experimental data is mapped on the 
processes and shown as red (up-regulation) and blue (down-regulation) circles of 
different intensity. Relative intensity corresponds to the expression value. 
See below for a set of results drawn as list of processes, pathways and their maps, 
and list of pathologies/malignancies from the 700 genes uploaded (though 450 are 
accepted as significantly differentially expressed) into MetaCore software.  
GeneGo Pathway Maps 
Canonical pathway maps represent a set of about 650 signaling and metabolic 
maps covering human biology (signaling and metabolism) in a comprehensive way. 
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All maps are drawn from scratch by GeneGo annotators and manually curated & 
edited. Experimental data is visualized on the maps as blue (for downregulation) 
and red (upregulation) histograms. The height of the histogram corresponds to the 
relative expression value for a particular gene/protein (Figure 3.44). 
 
 
 
 
 
 
 
Fig 3.44 GeneGo Pathway Maps. Sorting is done for the 'Statisti-
cally significant Maps' set. 
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Below are two examples of the maps generated from MetaCore analysis: 
1. Cytoskeleton remodelling: up-regulated genes shown in red bars are (PI3K reg 
class IA, LIMK, alpha-6/beta-4 integrin and c-Raf-1) and down-regulated genes 
shown in blue bars include (Collagen IV, Nucleolin, SMAD3). 
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7. Cell adhesion_ integrin-mediated cell adhesion and migration: the only up-
regulated gene shown in red bar is (LIMK2) and down-regulated genes shown 
in blue bars include (Collagen IV, MYLK1, ROCK, Nucleolin, Myosin heavy chain 
and Actin cytoskeletal). 
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In addition to the maps, a series of networks that relate to cellular processes are 
also generated automatically by the MetaCore software. A table summarising 
these processes based on the protein-protein interactions is provided below in 
Figure 3.45. 
 
 
   
 
 
 
 
 
Fig 3.45 GeneGo Process Networks. Sorting is done for the 'Statis-
tically significant Networks' set. 
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Below is one example of GeneGo process networks: 
1. Cell adhesion_ Attractive and repulsive receptors:   
 
 
Moreover, we could obtain a list of human diseases, whose gene content is anno-
tated by GeneGo, that are related to differentially expressed genes upon Bmi1 
over-expression in neurospheres. Disease folders are organized into a hierarchical 
tree. Gene content may vary greatly between such complex diseases as cancers 
and some Mendelian diseases. Also, coverage of different diseases in literature is 
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skewed. These two factors may affect p-value prioritization for diseases. The list 
diseases associated with our differentially expressed genes is shown in Figure 3.46. 
 
 
 
 
 
 
 
 
 
Fig 3.46 GeneGo Diseases (by Biomarkers). Sorting is done for the 
'Statistically significant Diseases' set. 
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3.4 Assessment of tumourigenicity of NSPC overexpressing Bmi1 in vivo. 
Background 
A central issue in cancer biology is to understand the molecular mechanisms of 
tumour formation and whether “normal stem cells” can be involved in the patho-
genesis of tumours. Particularly in the context of the adult brain, where the major-
ity of cells are terminally differentiated and post-mitotic, stem cells are an attrac-
tive cell of origin for brain tumours.  
Over the past 80 years, brain tumours were thought to originate from the cell 
types of the adult brain that they resembled most as assessed by comparison of 
histological features: for example,; astrocytomas were thought to arise from astro-
cytes; oligodendrogliomas from oligodendrocytes; ependymoma from ependymal 
cells (Louis et al., 2001, Louis, 2006). However, this concept is being increasingly 
challenged and the role of NSPC in brain tumour development is currently being 
investigated.  
Moreover, cells with stem cell properties have been isolated from paediatric and 
adult human brain tumours. These cells, so called “brain tumour stem cells” 
(BTSC), were shown to express stem cell markers Musashi-1, Sox2, nestin, MELK 
and CD133 (Hemmati et al., 2003, Galli et al., 2004, Singh et al., 2004b, Jackson et 
al., 2006), to have self-renewal capacity  (as assessed by neurosphere formation, in 
vitro) and to differentiate into cells that express glial and neuronal markers 
(Ignatova et al., 2002). Moreover, these cells were found to be tumourigenic; in 
fact they gave rise to tumours when injected into immunodeficient mice and re-
tained their tumour phenotype upon serial transplantation (Singh et al., 2004b).  
186 
 
This concept is intriguing and might imply that signalling pathways involved in the 
regulation of the balance between self-renewal and differentiation of adult NSPC 
could contribute as well to tumour initiation. Indeed, Jackson et al., has shown 
that deregulation of proliferation in B-type neural stem cells of the SVZ by stimu-
lating them through activation of their PDGFRα results in formation of hyperplasia 
resembling oligodendrogliomas (Jackson et al., 2006). Moreover, combination of 
deletions or mutations of tumour suppressor genes (Nf1, Pten and p53) in GFAP 
positive NSPC/astrocytes or nestin expressing NSPC in vivo resulted in formation of 
brain tumours. For example, GFAP promoter dependent Cre activation mediates 
somatic inactivation of Nf1 and p53 results in formation of malignant astrocytomas 
in a mouse model (Zhu et al., 2005). Additional haploinsufficiency of PTEN acceler-
ates formation of astrocytomas in this mouse model (Kwon et al., 2008). GFAP-Cre 
mediated inactivation of p53 and PTEN also led to malignant astrocytomas (Zheng 
et al., 2008). These studies cannot determine whether tumours arose from NSPC 
as GFAP is also expressed by white matter astrocytes. Interestingly, targeting inac-
tivation of Nf1, p53 or Nf1, p53 and PTEN in adult NSPC by means of nestin driven 
Cre expression results in formation of malignant gliomas (Alcantara Llaguno et al., 
2009), suggesting that cell of origin determines the phenotype of the tumours.  
Bmi1 and brain tumour stem cells 
Elevated Bmi1 expression has been shown to induce tumourigenesis in the haema-
topoietic system in transgenic mice (Alkema et al., 1997a). Increased expression of 
BMI1 has been demonstrated in humans, not only in haematological malignancies, 
such as high grade lymphomas (Bea et al., 2001), but also in neural tumours, e.g. 
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medulloblastomas and neuroblastomas (Leung et al., 2004, Cui et al., 2007). A 
study based on orthotopic transplantation model of glioma showed that Bmi1 
regulates development and phenotype of low-grade diffuse astrocytomas inde-
pendently of Ink4a/Arf tumour locus (Bruggeman et al., 2007). Moreover, neuro-
spheres derived from human tumours showed high levels of BMI1 expression both 
during proliferative stem cell state and upon differentiation (Hemmati et al., 
2003).  
Recent studies have shown that BTSC express high levels of Bmi1 (Abdouh et al., 
2009), are particularly resistant to apoptosis (Bao et al., 2006, Ghods et al., 2007) 
and express A2B5 (Rebetz et al., 2008). Similarly, in my studies, I found that Bmi1 
over-expression in postnatal NSPC leads to increased proliferation and self-
renewal, confers resilience to apoptosis to progenitors originating from these 
NSPC and increases the number of A2B5 positive cells in these neurospheres.  
It was therefore interesting to assess whether Bmi1 over-expression in NSPC 
would lead to glioma formation in vivo. 
We set out to investigate i) whether subcutaneous injection of tertiary neuro-
spheres, derived from Bmi-1 over-expressing NSPC would give rise to tumours ii) 
whether over-expression of Bmi1 specifically in nestin positive SVZ NSPC would 
initiate glioma formation (NestinCre;STOPFloxBmi1 mice), iii) whether postnatal 
activation of Bmi-1 over-expression in SVZ NSPC would result in brain tumours (in-
tra-ventricular injection of Adeno-Cre virus in STOPFloxBmi1 mice).  
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3.4.1 No tumours upon subcutaneous injection of neurospheres overexpressing 
Bmi1 in NOD-SCID mice  
Tertiary NS were dissociated and NSPC were infected with Adeno-Cre virus, as pre-
viously described. They were then cultured for 5 DIV until moderate size neuro-
spheres (100-120µm) formed. NS were pulled, respuspended in matrigel, which is 
a viscous substrate that provides nutritious environment for neurospheres and 
contribute to avoid their dispersion upon injection (BD Biosciences) and injected 
subcutaneously in both flanks of five of 2 months old NOD-SCID mice.  
The mice were kept under observation for 6 months, and all sites of injection were 
analysed at the time the experiment was terminated. No tumours or tumour like 
lesions were found (Table 3.3). 
3.4.2 Overexpression of Bmi1 in Nestin positive NSPC does not induce brain tu-
mour formation.  
In order to generate compound mice (NestinCre;STOPFloxBmi1) overexpressing 
Bmi1 in nestin positive NSPC, crossings between NestinCre male (Dubois et al., 
2006) and STOPFloxBmi1 females were set up. Note that only paternally inherited 
NestinCre allele ensures strong loxp recombination in neural tissues including 
NSPC (Dubois et al., 2006).   
A cohort of 17 compound mice was aged for up to 8 months. Of these 5 were sacri-
ficed at age 6 months to check for possible abnormal growth or hyperplastic le-
sions. The remaining 11 mice were kept until 8 months and then sacrificed for fur-
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ther analysis. Neither gross examinations nor histochemical analysis revealed any 
tumour like lesion in the brains of these mice (Table 3.3).  
We concluded that prolonged over-expression of Bmi1 in nestin expressing SVZ 
NSPC does not induce brain tumour formation.  
3.4.3 Bmi1 over-expression in SVZ of STOPFLOXBmi1 mice by adenovirus medi-
ated Cre activation does not trigger tumour formation 
We observed a dual effect of Bmi1 over-expression on apoptosis in NS, depending 
on whether the cultures were obtained from embryonic or postnatal cells with 
postnatal NS showing a lower apoptotic rate as measured by Annexin V positivity, 
suggesting a resistance to apoptosis. Therefore, we reasoned that activation of 
Bmi1 over-expression postnatally could be more likely to elicit tumour formation. 
We set out to test whether intraventricular injection of Adeno-CRE would effi-
ciently target SVZ NSPC. RosaLac-Z reporter mice (R26R) were used to test effi-
ciency and spread of Adeno-Cre mediated recombination of loxP sites in NSPC lin-
ing the lateral walls of lateral ventricles in vivo. Two months old R26R were intra-
ventricularly injected with different amounts of 109 plaque-forming units Adeno-
Cre virus, or with equal volume of PBS as control, to determine amount of virus 
needed to achieve optimal recombination at the site of interest. Mice were culled 
5 days post-injection and brains were processed for X-gal staining. Whole mount X-
gal staining reveals that recombination had occurred in the medial, lateral and 
dorsolateral walls of the lateral ventricles, where NSPC reside (Figure 3.47). We 
found that 5 µl of 109 plaque-forming units Adeno-Cre virus was sufficient to pro-
duce recombination of Lox-P sites at the lateral ventricles (Figure 3.47). Similar 
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analysis was performed by Jacques et al., (2010), where they used Adeno-GFP virus 
to identify the type of cells infected in the lateral ventricles; and their report shows 
that the nestin and GFAP positive lateral ventricular cells are targeted by this virus.  
 
 
Next, a cohort of 15 STOPFLOXBmi1 mice was injected intraventricularly with 5 µl 
Adeno-Cre and kept under observation for 20 months. All brains were analysed 
histologically at the termination of the experiment, no brain tumours were ob-
served (Table 3.3). 
 
 
Fig 3.47 X-gal staining on coronal section of ROSA26Lox mouse 5 
days after intra-ventricular infection with Adeno-Cre virus: Re-
combined cells seen as blue are confined to thin periventricular 
region where NSPC reside.  
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3.4.4 Induction of low grade astrocytoma in compound mutant mice over-
expressing Bmi1 and lacking p53 in SVZ NSPC in vivo 
Next, we set out to determine whether inactivation of key tumour suppressor 
genes such as PTEN (Marino et al., 2002) and P53 (Marino et al., 2000) in addition 
to over-expression of Bmi1 in SVZ NSPC would give rise to gliomas. We have cho-
sen to target these tumour suppressor genes -PTEN and p53- as they are fre-
quently altered in brain tumours of glial origin (Collins, 2002).    
While mice lacking PTENLoxP/LoxP and p53LoxP/LoxP in NSPC do not develop brain tu-
mours, previous reports have shown that GFAP-Cre-mediated conditional inactiva-
tion of these tumour suppressor genes in NSPC of SVZ results in formation of glio-
mas (Zheng et al., 2008, Jacques et al., 2009). 
To assess whether Bmi1 overexpression would induce glioma formation in combi-
nation with other genetic mutations known to play a role in glioma pathogenesis in 
mice and human, compound mice were generated where Bmi1 overexpression 
was induced while either p53 or PTEN were deleted. To this end crossings were set 
up between PTENLoxP/LoxP and STOPFloxBmi1 and between p53LoxP/LoxP and STOP-
FloxBmi1. Intermediate genotypes were further intercrossed to generate PTEN-
Floxhom;STOPFloxBmi1 and p53Floxhom;STOPFloxBmi1.  
Two recent studies have shown that concomitant deletion of PTEN and p53 tu-
mour suppressor genes in CNS specific NSCP results in the formation of gliomas 
(Zheng et al., 2008, Jacques et al., 2009). Here PTENFloxhom;p53Floxhom mice 
were also generated for use as positive control for the procedure. Adult mice were 
injected intra-ventricularly with Adeno-Cre to induce recombination of LoxP sites 
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leading to inactivation of PTEN, p53 and activation of Bmi1 in NSPC of the SVZ of 
adult mice, as previously described.  
A cohort of 21 compound (PTENFloxhom;STOPFLOXBmi1) and 22 control (PTEN-
Floxhom) mice was generated and injected intraventricularly with Adeno-Cre to 
test the tumourigenecity of Bmi1 over-expression in combination with deletion of 
PTEN in NSPC lining the SVZ (Table 3.3). A cohort of 28 compound (P53Floxhom; 
STOPFLOXBmi1) and 21 control (P53Floxhom) mice was treated as above to test 
the tumourigenecity of Bmi1 over-expression in combination of deletion of p53 in 
NSPC lining the SVZ (Table 3.3).   
A cohort of 12 PTENFloxhom;p53Floxhom compound mice was also injected intra-
ventricularly with Adeno-Cre virus as positive controls (see Table 3.3).  
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Table 3.3 
Genotype/treatment Age 
(months) 
Brains 
analyzed 
CNS 
tumours 
 
 
NOD-SCID (injection of NS) 
 
1-12 
 
17-24 
5 
 
0 
0 
 
0 
 
NestinCre;STOPFloxBmi1 
1-12 
 
17-24 
5 
 
16 
0 
 
0 
 
STOPFloxBmi1 (Adeno-Cre) 
1-12 
 
17-24 
11 
 
6 
0 
 
0 
 
PTENFloxhom;STOPFLOXBmi1 
(Adeno-Cre) 
1-12 
 
17-24 
5 
 
16 
0 
 
ongoing 
 
p53Floxhom;STOPFLOXBmi1 
(Adeno-Cre) 
1-12 
 
17-24 
5 
 
23 
2 
 
ongoing 
 
PTENp53RosaLacZFloxhom 
(Adeno-Cre) 
1-12 
 
17-24 
To be ana-
lysed 
 
0 
To be ana-
lysed 
0 
 
 
 
 
 
 
Table 3.3 A summary of all in vivo studies to test the role of Bmi1 in tumorigene-
sis. The column entitled Genotype/treatment indicated the mouse models (com-
pound conditional/transgenic) used, whereas the Age (months) indicates two 
categories of time points when the brains were examined. Note that activation of 
Bmi1 over-expression is initiated by intraventricular injection of Adeno-Cre virus. 
And that Bmi1 over-expression combined with deletion of p53 results in brain 
tumour formation. 
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These mice are on tumour watch since summer 2009. Interestingly, one brain tu-
mour with histological features of a low grade glial tumour has developed in a 
p53Floxhom; STOPFLOXBmi1 nine months after Adeno-Cre injection (Figure 3.48). 
The neoplasm showed increased cellularity, mild nuclear atypia, fibrillary cyto-
plasm and infiltrative growth pattern. Immunostaining for GFAP confirmed the 
glial nature of this tumour (data not shown). 
Although these are early days to draw any conclusion from these experiments - 
indeed we plan to continue the tumour watch for at least 6-8 months- it is possible 
to speculate that a p53 deficient background may provide a permissive environ-
ment for overexpression of Bmi1 to induce glioma formation in the mouse. 
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Chapter 4- General Discussion 
4.1 Evaluation of the effects of Bmi1 over-expression on biological properties of 
NSPC using a conditional transgenic mouse model 
This study set out to study the role of Bmi1 in NSPC, using a Cre/loxP conditional 
transgenic mouse model where Bmi1 is conditionally over-expressed, in order to 
identify i) functional changes in biological properties of NSPC and ii) changes in 
NSPC gene expression profile which may hint at novel genes and pathways regu-
lated by Bmi1 in these cells as well as iii)  whether Bmi1 over-expression in NSPC is 
sufficient to initiate brain tumour formation.      
To achieve in vitro activation of the transgene Adeno-CRE virus infection was used 
whereas for in vivo activation either intraventicular injection of Adeno-Cre or com-
pound STOPFloxBmi1 and Nestin-Cre mice were used. My experiments have 
shown that approximately 2 fold over-expression of Bmi1 is achievable in both 
embryonic and postnatal NSPC after activation of the transgene.  
4.1.1 Proliferation and Self-renewal 
Previously it has been shown that disruption of Bmi1 expression in mice leads to 
posterior transformation, neurological abnormalities and severe proliferative de-
fects in lymphoid cells (van der Lugt et al., 1994) whereas Bmi1 over-expression 
induces lymphomas (Alkema et al., 1997b). In the postnatal brain, Bmi1 is required 
for proliferation and self-renewal of SVZ NSC and cerebellar granule cell progeni-
tors (Molofsky et al., 2003, Leung et al., 2004). To study the role of Bmi1 over-
expression on the biological properties of SVZ NSPC in vitro and in vivo, the Marino 
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laboratory had generated a conditional transgenic mouse model to activate Bmi1 
expression in a cell specific and time controlled fashion by means of Cre-mediated 
recombination of LoxP sites. I took advantage of this system to study the effects of 
Bmi1 over-expression in NSPC at different developmental time points, and by 
means of acute and chronic/protracted activation of the transgene by Adeno-Cre 
infection in vitro or by crossing with NestinCre mice in vivo respectively.  Initially, I 
looked at the impact of increased Bmi1 expression on the proliferation and self-
renewal capacity of NSPC in vitro using Alamar Blue and EdU based assays for pro-
liferation and serial dilution and long-term passaging for self-renewal. Over-
expression of Bmi1 in embryonic NSPC leads to increased self renewal and prolif-
eration in vitro. These effects are independent of whether a protracted activation 
of Bmi1 expression was induced in vivo by means of nestin driven Cre expression 
or whether acute induction of Bmi1 expression was achieved in vitro by adenoviral 
mediated Cre delivery. These findings are well in keeping with independent in vivo 
studies, performed by a postdoc in the lab, in which the number of proliferating 
RG cells were shown to be increased upon overexpression of Bmi1 (pH3 and RC2 
immuno-labelling on E12.5 and E16.5 embryos). Similarly, activation of Bmi1 ex-
pression in postnatal NSPC leads to increased proliferation (as assessed by Alamar 
Blue assay) and self-renewal (as assessed by serial dilution and long-term passag-
ing). Interestingly, the cell density did not alter the effects of Bmi1 over-expression 
on NSPC self-renewal, raising the possibility that cell intrinsic changes are playing a 
crucial role in this context. 
These data support and extend a recent report where lentiviral mediated over-
expression of Bmi1 by intraventricular injection at E14 led to similar results, al-
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though the in vivo observation in this study was limited to 3 days after injection 
(Fasano et al., 2009). On the contrary, over-expression of Bmi1 in nestin positive 
progenitor cells did not elicit a similar effect in vivo, albeit inducing increased self 
renewal in vitro (He et al., 2009). Although it is currently unclear why this is the 
case, it is conceivable that different levels of Bmi1 expression may elicit different 
effects on self renewal/proliferation of embryonic NSPC.  
4.1.2 Apoptosis 
Next, I analysed the effects of Bmi1 over-expression on apoptotic death of cells 
contained within neurospheres. I found that the percentage of Annexin V positive 
cells was higher in neurospheres derived from Bmi1 over-expressing embryonic 
NSPC. In keeping with my in vitro data, experiments performed by a colleague in 
the lab have shown that Bmi1 over-expression in vivo during embryonic cortical 
development results in apoptosis of intermediate neuronal committed progeni-
tors, a phenomenon that could account for the reduced brain size of adult double 
mutant mice. However, NSC located in the VZ of the developing neocortex did not 
undergo apoptosis despite higher levels of Bmi1 expression. In keeping with these 
findings, no increased apoptosis was found in NSC cultured as a homogeneous 
monolayer under adherent conditions. These data show that the in vitro assays 
used are faithfully reproducing the phenotype observed in vivo and they are there-
fore a useful tool to gain further understyanding on the cellular and molecular 
mechanisms underlying the role of Bmi1 overexpression in NSPC. 
Interestingly, the apoptotic rate of cells contained in neurospheres arising from 
NSPC isolated from postnatal SVZ was lower than in control. These data allow us to 
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conclude that while the role of Bmi1 in self renewal and proliferation of NSPC is 
independent of the developmental timepoint analysed, its role in induction of 
apoptosis is dual and developmental timepoint-related. 
The study by Chatoo W. et al., (2009) has shown that Bmi1 expression is required 
for regulation of antioxidant defences, in neurons, through repression of p53 de-
pendent pro-oxidant activity (Chatoo et al., 2009). Although a recent study has 
shown that lack of Bmi1 is associated with impaired mitochondrial function evi-
dent from increased intracellular levels of reactive oxygen species (ROS) and acti-
vation of DNA damage response pathway in HSC (Liu et al., 2009), no previous 
study to date has linked Bmi1 over-expression with regulation of apoptosis in fore-
brain NSPC.  
4.1.3 Evaluation of changes in neurosphere composition upon Bmi1 over-
expression 
Neurospheres arise from clonal expansion of NSPC under conditions that favour 
proliferation and self-renewal of these cells. They are widely used to study self-
renewal and multipotency of NSPC in vitro. Moreover, neurospheres have been 
studied as a possible source of new cells for therapies of human nervous system 
diseases such as multiple sclerosis, Parkinson’s and spinal cord lesions (Pluchino et 
al., 2003). Recently, the value of this culture system in drug testing on spheres de-
rived from individual glioblastoma cells has also been tested (Gal et al., 2007).   
To gain insight into the cellular composition of neurospheres derived from NSPC 
over-expressing Bmi1, I used both flow cytometry for quantification and immuno-
histochemistry for localisation of specific cellular markers.  
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Interestingly, we found that tertiary neurospheres derived from Bmi1 over-
expressing NSPC contain higher percentage of cells that are double positive for 
NG2 and A2B5. Cells expressing NG2+ and A2B5+ in neurospheres have previously 
been shown to be self-renewing and multipotent (Dromard et al., 2008). These 
data may therefore support our previous observation that over-expression of Bmi-
1 in NSPC results in expansion of the pool of self-renewing and NS-forming cells in 
vitro. However, as it is at present unclear how NG2 and A2B5 positive cells relate 
to Nestin, Sox2, Musashi positive cells, it is also conceivable that over-expression 
of Bmi1 skews the identity of cells contained within neurospheres toward a glial 
fate, indeed we also found more cells that are positive for GFAP and A2B5, GFAP 
and NG2. This conclusion is in keeping with data obtained by a colleague in the lab. 
She has shown that the number of neuronal committed progenitors arising within 
neurospheres over-expressing Bmi1 is lower, therefore supporting the notion that 
Bmi1 influences fate specification at least in vitro. 
4.1.4 Differentiation 
In mammals, symmetric cell divisions are thought to maintain the size of the NSC 
pool at any given time (Potten and Loeffler, 1990). In contrast, NSC may undergo 
asymmetric divisions to maintain the balance between self renewal and  differen-
tiation (Reya et al., 2001). Our data show that overexpression of Bmi1 increases 
the pool of NSC both in vivo and in vitro and that this is linked to an increased pro-
liferation of these cells.  
A previous study showed that lack of Bmi1 leads to increased population of astro-
glial cells capable of proliferation, and Bmi1 deficient mice have more astrocytes at 
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birth (Zencak et al., 2005). The same study has shown that Bmi1 is expressed in the 
germinal zones in vivo and in NSPC in vitro, but not in differentiated cells, suggest-
ing that down-regulation of Bmi1 is necessary for differentiation of NSPC (Zencak 
et al., 2005). However, no previous report has associated Bmi1 over-expression 
with NSPC differentiation. Moreover, our own data obtained with the analysis of 
neurospheres composition had hinted at a potential role of Bmi1 in fate specifica-
tion.  
To evaluate the effects of Bmi1 over-expression on differentiation of E16.5 NSPC, I 
cultured several neurospheres on laminin coated coverslips for 5DIV and 9DIV. 
Upon induction of differentiation at 5DIV, a significant reduction of βIII-tubulin 
positive neurons was noted in Bmi1 overexpressing cultures, although the per-
centage of GFAP+ astrocytes and O4+ oligodendrocytes were similar to control. 
This suggests that neuronal fate specification is linked to attenuation of Bmi1 ex-
pression. The increased number of Musashi positive cells noted in differentiating 
NSPC over-expressing Bmi1 at DIV5 gives additional support to this interpretation. 
Musashi promotes self-renewal and maintenance of NSC through transcriptional 
inhibition of p21WAF1/Cip1 and it is downregulated during neuronal differentiation 
(Okano et al., 2005, Battelli et al., 2006).  
4.2  Bmi1 acts through different downstream targets depending on the de-
velopmental time point  
Previous findings (He et al., 2009) showed that upregulation of Bmi1 expression 
led to reduced expression of p16Ink4a and p19Arf in a developmental stage-
independent fashion. Indeed we also observe this effect both in embryonic and 
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postnatal NSPC. Importantly, downregulation of the expression of these genes was 
observed both when Bmi1 activation was achieved during in a chronic/protracted 
way by means of nestin-driven Cre expression and acutely in vitro by adenoviral 
mediated Cre delivery. Downregulation of p21 WAF1/Cip1 expression was also ob-
served at all time points analysed and both upon chronic and acute overexpression 
of Bmi1. Whilst we could confirm upregulation of Foxg1 in embryonic NSC/NPC 
upon activation of Bmi1, as recently reported by Fasano et al., (2009), we could 
not detect a similar upregulation at both postnatal timepoints analysed (Fasano et 
al., 2009). We cannot exclude that this might reflect a dosage effect. Our single 
copy gene approach allows us to obtain a tightly controlled 1.8 fold increase of 
Bmi1 expression compared with a potentially greater upregulation (approximately 
8 fold) obtained using a lentiviral transduction approach of Fasano et al. (Fasano et 
al., 2009). This observation may be interesting to explore further, due to the dif-
ferences in the level of expression between our model and that of Fasano’, as it 
suggest that Bmi1 may act in a “concentration dependent manner”. However, it is 
also conceivable that downregulation of p21 WAF1/Cip1, either directly through Bmi1 
or indirectly in the context of p19Arf downregulation, contributes to self re-
newal/proliferation control of postnatal NSPC independently of Foxg1 upregula-
tion. 
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4.3 Microarray based analysis of gene expression of Bmi1 over-expressing 
neurospheres reveal novel targets involved in stem cell function regula-
tion 
Bmi1 is known to control biological properties of NSPC partly by transcriptional 
repression of the ink4a locus (Jacobs et al., 1999a), and downregulation of p21 
WAF1/Cip1 during embryonic development (Fasano et al., 2007), or in association with 
Foxg1 upregulation (Fasano et al., 2009).  
However, concomitant deletion/suppression of either p16Ink4a or p19ARF or or both 
did not completely rescue the proliferation and self-renewal defects of NSPC de-
rived from Bmi1-/- mice (Molofsky et al., 2003, Bruggeman et al., 2005). Other 
NSPC functions, such as migration, have also been shown to be controlled by Bmi1 
in an ink4a independent manner (Bruggeman et al., 2009). Our experiments have 
shown that the developmental stage of NSPC influence the effect of Bmi1 overex-
pression on some of their properties such as for example on their susceptibility to 
apoptotic death. However, downregulation of the “canonical” downstream targets 
of Bmi1 has been seen at all developmental timepoints. It is therefore likely that 
additional unknown target genes of Bmi1 exist. Full transcriptome screening by 
means of Illumina BeadChip arrays was performed to try and identify novel genes 
and pathways, which may be deregulated upon over-expression of Bmi1.   
From a list of 700 significantly differentially expressed genes in experimental sam-
ples, we have chosen to independently verify and further study a selection of 
genes that are most relevant to the biological changes observed in NSPC upon 
Bmi1 over-expression. As Bmi1 is a transcriptional repressor, we focused in first 
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instance on genes that showed reduced expression. We have chosen transcription 
factors (Dlx2, Dbx2, and Irx2) and other genes (Ng2, Ncan, Ncam and Bcan) known 
to play a role in regulation of neurogenesis and differentiation, as well as cell ad-
hesion molecules (Col9a1, Col1a1, Col4a1 and Col4a2). We reasoned that these 
genes would be the most appropriate for further studies as our functional studies 
on Bmi1 over-expressing neurospheres have shown that differentiation is delayed, 
proliferation and self-renewal are increased, and migration is impaired (the latter 
data has not been described as it was performed by a colleague).  
We show, using quantitative RT-PCR, that increased expression of Bmi1 results in 
downregulation of the expression of several members of the collagen family cell 
adhesion molecules such as Collagen Ia1, IVa1 and IVa2 and IXa1, as well as cell 
adhesion molecules Ncan and Bcan, whereas NG2 and Ncam were upregulated. 
Note that reduced expression of members of the Collagen IV family and changes in 
expression of cell adhesion molecules may have functional consequences on mi-
gration of NSPC as Bmi1 has been previously shown to be regulating this process in 
vitro by Bruggeman et al., (2009). Therefore, it is also conceivable that Bmi1 regu-
lates migration of NSPC through modulation of cell adhesion (Bruggeman et al., 
2009), through suppressing the expression of Collagens I, IV and IX in these cul-
tures. 
Moreover, upregulation of NG2 in Bmi1 over-expressing neurospheres may ac-
count for the increased number of intermediate glial progenitors identified upon 
induction of differentiation. Reduced expression of Dlx2 in Bmi1 over-expressing 
neurospheres is in keeping with previous immunohistochemistry studies. More-
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over, Bmi1 over-expressing neurospheres have significantly lower expression of a 
series of transcription factors - Dbx2,Neurogenin2, Irx2 (and Dlx2)- all of which play 
an important role in neuronal fate commitment (Ahn et al., 2004; Lacin et al., 
2009; Roybon et al., 2009). Dlx2 in particular is known to regulate the balance be-
tween neurogenesis and oligodendrogenesis in the developing forebrain 
(Petryniak et al., 2007). We can therefore speculate that a Bmi1- mediated down-
regulation of Dlx2 may explain the delayed neuronal differentiation and increased 
number of oligodendroglial progenitors observed in Bmi1 overexpressing cultures.  
Next, I set out to determine whether similar changes in gene expression were also 
induced in the postnatal NSPC upon activation of Bmi1 over-expression. Similar 
QPCR assays were performed for cDNA obtained from postanatal NS for the most 
differentially expressed genes identified at embryonic time point:  Col4a1, Col4a2, 
Ng2, Ncan, Bcan, Ncam, Dlx-2, Foxg1 and Irx-2. To our surprise only Col4a1 was 
siginificantly differentially expressed by Bmi1 over-expressing postnatal NSPC. It is 
therefore possible to speculate that these differences observed in the expression 
profile of these genes may be involved in the differential role Bmi1 plays in the 
embryonic and postnatal NSPC context.    
We were able to draw a list of pathways, network processes and disease that are 
associated with differentially expressed genes, using multifunctional MetaCore 
software. As the manually curated Metacore software relies on the accuracy of the 
differentially expressed genes in building pathways and networks that could be 
related to a biological phenomenon, independent confirmation of most signifi-
cantly differentially expressed genes gains importance. For most cases the results 
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from RT-PCR studies were compatible with array findings. However, in the case of 
Ncam, we found a discrepancy between what the array data (1.3 fold up-
regulation in the Bmi1 over-expressing cells) and RT-PCR results (1.5 fold down-
regulation). Note that the discrepancy is not confined to the magnitute of Ncam 
expression (which would have been a quantitative difference due to statistical pa-
rameters or power of detection etc.) but to a qualitative shift from induction to 
repression, which could lead to false interpretation of biological processes. Of 
course, the discrepant result could be due to sequences used for amplification of 
the gene of interest or simply be a false readout. Hence the importance of using 
quantitative RT-PCR that is sensitive and linear in gene expression measurement 
validation.  
Moreover, it is worth mentioning that the interpretation of the data obtained with 
Metacore analysis warrant some caution and independent validation of the most 
significantly deregulated pathways and network would be needed. In fact while 
KEGG pathway analysis, which uses a similar software platform, revealed that sev-
eral components of MAPK pathway were altered upon Bmi1 over-expression, 
these findings could not be confirmed with assay aiming at assessing pathway ac-
tivity. Indeed, when we performed Western Blotting to confirm that MAPK path-
way was altered at the level of protein phosphorylation, we were surprised to find 
out that the phosphorylation of both MAPK and of its specific components such as 
p38, c-Jun or JNK was unaltered. Although we cannot exclude that this may be due 
to protein turn over, it is also well known that differences at the RNA lavel may not 
translate into functional difference of the pathway.  
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4.4 Brain tumours and Bmi1 over-expression 
Cells with stem cell properties, so called brain tumour stem cells (BTSC), are 
thought to play a crucial role in initiation and maintenance of brain tumours (re-
viewed in (Stiles and Rowitch, 2008). These cells express high levels of Bmi1 
(Abdouh et al., 2009), are particularly resistant to apoptosis (Bao et al., 2006, 
Ghods et al., 2007) and have recently been shown to be A2B5 positive (Rebetz et 
al., 2008).  
Overexpression of Bmi1 in postnatal SVZ NSC/NPC in vitro led to increased self re-
newal capacity of both embryonic and postnatal NSC/NPC. However, resilience to 
apoptosis was noted in NS originating from postnatal NSC/NPC overexpressing 
Bmi1. Moreover, we observed increased number of A2B5 positive undifferenti-
ated, glial progenitor cells, in these NS. It was therefore interesting to assess 
whether Bmi1 overexpression in NSC/NPC in vivo led to tumour formation. We 
show that both embryonic and postnatal activation of Bmi1 overexpression in 
stem cells did not lead to brain tumour formation in mice kept under observation 
for up to 20 months. This is in agreement with the study of He et al., (2009) where 
tumours were not seen when Bmi1 overexpression was induced in nestin positive 
progenitor cells. Fasano et al., (2009), however, reports that overexpression of 
Bmi1 by means of intraventricular lentiviral injections led to tumour formation in 
the first week after birth, although no further details were given on the type of 
tumour these mice developed. More studies are clearly needed to elucidate these 
differences. It is important to mention that He et al. (2009) and potentially also 
Fasano et al. (2009) achieved higher expression levels of Bmi1 in their systems as 
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compared with our single copy gene approach. Moreover, the genetic background 
of the mice used in the experiments might account for some of these apparently 
contradictory results. It is noteworthy that both our study and the one of He were 
carried out in C57Bl6 genetic background while Fasano et al. used Swiss Webster 
mice for their experiments.  
Finally, I set out to test whether Bmi1 over-expression in SVZ NSPC concomitantly 
with deletion of PTEN or p53 would be sufficient to induce tumourigenesis. PTEN 
and P53 are the most frequently mutated/deleted tumour-suppressor genes in 
human cancers. Combination of genetic mutations rather than single dele-
tions/mutations provides a more favourable environment for de novo formation of 
tumours. It is well established that induction of haploinsufficiency of PTEN in 
Nf1/p53 astrocytoma mouse model accelerates formation of grade III astrocy-
tomas, whereas deletion of PTEN with activation of Akt pathway leads to grade IV 
tumours (Kwon et al., 2008). Moreover, activation of Ras pathway in p53-deficient 
astrocytes renders them more prone to transformation into self-renewing, multi-
potent cells that are positive for nestin and CD133 (Lee et al., 2008). Deletion of 
p53 and PTEN in GFAP positive SVZ NSC leads to formation of high grade gliomas 
(Jacques et al., 2009).   
A colony of 40 mice for each conditional transgenic genotype (STOPFloxBmi1; 
p53lox/lox or STOPFloxBmi1; Ptenlox/lox) was activated by intraventricular injection of 
A-Cre virus. Intraventricular injection of virus ensures activation of Bmi1 expres-
sion and deletion of homozygous floxed alleles of Pten or p53 in a thin layer of 
periventricular cells. The experiment is still ongoing and it is premature to draw 
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any conclusion at the present time, however it is encouraging that a low grade as-
trocytoma was seen in one STOPFloxBmi1; p53lox/lox mouse.  
In conclusion we show that fine tuning of the expression level of the PcG gene 
Bmi1 is a viable tool to increase self renewal capacity of both embryonic and post-
natal NSC/NPC in the mouse and this approach does not impair the long term dif-
ferentiation capacity of these cells. However, sustained over-expression of Bmi1 in 
differentiating progenitor cells leads to increased apoptosis and delayed neuronal 
differentiation. Upregulation of Bmi1 expression during embryonic development 
and in the postnatal SVZ does not lead to neoplastic transformation of these cells. 
However, Bmi1 over-expression in combination with p53 deletion in periventricu-
lar cells of adult mice results in formation of low grade gliomas. 
4.5 Statement regarding the hypotheses 
In this study I have showed that Bmi1 over-expression in NSC increases their pro-
liferation and self-renewal in vitro. Changes in these properties of NSC are associ-
ated with reduced expression of cell cycle inhibitors, namely p16Ink4a, p19ARF and 
p21WAF1/Cip1, which are previously shown to be targets of Bmi1. I showed that ex-
pression of the above mentioned cell cycle inhibitors are reduced upon Bmi1 over-
expression, at all developmental time points studied.   
I found that induction of Bmi1 over-expression in embryonic NSC (E16.5) increased 
their apoptosis in vitro—a diametrically opposite result to my hypothesis. This 
could possibly be due to changes in expression of anti-apoptotic genes such as sur-
vivin. Further studies are needed to elucidate this.  However, in the postnatal and 
adult NSC, Bmi1 over-expression confers resistance to apoptosis; a finding in line 
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with my hypothesis. Interestingly, taken together, these partially conflicting results 
suggest that Bmi1 regulates apoptosis in NSC through different genes and path-
ways at different developmental time points.   
Bmi1 over-expression alone is insufficient for transformation of NSC into tumour 
initiating cells. However, in combination with deletion of p53, Bmi1 over-
expression in NSPC is sufficient for intiation of low grade glioma in mice.  
Over-expression of Bmi1 in NSC leads to changes in expression of 700 genes some 
of which I have selected on the basis of possible significance in NSC functions and 
verified using RT-QPCR. These include transcription factors (Dlx2, Dbx2, and Irx2) 
and other genes (Ng2, Ncan, Ncam and Bcan) known to play a role in regulation of 
neurogenesis and differentiation, as well as cell adhesion molecules (Col9a1, 
Col1a1, Col4a1 and Col4a2). Further studies are needed to elucidate a direct and 
functional connection between Bmi1 and these targets.  
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Chapter 5—Future Studies 
In this thesis, I have shown that sustained over-expression of Bmi1 in neuros-
pheres delays neuronal differentiation at 5DIV, possibly by counteracting repres-
sion of Nestin and musashi-1 expression and/or by repressing proneural genes 
such as Dlx2. This effect was transient and at the later days of differentiation 
(9DIV), more neurons and oligodendrocytes developed. It was previously shown 
that absence of Bmi1 leads to depletion of postnatal NSC, highlighting Bmi1 as a 
transcription factor required for maintenance of stem cell in adult mice. However, 
it was not shown whether sustained over-expression of Bmi1 would counteract 
differentiation of NSPC, when placed in conditions promoting differentiation. 
These new lines of evidence, besides endowing Bmi1 with a strong role in differen-
tiation of NSPC, also deserved further direct studies to clarify the nature of possi-
ble interaction between Bmi1, Dlx2, nestin and Musashi-1. Co-
immunohistochemistry and co-immunoprecipitation assays could be used for ex-
ample to check for any direct interaction between Bmi1 and Dlx2.  
In this thesis, I have shown that Bmi1 over-expression has a different impact on 
apoptosis of NSPC contained within NS depending on the developmental stage. 
These results are in line with in vivo studies where a colleague in the lab has found 
that sustained Bmi1 over-expression in neuronal committed progenitor cells dur-
ing neocortical development induces their apoptotic death. Resistance to apopto-
sis in postnatal NSPC could be tested further by application of glutamate or other 
apoptosis inducing agents to cultures. Given that Bmi1 has been recently asso-
ciated with recruitment of DNA damage response machinery (Facchino et al., 
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2010) in both normal and cancerous neural stem cells positive for CD133, it would 
be interesting to investigate this feature further. Our conditional transgenic mouse 
would be a good model to test whether Bmi1 over-expression would confer 
greater resistance to apoptosis or other forms of cell death. A better understand-
ing of the mechanisms involved in Bmi1 mediated resistance to apoptosis would 
help designing more targeted treatments for cancer patients.  
Moreover, in my thesis I showed by gene expression analysis, and validation assays 
by RT-PCR, that Bmi1 over-expression induces significant changes to the expres-
sion of genes involved in a variety of cellular processes:  these genes included tran-
scription factors (Dlx2, Dbx2, and Irx2) and others (Ng2, Ncan, Ncam and Bcan) po-
tentially involved in regulation of neurogenesis and differentiation, as well as cell 
adhesion molecules (Col9a1, Col1a1, Col4a1 and Col4a2). In order to further char-
acterise the role of these genes in inducing the phenotype observed in my studies 
it would be interesting to reconstitute the expression of downregulated genes 
and/or knockdown the expression of upregulated genes by shRNA and study the 
functional consequences of this manipulation.  
Lastly, in this thesis I have provided preliminary data showning that Bmi1 over-
expression in SVZ NSPC in mice is not sufficient to induce tumourigenesis. How-
ever, in combination with p53 deficiency, Bmi1 over-expression is sufficient to 
produce low grade glioma. These are very preliminary data, the mice are still on 
tumour watch and we currently do not know whether the incidence of the tu-
mours will be high enough to justify further studies. However further characterisa-
tion of the morphological characteristics of these tumours, including marker ex-
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pression analysis as well as studies of early neoplastic lesions and cell of origin 
could be carried out to try and gain more insights into the collaboration Bmi1-p53 
in gliomas pathogenesis.   
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